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Abstract 
Multidrug resistance (MDR) efflux pumps and biofilm formation are two mechanisms 
by which bacteria can evade the action of many antimicrobials. MDR efflux pumps 
are able to confer low level multidrug resistance and have found to be 
over-expressed in MDR clinical isolates. Biofilms are three dimensional, complex, 
dynamic communities of bacteria encased in a self produced extra cellular matrix. 
Biofilms protect the bacteria that reside within them both physically by acting as a 
barrier to any external threats, and metabolically by containing high proportions of 
persister cells within the biofilm that are metabolically dormant resisting the action of 
bacteriostatic antimicrobials.  
This thesis explores the link between MDR efflux and biofilm formation in 
S. Typhimurium and shows that genetic inactivation of any one of the nine MDR 
efflux systems results in a biofilm defect. We found that the transcriptional repression 
of curli, an essential component of the Salmonella extracellular matrix, is the reason 
for the efflux mutants’ inability to form a biofilm.  
Specifically, the biofilm defect in a strain lacking a functional TolC (outer membrane 
porin) was able to be rescued by inactivation of a gene encoding a osmolarity sensor, 
envZ, suggesting that activation of a membrane stress response that mediates curli 
repression is the reason for the efflux mutant’s biofilm defect. 
Three compounds that are known to inhibit efflux were also found to impart curli 
repression and cause a subsequent biofilm defect in S. Typhimurium. This finding is 
of clinical relevance as biofilms are a major cause of infection and efflux inhibitors 
could be a potential novel future anti-biofilm compound.  
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CHAPTER ONE: 
INTRODUCTION
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1 Introduction 
1.1 Salmonella 
Theobald Smith first discovered and named Salmonella after isolation from pigs, 
although it was named after his supervisor, Daniel Elmer Salmon. It was first 
described in the literature in 1885 (Salmon 1885; Salmon 1886). Salmonella is a 
Gram negative rod shaped member of the Enterobacteriaceae family (Figure 1.1) 
and was discovered by Herbert Durham in 1898 that strains of Salmonella can be 
split into distinct groups using agglutination tests (Mochmann and Kohler 1989; 
Hardy 2004). Serotyping was used as a means to discriminate between different 
types or serovars of Salmonella for many years and helped study the epidemiology of 
Salmonella infections (Hardy 2004). The introduction of genomic analysis has 
revealed the Salmonella genus contains two distinct species; Salmonella enterica 
and Salmonella bongori. Salmonella enterica can be further categorised into six sub-
species; enterica, salamae, arizonae, diarizonae, houtenae and indica (Kauffmann 
1966; Crosa et al. 1973; Le Minor et al. 1982; Le Minor et al. 1982; Brenner et al. 
2000; Fookes et al. 2011) and contains over 2500 serovars including those 
pathogenic to man. These serovars are distinguished serologically by the 
combinations of somatic, flagella and capsular antigens present on the surface of the 
outer membrane (Mochmann and Kohler 1989; Tindall et al. 2005). The use of 
multilocus sequence typing (MLST) has recently been shown to be superior to 
serotyping for the analysis of Salmonella population structure as serological 
characteristics are not fixed and can change in isolation from the genome as a whole 
(Achtman et al. 2012).  
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Figure 1.1 Scanning electron microscopy image of Salmonella enterica serovar Typhimurium 
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Salmonella has many different natural reservoirs including the gastrointestinal tracts 
of many animals including chickens and other poultry (Gast et al. 2005), pigs (Boyen 
et al. 2008) and rodents (Valdezate et al. 2007), the skin of reptiles including lizards, 
snakes and turtles (Lamm et al. 1972; Pedersen et al. 2009) and amphibians 
including frogs (Anon 2010). 
1.1.1 Salmonella infections 
Salmonella infections have been amongst the major causes of food poisoning in the 
developing world for almost the whole of the 20th century but their importance has 
only been recognised in the last few decades (Hardy 2004). All infections caused by 
Salmonella are known as salmonellosis, of which there are two main types, non-
typhoidal and typhoidal (Valdezate et al. 2007). Figure 1.2 shows the number of 
cases of both non-typhoidal and typhoidal Salmonella in England and Wales reported 
during the last decade; 2000-2010 (http://www.hpa.org.uk).  
Non-typhoidal salmonellosis (NTS) is most commonly caused by the serovars 
Salmonella enterica serovar Enteritidis (hereafter S. Enteritidis) and Salmonella 
enterica serovar Typhimurium (hereafter S. Typhimurium) in human hosts. In 
England and Wales approximately 2444 and 1959 cases of S. Enteritidis and S. 
Typhimurium, respectively, were reported in 2010 making up nearly half of all 
reported NTS cases (http://www.hpa.org.uk). NTS is the second largest cause of 
bacterial gastroenteritis in the U.K., the first being Campylobacter (Lucey et al. 2000; 
Natrajan and Sheldon 2000; http://www.hpa.org.uk 2010).  
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Figure 1.2 Public Health England reports of Salmonella infections (both non-
typhoidal Salmonellosis and typhoidal Salmonellosis,, data shown by serovar) from 
the last decade, 2000 – 2010. (Latest figures as of July 2013)  
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Salmonella infections are frequently transmitted via contaminated poultry and eggs 
(Valdezate et al. 2007), however Salmonella is a commensal in many animals 
intestines and so can be transmitted via a variety of different meats (Hardy 2004). It 
is also thought to be contracted through vegetables or other products contaminated 
with manure (http://www.who.int 2010). Symptoms of NTS are mainly sickness, 
diarrhoea, (Valdezate et al. 2007) abdominal pain and fever and it is usually a self 
limiting condition (http://www.emedicine.com 2010). However, the infection can 
spread to the blood stream where intervention with antibiotics, such as ciprofloxacin 
or ceftriaxone is required (http://www.emedicine.com; Dutta et al. 1995; Lin et al. 
2003). Reported NTS infections have almost halved in England and Wales in the last 
decade (from 15,104 cases in 2000 to 8,564 in 2010) although a significant number 
of people still fall ill because of this organism (Figure 1.2). Enteric fever is caused by 
Salmonella enterica serovar Typhi (Typhoid fever) and Salmonella enterica serovar 
Paratyphi (Paratyphoid fever) (Crump and Mintz 2010). Infections with these serovars 
are contracted via the faecal-oral route and have no animal or environmental 
reservoirs; they are entirely adapted to humans (Mandell GL et al. 2005). Symptoms 
include profuse sweating, sickness and a rash of flat rose coloured spots (Mathura et 
al. 2003; Darby and Sheorey 2008). Enteric fever is a more severe disease than 
NTS, as the infection is likely to become systemic, prompt antibiotic intervention is 
required for a good prognosis. Approximately 30% of enteric fever cases are fatal 
when antibiotic treatment is not available, however upon prompt antibiotic treatment 
with fluoroquinolones such as ofloxacin or ciprofloxacin the prognosis for typhoid 
fever is good (Bhutta 2006; Crump and Mintz 2010; Effa et al. 2011). 
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Although enteric fever is a more severe disease than NTS, it is very uncommon in the 
U.K. and therefore doesn’t represent a great economic or health burden. However, 
NTS caused by S. Enteritidis and S. Typhimurium alone, in the U.K. is estimated to 
cost £6.5 million per annum, this figure includes medical costs and time lost from 
work either by the patient, parents or carer (Santos et al. 2010). 
1.1.2 Salmonella enterica serovar Typhimurium 
The particular serovar of Salmonella that is the focus of this project is Salmonella 
enterica serovar Typhimurium (S. Typhimurium). This serovar is of particular clinical 
relevance as it is not only a major cause of NTS but of the cases reported in the 
European Union almost half are multi-drug resistant which presents challenges if the 
infection needs to be treated with antibiotics (Meakins et al. 2008). Infections caused 
by quinolone resistant strains of S. Typhimurium have been shown to be three times 
more likely to become systemic, increasing the risk of fatality, when compared to 
infections with quinolone susceptible strains (Helms et al. 2004). 
1.2 Bacterial biofilms 
A bacterial biofilm can be defined as a community of bacteria adhered to a surface 
and each other by an extracellular matrix secreted by the bacterial cells (Stoodley et 
al. 2002). In the mid-twentieth century it was noted that marine bacteria preferred to 
survive in groups attached to surfaces (Zobell 1943), these bacterial structures would 
later become known as biofilms and up until 1987 biofilms were seen as simple 
“chunks” of randomly positioned bacteria within a matrix material (Costerton et al. 
1987). However with the development of new techniques which have allowed 
microbiologists to see how bacteria develop in three dimensions, it was discovered 
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that biofilms are not a stationary, inactive group of bacterial cells but in fact are a 
complex, diverse community of cells with an ordered and efficient three dimensional 
structure (Watnick and Kolter 2000; Branda et al. 2005). The advantages for bacteria 
of forming biofilms are many and include a number of adaptations which result from 
the ability of a community to behave in a way individual cells cannot (Branda et al. 
2005). Belonging to a biofilm community has one large benefit to an individual 
bacterium, protection from environmental stress. The manner in which biofilms form 
means that bacteria can be protected from the environmental conditions via an 
extracellular matrix that is secreted by the bacterial cells whilst receiving all of the 
nutrients needed to survive (Watnick and Kolter 2000; Branda et al. 2005). 
1.2.1 Composition of biofilms 
The specificity of biofilm development varies between species and under different 
conditions, there are however five distinct generalised stages (Figure 1.3). The initial 
stage of biofilm formation is where a motile planktonic cell initially colonises a 
surface, these cells attach to a surface via weak reversible bonds (Van der Waals 
forces of attraction). During this reversible attachment the bacteria start to 
demonstrate species-specific behaviours such as rolling, creeping, aggregate 
formation and windrow formation (Korber et al. 1997). The attached bacteria begin 
excreting an extracellular matrix and the initial reversible binding is superseded by 
much stronger, irreversible covalent bonds which prevent independent movement of 
cells (Pesci et al. 1999). Once the bacterial attachment is established they begin to 
form a microcolony by recruiting other bacteria from the surrounding environment 
and replicating. This rapidly growing bacterial community evolves into a fully three 
dimensional biofilm. 
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Figure 1.3 A schematic diagram showing the five different stages of biofilm formation (http://woundsinternational.wordpress.com/) 
1 – Initial Attachment; 2 – Irreversible Attachment; 3 – Maturation I; 4 – Maturation II; 5 – Dispersal  
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When the biofilm reaches maturity some cells are released and become planktonic to 
migrate to other locations suitable for colonisation (Watnick and Kolter 2000; Branda 
et al. 2005). There are many factors that contribute to an ideal biofilm environment, 
these include; the nature, type and shape of surface, the charge or lack of charge, 
hydrophobicity and hydrodynamics (Stoodley et al. 2002). There are also different 
features that determine the maturation of the biofilm, including, the physical 
environment, motility, growth rate, cell signalling ability and extracellular polymeric 
substance production. Again many of these are species specific (Stoodley et al. 
2002). As competent biofilm formation relies upon so many different factors it is not 
surprising that many diverse bacterial genes have been identified which contribute to 
the ability to form biofilms in different species. 
1.2.2 Genetic differentiation within biofilms 
Within a complex, differentiated biofilm local conditions will vary, consequently it has 
been suggested that biofilms comprise a heterogeneous population of different 
bacterial cells that have differentiated along distinct developmental pathways 
(Lazazzera 2005; An and Parsek 2007). Cells within a biofilm express genes in a 
pattern that varies greatly from their planktonic equivalents and the commitment to a 
sessile mode of growth involves a switch to a distinct pattern of gene expression 
(Stoodley et al. 2002). 
Microarray transcriptomic studies have revealed that biofilms of P. aeruginosa, 
V. cholera, E. coli and S. aureus differentially express as much as 10% of their 
genome in contrast to isogenic planktonic cultures (Schoolnik et al. 2001; Whiteley et 
al. 2001; Schembri et al. 2003; Beenken et al. 2004).  
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The different stages of biofilm formation are characterised by expression of distinct 
sets of genes. Initial attachment requires the expression of pili and fimbriae to assist 
in making contact with the surface and helping the cell overcome electrostatic force 
that the surface will have upon them. This primary attachment is reversible and cells 
can easily become detached and return to planktonic state. To adhere irreversibly the 
bacteria must decrease expression of motility genes and induce expression of genes 
that encode for extracellular matrix components; curli and cellulose in Salmonella. 
Maturation of a biofilm into a complex three dimensional structure can see further 
changes in gene expression including quorum sensing molecules in some species. 
The switch between planktonic and biofilm lifestyles in many species of bacteria can 
be attributed to the signalling molecule, cyclic diguanylic acid (c-di-GMP). At high 
levels, c-di-GMP, increases the expression of many genes conducive to forming 
biofilms and turns down any motility genes required for a planktonic lifestyle. In the 
same way, low levels of c-di-GMP decrease biofilm genes and increase motility 
genes. The biosynthesis of c-di-GMP is controlled by diguanylate cyclases (DGCs) 
and the degradation mediated by phosphodiesterases (PDEs). Bacteria tend to have 
several DGCs and PDEs which allow the level of c-di-GMP to be adjusted by a 
complex group of catabolic and anabolic enzymes which can respond to a range of 
environmental cues (Petrova and Sauer 2012). 
The differentiation of structure within a biofilm allows formations to be made which 
are permissive for life at high density. One example is the maintenance of nutrient 
channels, which requires communication between individual bacteria to ensure cells 
grow in the correct direction and the extracellular polymeric substance is secreted 
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from the cells in the right direction so as to not block the channels that can be an 
essential source of oxygen and nutrients (Stoodley et al. 2002).  
1.2.3 Antimicrobial resistance in Salmonella 
Resistance to antibiotics is an emerging and increasing problem in many pathogenic 
bacteria and is a huge clinical challenge for modern medicine. Bacteria are 
increasingly being isolated that are resistant to multiple clinically relevant antibiotics. 
Methicillin-resistant Staphylococcus aureus (MRSA) and carbapenem resistant 
Gram-negative bacteria are recent examples of antibiotic resistance causing huge 
problems in hospitals across the world (Reacher et al. 2000; Padmanabhan and 
Fraser 2005; Grundmann et al. 2006). For Salmonella in particular, antibiotic 
resistance has been seen in both typhoidal and non-typhoidal serovars (Stevens et 
al. 2009; Harish and Menezes 2011). In Salmonella, resistance to β-lactams, 
tetracyclines, phenicols, aminoglycosides and fluoroquinolones is commonly seen. 
Resistance can be mediated by the acquisition of multiple antibiotic resistance genes 
on genomic islands (as seen in S. Typhimurium DT104) and transmissible elements 
such as plasmids and integrons. Antibiotic resistance has profound clinical 
implications and drug resistant infections have a poor prognosis (Helms et al. 2004). 
Although more infections are caused by S. Enteritidis in Europe, S. Typhimurium is of 
particular clinical relevance as it is not only the second largest cause of NTS but of 
the cases reported in the European Union, almost half are multi-drug resistant. This 
presents challenges if the infection is extra-intestinal and needs to be treated with 
antibiotics (http://www.enter.net 2008). Infections caused by fluoroquinolone resistant 
strains of S. Typhimurium are three times more likely to become systemic or even 
fatal when compared to strains without such resistance (Helms et al. 2004). As well 
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as specific antibiotic resistance genes efflux is also an important mechanism of 
clinically relevant antibiotic resistance in Salmonella. 
1.2.4 Antibiotic resistance and biofilms – diffusion barrier, gene exchange, 
dormancy and persistence 
As well as bacteria becoming resistant via genetic variation they can also become 
more antibiotic resistant when adapting the physiologically distinct biofilm mode of 
growth even though no mutation or acquisition of novel DNA has occurred. Bacteria 
in a biofilm can be up to 1000 fold more resistant to antibiotics than their planktonic 
counterparts (Costerton et al. 1987). This increased resistance was initially thought to 
be due to the three dimensional structure of a biofilm dictating that the antibiotics 
could not penetrate through the extracellular matrix and peripheral cells to reach the 
cells residing within the biofilm (Costerton et al. 1987). More recent research 
suggests that the difference in metabolism of bacteria within a biofilm compared to 
planktonic bacteria has a major role in the antibiotic resistance of biofilms. Biofilms 
contain large numbers of ‘persister’ cells, cells which survive treatment with normally 
effective antibiotic concentrations due to their metabolic dormancy. This also means 
that bacteriostatic antibiotics (antibiotics that work by halting division) become 
ineffective as the cells are not dividing or are only dividing at a low rate. Similarly any 
target of an antibiotic which is only produced by active cells will not be present at 
high levels in a metabolically dormant cell (Lewis 2007).  
1.2.5 Biofilms in the environment  
Bacteria forming a biofilm can survive in varying environments, and adapt to diverse 
surroundings, the environment has a large impact on biofilm structure (Hall-Stoodley 
et al. 2004). Bacteria in natural aquatic environments are often attached to surfaces 
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(Zobell 1943), biofilms that dwell in fast flowing water have a tendency to form 
filamentous streamers, these streamers are attached to the surface by an upstream 
‘head’ which allows the ‘tail’ oscillate downstream in the current. In calm or slow 
flowing waters biofilms form stromatolites (mushroom and tower shaped structures), 
with an isotropic pattern where there is no sign of  flow influencing morphology of the 
biofilm (Hall-Stoodley et al. 2004). 
1.2.6 Biofilms and food contamination 
Bacterial contamination of food leads to many cases of gastroenteritis every year. 
These infections are not only caused by contamination of meat and poultry products 
but also from fresh fruit and vegetables (http://www.food.gov.uk; Fatica and 
Schneider 2011). Bacterial biofilms have been found to exist on surfaces within the 
food processing plants where produce is packaged (allowing persistence of 
pathogenic bacteria which is easily transferable to the produce) and also on the 
surface of the food itself (source of bacterial gastroenteritis for humans) due to the 
availability of nutrients and moisture. The occurrence of food borne disease 
outbreaks due to contaminated fresh fruit and vegetables are not unusual, for 
example; Escherichia coli on lettuce leaves, apple cider (Tauxe 1997), radishes (Itoh 
et al. 1998), alfafa (Anon 1999) and beansprouts (Buchholz et al. 2011) Cyclospora 
cayetanesis on raspberries (Herwaldt and Ackers 1997), lettuce (Herwaldt 2000; 
Doller et al. 2002), and basil (Lopez et al. 2001) and Shigella on shredded lettuce 
(Tauxe 1997). Salmonella serovars, in particular, have been associated with many 
outbreaks in the U.K. including two outbreaks in 2010 associated with beansprouts 
and salad leaves causing over 250 cases of salmonellosis (http://www.hpa.org.uk 
2010). 
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1.2.7  Mixed population biofilms 
Biofilms in nature usually exist as multi species communities. These mixed species 
environments often contain species which benefit from each other’s presence. One 
example of this was described recently in the human oral microbiome. It was 
discovered that previously unculturable species that exist as biofilms in the mouth 
can be grown in vitro using a helper bacteria to condition the media (Vartoukian et al. 
2010). Particular genera of bacteria for which new species have been found using 
this model of culture include Catellibacterium, Psychrobacter, Sphingomonas and 
Symbiobacterium (Tanaka et al. 2004; Bae et al. 2005; Kim et al. 2008; Nichols et al. 
2008). Another example of co-operative behaviour in a biofilm is seen with 
Pseudomonas putida and Acinetobacter sp. which can form mixed species biofilms in 
the laboratory when benzyl alcohol is the only source of carbon from the 
environment. Acinetobacter can utilize benzyl alcohol as a carbon source which 
creates a by product, benzoate, which is excreted into the environment. P putida 
although not being able to catabolise benzyl alcohol can still thrive in an environment 
where this is the only carbon source in the presence of Acinetobacter sp. This is due 
to P. putida utilizing the by product, benzoate, as its source of carbon (Moller et al. 
1998). 
1.2.8 Clinical relevance of bacterial biofilms 
1.2.8.1 Medical biomaterials 
Infection from biofilm dwelling bacteria can be caused when using an array of 
different medical biomaterials in clinical practice. Bacteria can form biofilms on 
prosthetic cardiac valves (Dismukes et al. 1973; Blouse et al. 1978), cerebrospinal 
fluid shunts (Callaghan et al. 1961; Schoenbaum et al. 1975), orthopaedic appliances 
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(Patterson and Brown 1972; Wilson 1977) and intravascular catheters (Archer 1978; 
Bender and Hughes 1980). Common bacteria that cause device related biofilm 
infections include Staphylococci, Escherichia coli, Proteus species, Serratia 
marcescens and Morganella morganii (Geipel 2009). These infections are common 
as artificial materials are often poorly served by the immune system, and are often 
easier for the bacteria to adhere to than biological surfaces, which create a route of 
entry into the body (Peel et al. 2012). 
In the U.S.A, catheter related infections alone are estimated to cost up to £1.4 billion 
annually with around 250,000 infections and a mortality rate of 12-25% (Rello et al. 
2000; von Eiff et al. 2005) 
1.2.8.2 Cystic fibrosis 
The lungs of cystic fibrosis sufferers present an attractive setting for P. aeruginosa 
colonization and biofilm formation (Gomez and Prince 2007). As biofilms are less 
prone to disruption or killing by surfactants, antibiotics, grazing predatory white cells 
and host defences (including antimicrobial peptides) these chronic P. aeruginosa 
biofilm lung infections are extremely difficult to treat (Costerton 2001). By late 
adolescence 80% of cystic fibrosis sufferers have chronic lung infection, with 
P. aeruginosa as one of the main causes (Lyczak et al. 2002). Once acquired, 
P. aeruginosa is almost impossible to eradicate from the lungs of cystic fibrosis 
sufferers and eventually this infection will become fatal (Høiby et al. 2005).  
More recently strains of the Burkholderia cepacia complex (Bcc) have been identified 
as important lung pathogens producing an array of different disease states from 
asymptomatic to “cepacia syndrome” which is lethal. Whilst colonisation with either 
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pathogen is detrimental to the patient’s health, co-colonisation can exhibit a more 
severe decline in pulmonary function (Jacques et al. 1998). It has been suggested 
that in vitro there is a synergistic relationship between these two microorganisms 
which allows Bcc strains to increase expression of virulence factors (McKenney et al. 
1995) and also increase binding to epithelial cells (Saiman et al. 1990) in the 
presence of P. aeruginosa conditioned media. This synergy was investigated by 
Tomlin et al who showed dual species biofilm formation was easily achieved in vitro 
and both species readily integrated in close proximity within a biofilm, however it is 
still unknown if this is the cause of the damaging effects co-colonisation has on the 
lungs of CF patients (Tomlin et al. 2001). 
Bacteria readily form biofilms in cystic fibrosis lungs and it is thought that the dense, 
stagnent mucus present decreases motility of the bacterial cell which results in 
bacterial cell clusters forming, accumulation of quorum sensing molecules (which 
trigger biofilm formation) and subsequent biofilm formation. Normal hydrated mucus 
allows the bacteria to move around freely and prevents bacteria from accumulating in 
clusters in one area therefore reducing the likelihood of biofilm formation (Matsui et 
al. 2006). 
1.2.8.3 Gall stones 
Salmonella enterica serovar Typhi (S. Typhi) can form biofilms on gall stones in the 
gall bladder of humans during an active, acute infection and these cells can persist 
long after the symptoms have subsided and can be the source of recurrent Typhoid 
infections. This persistence suggests that S. Typhi has established a mechanism 
(biofilm) of evading the antimicrobial action of bile in the gall bladder (Sinnott and 
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Teall 1987; Vaishnavi et al. 2005). Antibiotics are typically ineffective when the 
patient exhibits both cholesterol gall stones and an S. Typhi infection (Lai et al. 
1992), and there is also a high chance of developing hepatobiliary carcinomas (Dutta 
et al. 2000; Kumar et al. 2006). It is currently not known whether other Salmonella 
serovars also form biofilms on gallstones in vivo.  
1.2.8.4 Legionellosis 
Legionella pneumophilia causes 90% of Legionellosis cases (Yu 2002) although 
there are more than 50 known sub-species of Legionella (Diederen 2008). 
Legionellosis includes two distinct diseases; Legionnaires’ disease, a pneumonia that 
is frequently fatal if not caught early and treated, and Pontiac fever, a milder flu-like 
illness (Diederen 2008). L. pneumophilia rarely causes infection when in a natural 
water system as conditions do not allow the bacteria to proliferate sufficiently. 
However if L. pneumophilia enters a man made water system where the 
temperatures are generally higher than ambient the bacteria can colonize existing 
biofilms formed by other species and proliferate to high numbers if disinfection 
regimes are not adhered to (Rogers et al. 1994). L. pneumophilia is extremely 
particular when it comes to its favoured conditions for growth and when cultured in 
the laboratory it requires several different nutrients including iron salts and amino 
acids (George et al. 1980). In artificial water systems L. pneumophilia survive by 
parasitizing protozoans which graze on the biofilm (Greub and Raoult 2004). Without 
this association with other bacterial biofilms L. pneumophilia would not be able to 
proliferate to high enough levels to cause disease in humans. 
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1.2.8.5 Oral biofilms 
Dental plaque is a oral bacterial biofilm which is a dynamic and extremely complex 
ecosystem (Marsh 2003). Many bacterial species can form plaque; these species 
have been grouped according to clinical parameters, the disease stage and location 
in the oral cavity. Several key species can be involved in oral disease, these include; 
Porphyromonas gingivalis, Treponema denticola, Prevotella intermedia, 
Aggregatibacter actinomycetemconitans, Bacteroides forsythus, Campylobacter 
rectus and Eubacterium nodatum (Lovegrove 2004). The biofilms that form in the 
gingival cavity gives rise to a cellular inflammatory response of the gingiva and 
surrounding connective tissue. These periodontal diseases are split into two clinical 
classes; gingivitis and periodontitis. Gingivitis is extremely common and is defined by 
an inflamed gingival cavity. Periodontitis is a more severe disease where the plaque 
induced inflammatory response leads to loss of collagen attachment (between the 
tooth and the bone) and bone loss (Savage et al. 2009). Periodontal disease has 
also been linked with increased susceptibility to other systemic disorders (Amar and 
Han 2003; Kuo et al. 2008) including diabetes mellitus (Kuo et al. 2008), Alzheimer’s 
disease (Kamer et al. 2008; Kamer et al. 2008; Watts et al. 2008), cardiovascular 
disease (Mattila et al. 2005), osteoporosis  (Kuo et al. 2008) and chorioamnionitis 
leading to premature delivery and low birth weight (Offenbacher et al. 1996).  
1.3 Salmonella biofilms 
As well as Salmonella Typhi forming biofilms on gallstones during infection 
(Section 1.2.8.3), non typhoidal Salmonella biofilms are a recognized problem in a 
number of industrial, veterinary and medical settings (Veldman et al. 1995). Vestby et 
al showed that the period of persistence of NTS within Norwegian fish meal and food 
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factories correlated with the ability of strains to form biofilms (Vestby et al. 2009). The 
serovars Agona and Montevideo formed superior biofilms to all other serovars tested 
and were also found to persist for the longest time period within processing plants. 
As biofilms are more tolerant to disinfectants than planktonic cells the presence of 
biofilms in the food industry is a problem requiring very rigorous disinfection regimes. 
Survival of NTS in biofilms in the food industry increases the risk of food 
contamination and possible human infections (Veldman et al. 1995). 
As with other species a number of genes have been shown to contribute to the ability 
of Salmonella to form a biofilm. These include genes required for motility (flagella) 
and the initial attachment phase (fimbriae, pili etc) and genes which encode the 
matrix components and promote cell:cell interactions (curli, cellulose etc). Additionally 
a large number of genes have been identified as having regulatory roles, 
predominantly by controlling the expression of the matrix components and in 
particular, csgD. Table 1.1 gives a list of genes identified as being involved in biofilm 
formation of Salmonella and an indication of their suggested role in biofilm formation. 
1.3.1 Composition of the Salmonella biofilm matrix – curli and cellulose 
Salmonella biofilms are encased in a matrix largely composed of two major 
components; curli and cellulose. Curli are thin, hair like filaments which can 
polymerise to form amyloid fibres protruding from the outer membrane of many 
bacteria from the Enterobacteriaceae family (Zogaj et al. 2003). They are involved in 
many functions including adhesion, cell aggregation, environmental persistence and 
biofilm formation (White et al. 2003; Cogan et al. 2004; Jonas et al. 2007). 
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Table 1.1 Genes known to be involved in biofilm formation of Salmonella 
Gene/ 
Operon 
Intermediate 
gene 
Gene/Operon Description Role in biofilm formation Reference 
csgBA  Major and minor curli subunits Structural curli proteins (extracellular 
proteinaceous fibres)  
(Grund and Weber 1988) 
csgD  Master biofilm regulator  Transcriptional activator of csgBA, adrA, bapA and 
bcsABCD 
(Grund and Weber 1988) 
csgEFG  Curli subunit translocation and 
assembly 
Efficient assembly of curli subunits on bacterial cell 
surface 
(Grund and Weber 1988) 
bscABCD  Cellulose biosynthesis operon Cellulose (extracellular polysaccharide) 
biosynthesis 
(Zogaj et al. 2001) 
bcsEFG  Cellulose biosynthesis operon Cellulose (extracellular polysaccharide) 
biosynthesis 
(Zogaj et al. 2001) 
bapA  Large cell surface protein Pellicle formation (biofilm at liquid-air interface) (Latasa et al. 2005) 
dos  cAMP phospohodiesterase csgD repressor (Tagliabue et al. 2010) 
rcsBC  two component system csgD repressor (Latasa et al. 2012) 
cpxRA  Envelope stress response two 
component system 
csgD repressor (Gerstel and Romling 2003) 
fecR  Transmembrane signal transducer csgD repressor (Brombacher et al. 2006) 
omrAB  Small RNAs csgD repressor (Holmqvist et al. 2010) 
hns  DNA binding protein csgD activator/ repressor (Ledeboer and Jones 2005) 
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Gene/ 
Operon 
Intermediate 
gene 
Gene/Operon Description Role in biofilm formation Reference 
ompR/envZ  Osmolarity response two component 
system 
csgD activator  
yegE  Putative diguanylate 
cyclase/phophodiesterase 
csgD activator (Kader et al. 2006; Simm et 
al. 2007) 
yedQ  Diguanylate cyclase csgD activator (Da Re and Ghigo 2006) 
ydaM  Diguanylate cyclase csgD activator (Mika and Hengge 2013) 
yciR  cGMP phosphodiesterase csgD activator (Garcia et al. 2004) 
yjcC  Putative diguanylate 
cyclase/phophodiesterase 
csgD repression Kader et al. 2006; Simm et 
al. 2007) 
mlrA  DNA binding transcriptional activator csgD activator (Garcia et al. 2004) 
yddV  Diguanylate cyclase csgD activator (Tagliabue et al. 2010) 
ihf  Integration host factor csgD activator (Garcia-Contreras et al. 
2008) 
mltC  Membrane bound lytic 
transglcosylase 
csgD activator (Monteiro et al. 2011) 
mltE  Soluble lytic transglcosylase csgD activator (Monteiro et al. 2011) 
yoaD  Phosphodiesterase bcsABCD activator (Romling et al. 2000) 
adrA  Diguanylate cyclase bcsABCD activator (Garcia et al. 2004) 
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Gene/ 
Operon 
Intermediate 
gene 
Gene/Operon Description Role in biofilm formation Reference 
rpoS yepE 
yedQ 
ydaM 
yciR 
mlrA 
RNA polymerase sigma factor yepE/yedQ/ydaM/ 
yciR/mlrA activator 
(Cabeza et al. 2007) 
sdiA rpoS DNA binding transcriptional activator rpoS activator (Janssens et al. 2008) 
crl rpoS DNA binding transcriptional activator rpoS activator (Robbe-Saule et al. 2006) 
fur hns Ferric uptake regulation  hns repressor (Janssens et al. 2008) 
csrA ompR 
rpoS 
Carbon storage regulator ompR and rpoS repressor (Jackson et al. 2002) 
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In S. Typhimurium, curli fimbriae are encoded by two operons; csgBA and csgDEFG 
(Hammar et al. 1995). csgA and csgB encode the two structural proteins of identical 
size and contain similar repeat motifs. Both proteins are needed to form polymerized 
protein chains on the cellular surface (Collinson et al. 1999; White et al. 2001). csgC 
is found downstream of csgBA but has no reported role in curli biogenesis and no 
transcript has been detected (Barnhart and Chapman 2006). CsgD, CsgE, CsgF and 
CsgG are all curli accessory proteins and all are required for efficient curli 
translocation and assembly. CsgD is a positive transcriptional regulator of the csgBA 
operon. CsgE and CsgF are both periplasmic proteins which interact with CsgG in 
the outer membrane and are thought to work with CsgG to promote curli assembly, 
however the exact function of these two proteins is unknown (Hammar et al. 1995; 
Barnhart and Chapman 2006). CsgG is an outer membrane lipoprotein and is 
essential for the secretion and stability of CsgA and CsgB and has been suggested 
to be required for CsgA and CsgB to cross the membrane and be translocated into 
the extracellular milieu where polymerisation can occur (Figure 1.4) (Robinson et al. 
2006). 
Cellulose is a polysaccharide secreted by the bacterial cell that helps cement the 
cells together and is therefore extremely important in maintaining bacterial 
multicellular biofilm communities. Cellulose synthesis is encoded by the operon 
bcsABZC (Zogaj et al. 2003). As well as their adhesion functions curli and cellulose 
have also been suggested to have roles in virulence, invasion and chlorine 
resistance (Sukupolvi et al. 1997; Dibb-Fuller et al. 1999; Gophna et al. 2001).  
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Figure 1.4 Diagram of the curli translocation and assembly apparatus (Barnhart and Chapman 2006) 
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Many genes are known to regulate expression of biofilm extracellular matrix 
components via CsgD, a transcriptional activator of the curli operons as well as other 
biofilm related operons, adrA, bapA and bcsABCD (Gerstel and Romling 2003). 
CsgD is the master curli regulator in Salmonella and other Gram negative bacteria 
and csgD expression is influenced by a huge number of proteins, small RNAs and 
signalling molecules. This complex regulation allows csgD expression to respond to a 
number of different extracellular stimuli such as pH, temperature, salt concentration, 
nutrient supply amongst others (Jubelin et al. 2005; Brombacher et al. 2006; 
Ogasawara et al. 2010). 
1.3.2  ‘RDAR’ phenotype 
Expression of the Salmonella extra cellular matrix components give Salmonella a 
very distinct phenotype when plated on to LB agar without salt supplemented with a 
dye called Congo red (a planar hydrophobic diazo dye). Colony morphologies of 
strains producing a normal matrix appear red, dry and rough (RDAR), both curli and 
cellulose are bound by Congo red so the colonies also appear dark red (Romling 
2005). Mutants lacking the ability to make curli, cellulose or both present with a range 
of different colony types when stained with Congo red, easily distinguished from 
‘RDAR’ colonies (Solano et al. 2002). 
1.4 Efflux pumps  
1.4.1 Multidrug efflux systems 
Efflux pumps are proteins located in the cytoplasmic membrane of all bacteria. Their 
primary role is to keep cytoplasmic levels of various metabolites and chemicals at a 
level non detrimental to the cell or to transport molecules to the cell surface or 
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extracellular milieu to carry out their function. Cytoplasmic efflux pump proteins either 
work alone or in Gram negative bacteria sometimes as part of a tripartitie system with 
an additional outer membrane porin protein and periplasmic adapter protein. Some 
efflux systems are able to extrude antibiotics from within the cell and keep the 
intracellular concentration of antibiotics at sub lethal levels. If a single efflux pump or 
system is responsible for conferring even low level resistance to three or more 
different classes of antibiotics they are known as multidrug efflux systems (Blair and 
Piddock 2009). 
1.4.2 Multidrug resistance efflux pumps in Salmonella 
Efflux pumps play an essential role in the physiology of bacteria. They do this by 
mediating the entry and extrusion of essential nutrients, metabolic waste and 
xenobiotics. As for other Gram negative bacteria there are four classes of solute 
transporters defined in the Transport Classification (TC) system found within 
Salmonella; channels, secondary transporters, primary active transporters and group 
translocators. Channels do not depend upon energy but use the gradient of the 
substrate to drive translocation. Primary active transporters use a source of energy 
such as the hydrolysis of ATP. Secondary transporters exploit an ion or 
electrochemical gradient such as the sodium or proton motive force. Group 
translocators alter their substrates during the transport process (e.g. substrate 
phoshorylation) (Ren and Paulsen 2007). 
A genomic analysis of all membrane transport systems within prokaryotes predicts 
that S. Typhimurium has 350 membrane transporters (73 transporters per Mb of 
genome). Of these, 83 (23.7%) are primary active transporters (all using ATP as their 
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energy source), 15 (4.3%) are channels, 29 (8.3%) are group translocators (all using 
phosphorylation to modify their substrates), 218 (62.3%) are secondary transporters 
(using either sodium or proton motive force) and 2 (0.6%) are as yet unclassified 
(Ren and Paulsen 2007). 
Of the 350 predicted transport proteins within Salmonella there are nine known and 
experimentally characterised multidrug resistance (MDR) efflux pumps which 
individually confer low level MDR to three or more different classes of antibiotics, 
dyes or detergents (Table 1.2) (Baucheron et al. 2004; Eaves et al. 2004; Buckley et 
al. 2006; Nishino et al. 2006). These nine systems belong to four of the five distinct 
families of efflux pumps known to confer multidrug resistance (Figure 1.5); the ATP 
binding cassette (ABC) family, the multidrug and toxic compound extrusion (MATE) 
family, the major facilitator superfamily (MFS), the resistance nodulation division 
(RND) family and the small multidrug resistance (SMR) family (Piddock 2006). 
Salmonella has at least one MDR pump from each family with the exception of the 
SMR family of efflux pumps. With the exception of MdsABC (mds-multidrug 
transporter for Salmonella) which is unique to Salmonella, all of the identified MDR 
efflux systems also exist in E. coli (Nishino et al. 2006).Their ability to export a very 
broad range of other toxic compounds including antibiotics and biocides allows the 
bacteria to survive in hostile environments (Piddock 2006; Blair and Piddock 2009).  
 
. 
28 
 
Table 1.2 Nine known MDR efflux pumps of Salmonella, their periplasmic adapter protein, outer membrane protein and known 
substrates. 
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Figure 1.5 Schematic diagram of the four families of multidrug efflux systems known in Salmonella with example inner membrane 
pump protein, periplasmic adapter protein, outer membrane porin and example substrates for each family. 
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1.4.3 Resistance Nodulation Division (RND) family 
The RND family of efflux pumps are secondary transporters organised as tripartite 
systems with three components; an inner membrane pump protein, a periplasmic 
accessory protein and an outer membrane porin protein (Koronakis et al. 2004; Ren 
and Paulsen 2007). The inner membrane pump protein captures substrates from the 
periplasmic leaflet of the inner membrane phospholipid bilayer and exports them via 
the outer membrane porin protein into the extracellular milieu (Aires and Nikaido 
2005). The RND systems are proton antiporters as they use the proton gradient 
across the inner membrane to power efflux, substituting one hydrogen ion for one 
molecule of substrate in an antiport reaction (Paulsen et al. 1996). RND pumps 
assemble as a trimer, linked to an outer membrane channel which is also trimeric 
(Murakami et al. 2002; Murakami et al. 2006). Both the pump and porin are stabilised 
by an adapter protein, the stoichiometry of this adapter protein is as yet uncertain. 
Salmonella possess five different MDR RND efflux proteins, AcrB, AcrD, AcrF, MdsB 
and MdtBC. AcrB and AcrD associate with AcrA and TolC to form their tripartite 
systems. AcrF, MdsB and MdtBC all have their own accessory proteins, AcrE, MdsA 
and MdtA, and all complex with TolC as their outer membrane porin. MdsB as well as 
associating with TolC in the outer membrane can also associate with its own OMP, 
MdsC (Nishino et al. 2006) (Table 1.2). There is a high level of identity between the 
RND efflux components of S. Typhimurium and the corresponding homologues in 
E. coli, for example AcrA has 94% identity and AcrB has 97% identity between the 
species (Eaves et al. 2004). Although this similarity between E. coli and 
S. Typhimurium efflux pumps exists, the substrate profile can differ between them 
(Nishino et al. 2009).  
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1.4.3.1 AcrAB-TolC 
The most well characterised of the RND pumps in Salmonella is AcrB and its tripartite 
complex AcrAB-TolC (Figure 1.6). It comprises the three proteins; AcrB (the inner 
membrane pump protein), AcrA (the periplasmic protein) and TolC (the outer 
membrane porin protein). Typically, the genes that encode the three proteins that 
comprise of RND pump systems are co-localised within an operon with the local 
regulator followed by the periplasmic adapter protein gene, the pump gene and finally 
the outer membrane porin gene. However, in Salmonella this is not the case for 
AcrAB-TolC as acrR (regulator), acrA and acrB are located together but tolC is 
elsewhere on the chromosome (Nishino et al. 2006). 
AcrAB-TolC has many different substrates making this efflux pump (and other RND 
homologues) a key mediator of multidrug resistance in Gram negative bacteria 
including many Enterobacteriaceae (Paulsen et al. 1996). AcrB can export a range of 
substrates including cationic dyes (including crystal violet, ethidium bromide, 
rhodamine 6G), antibiotics (including penicillins, cephalosporins, fluoroquinolones, 
macrolides, chloramphenicol, tetracyclins, novobiocin, fusidic acid, oxazolidinones 
and rifampicin) and detergents (including Triton X-100, sodium dodecylsulfate and 
bile acids). Clearly there is little correlation between the structures of this diverse 
array of substrates, the only feature that they have in common is the inclusion of 
lipophilic domains within the molecule (Nikaido 1996; Eaves et al. 2004; Nishino et al. 
2006; Bailey et al. 2008). The presence of these lipophilic domains is thought to allow 
them to associate with the complex binding sites present in the hydrophobic interior 
of AcrB (Nikaido and Takatsuka 2009). 
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Figure 1.6 Diagrammatic representation of the AcrAB-TolC efflux system, the archetypal RND efflux pump in Enterobacteriaceae 
(Blair and Piddock 2009). 
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All three proteins in the AcrAB-TolC system are essential for efficient efflux of 
antimicrobial compounds across both membranes, and the lack of any component 
compromises the activity of the entire complex although not to the same degree (Ma 
et al. 1995; Ma et al. 1996; Blair et al. 2009). 
1.4.4 Major facilitator superfamily (MFS)  
MFS pumps also fall under the category of secondary transporters (Ren and Paulsen 
2007). Around 25% of all known prokaryotic membrane transporters belong to the 
MFS, which is the largest and most varied family of transporters containing 58 sub 
families. There are around 15,000 MFS pumps identified to date (Saier et al. 1999). 
MFS pumps are similar to RND pumps in that they are driven by the proton motive 
force exchanging one hydrogen ion for one substrate molecule and they span the 
periplasmic membrane with 12 transmembrane regions (Piddock 2006). However, 
they do not always form a tripartite complex with an adapter protein and outer 
membrane porin and can exist as a single protein within the cytoplasmic membrane. 
MdfA and EmrAB are the two MFS MDR pumps described in Salmonella. MdfA exists 
as a single cytoplasmic efflux protein and exports chloramphenicol, doxorubicin, 
norfloxacin and tetracycline in S. Typhimurium. Unlike MdfA, EmrB can associate 
with its own periplasmic adapter protein, EmrA, and TolC in the outer membrane  to 
form a tripartite system (Horiyama et al. 2010). This EmrAB-TolC complex in S. 
Typhimurium can transport substrates such as novobiocin, naladixic acid, SDS and 
sodium deoxycholate across both membranes into the extracellular milieu (Nishino et 
al. 2006). 
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1.4.5 Multidrug and toxic compound extrusion (MATE) family 
MATE pumps, similar to the RND and MFS pumps, are also secondary transporters 
with 12 or 14 transmembrane domains and use the proton motive force as an energy 
source. However, some MATE pumps use a sodium ion gradient to power efflux. 
MATE pumps in contrast to RND and MFS pumps never exist as a tripartite system. 
Salmonella has one known MATE MDR efflux pump, MdtK. MdtK is a NorE family 
MDR MATE transporter that uses the proton motive force to translocate substrates 
across the periplasmic membrane. MdtK can confer low level resistance to 
norfloxacin, acriflavin and doxorubicin (Nishino et al. 2006). 
1.4.6 ATP-binding cassette (ABC) family 
ABC transporters are primary active transporters and typically have six 
transmembrane domains spanning the periplasmic membrane which differs from the 
12 domains that RND and MFS pumps possess and assemble as dimers. The 
characteristic of the ABC family of efflux pumps is the motor domain of the protein 
that binds and hydrolyses ATP, as it is the only family of transporters that uses ATP 
as its energy source to drive the export of substrates (Bouige et al. 2002). MacB is 
the only known ABC MDR efflux pump in Salmonella and associates with MacA as its 
accessory protein and TolC as its outer membrane protein. MacB forms the tripartite 
system, MacAB-TolC, and has been shown to export 14- and 15-membered lactone 
macrolides, for example erythromycin and azithromycin. MacB is the inner membrane 
pump protein localised in the cytoplasm and functions as a dimer. MacA is thought to 
form a hexamer and interacts with the α barrel tip region of TolC to stimulate the 
activity of the MacB ATPase upon assembly (Tikhonova et al. 2007). Expression of 
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macB is controlled by the PhoPQ system, an essential regulator of virulence in 
Salmonella (Nishino et al. 2006). 
1.4.7 Promiscuity of efflux pump proteins 
TolC is not encoded in the same genetic locus as any of the MDR systems of 
Salmonella but acts as an outer membrane porin protein for several of these efflux 
system. In S. Typhimurium, TolC is known to interact with eight multidrug efflux 
systems including AcrAB (Nishino et al. 2006; Horiyama et al. 2010), MdsAB (Nishino 
et al. 2006). AcrD (Hirakawa et al. 2003; Nishino et al. 2003), AcrEF (Nishino et al. 
2003), MdtABC (Nagakubo et al. 2002), EmrAB, (Nishino and Yamaguchi 2002) and 
MacAB (Kobayashi et al. 2001). Clearly TolC is not restricted by the family of efflux 
pump it associates with as it can form tripartite systems with proteins from RND, MFS 
and ABC families. AcrA has also been shown to be promiscuous and can combine 
with three other transporter proteins; AcrD (Elkins and Nikaido 2002), AcrF 
(Kobayashi et al. 2001) and MdtF (Elkins and Nikaido 2002) in addition to AcrB.  
1.4.8 Regulation of efflux in Salmonella  
Multidrug transporters of Salmonella and other bacteria are subject to precise and 
complex transcriptional control (Figure 1.7). In E. coli and S. Typhimurium, acrAB has 
a local repressor, AcrR. In addition there are global networks of regulation controlled 
by MarA and SoxS, both members of the AraC/XylS family of transcriptional 
activators. In many Enterobacteriaceae, including S. Typhimurium, another 
AraC/XylS transcriptional activator is RamA which plays a major role in the regulation 
of acrAB (van der Straaten et al. 2004; Bailey et al. 2010). 
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Figure 1.7 Regulation network including environmental cues of efflux pumps in Salmonella 
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These regulators can respond to many environmental stresses to both increase 
expression of efflux pumps and down-regulate porin expression in order to reduce 
accumulation of potentially toxic substrates within the cytoplasm. These regulators 
consist of two components; a repressor and activator gene. In the case of RamA, 
RamR acts as a repressor of RamA and blocks it’s transcription, inducer molecules 
can then de-repress transcription of ramA. Production of elevated levels of RamA 
results in RamA binding upstream of it’s target operons to a recognised amino acid 
sequence known as the “ram box” where it acts as a transcriptional activator (Bailey 
et al. 2010). As well as controlling efflux pump expression, MarA, SoxS and RamA 
can all influence relatively large regulons (Martin and Rosner 2002; Bailey et al. 
2010; Chubiz and Rao 2011). The de-repression of acrB, acrD and acrF is also co-
ordinately regulated and the expression of each other and all respond to these three 
pumps influences the expression of the global transcriptional activators marA and 
soxS (Eaves et al. 2004). For example acrS is a repressor located upstream of acrEF 
which actually exerts its repressive effect on acrAB so if acrSEF is induced acrAB is 
repressed (Hirakawa et al. 2008). Expression of acrD and mdtABC are induced by 
high intracellular levels of copper and zinc (2mM and 1mM respectively) via the 
regulator two component regulatory system, BaeSR, suggesting that these two efflux 
systems AcrD and MdtABC have a physiological role in metal homeostatis in 
Salmonella as well as multidrug resistance (Nishino et al. 2007) 
1.4.9 Inducers of efflux in Salmonella 
There are a variety of compounds known to induce acrAB in Salmonella via the 
global regulator ramA. Bile salts, indole, cholic and deoxycholic acid are all thought to 
induce acrAB via ramA. This has been shown by mutating ramA in S. Typhimurium 
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which has subsequently decreased induction of acrAB on addition of these 
compounds. Indole has also been shown to induce ramA directly using a beta-
galactosidase reporter plasmid fused to the promoter region of ramA (Nikaido et al. 
2008).  
1.4.10 Other physiological roles for MDR efflux pumps in Salmonella 
Whilst export of antimicrobials is a feature of MDR efflux these pumps have been 
found to have diverse functional roles. It is thought that the physiological role of efflux 
pumps in Salmonella is to mediate the extrusion of certain molecules produced by 
the host organism (including bile, hormones, fatty acids and host defence molecules), 
in order to allow persistence in the face of host factors and invade host cells as well 
as export toxins, metabolites and other environmental compounds (Piddock 2006; 
Blair et al. 2009). Both Salmonella Typhi and Typhimurium are able to export bile 
salts and other host defence molecules and are able to survive in concentrations of 
bile much higher than those they would encounter in the animal gastrointestinal tract 
(van Velkinburgh and Gunn 1999). 
Loss of TolC confers a virulence defect in Salmonella, tolC mutants poorly adhered 
to in vitro embryonic intestinal cells and mouse monocyte macrophages and were 
also unable to invade these cells (Buckley et al. 2006; Nishino et al. 2006). In vivo, 
tolC mutants colonised the avian gut poorly and also did not persist. However, acrB 
mutants were able to adhere to tissue culture cells in vitro, but could not invade 
(Buckley et al. 2006). Other RND family efflux systems were also required for 
virulence in a mouse model. MdtABC and MdsABC were all required for full virulence 
and AcrAB and AcrEF mutants showed a delay in the time taken to cause mortality of 
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the mice (Nishino et al. 2006). In the same study it was also found that MacAB, an 
ABC transporter, was also essential for full virulence of Salmonella in the BALB/c 
mouse model (Nishino et al. 2006). 
Loss of TolC and AcrB has been shown to result in reduced expression of 
Salmonella Pathogenicity Island 1 genes and loss of AcrA has been linked with 
reduced expression of Salmonella Pathogenicity Island 2 genes (Webber et al. 
2009). These pathogenicity islands encode Type IV secretion systems used to 
invade host cells and survive within macrophages.  
The involvement of MDR efflux pumps in virulence is not restricted to Salmonella. 
Efflux systems known to be essential for virulence in other species include; AcrAB-
TolC in Erwinia amylovora (Burse et al. 2004), and Enterobacter cloacae (Burse et al. 
2004), MtrCDE in Neisseria gonorrhoeae (Jerse et al. 2003) and MexAB-OprM in 
Pseudomonas aeruginosa (Hirakata et al. 2002). The exogenous addition of efflux 
inhibitors (EIs) can also re-create similar virulence defects. EIs known to reduce 
virulence are; PAβN (a known competitive inhibitor of RND pumps) in Pseudomonas 
aeruginosa (Hirakata et al. 2009) and Campylobacter jejuni (Lin and Martinez 2006) 
and capsaicin (an inhibitor of the MFS NorA efflux pump) in Staphylococcus aureus 
(Kalia et al. 2012) .  
1.5 Efflux pumps and biofilm formation 
It has previously been shown that inhibition of efflux pumps by EIs, 
1-(1-naphtylmethyl)-piperazine (NMP), PAβN and thioridazine reduced biofilm 
formation of E. coli, Klebsiella, S. aureus and P. putida (Kvist et al. 2008). Recent 
work in our laboratory with S. Typhimurium has shown a similar biofilm defect results 
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from inactivation of any of the nine MDR pumps (Baugh et al. 2012). Using the well 
characterised, AcrAB-TolC as a model system, I have shown that tolC and acrB 
mutant of S. Typhimurium are unable to produce a competent biofilm in many 
different laboratory models, and that these mutants have repressed transcription of 
both curli operons. However acrA mutants (lacking the periplasmic adapter protein) 
have a wild-type biofilm phenotype (Baugh et al. 2012).  
1.6 Hypotheses 
This project set out to investigate the link between efflux and biofilm formation in 
Salmonella. Three specific hypotheses which may explain why these are linked were 
investigated: 
1. AcrAB-TolC exports a biofilm crucial factor(s) 
2. Inactivation of AcrAB-TolC components alters cell surface hydrophobicity 
3. Inactivation of acrB or tolC leads to expression changes of other biofilm related 
proteins. 
1.7 Aims and Objectives 
 Optimise an in vitro biofilm assay for Salmonella enterica serovar Typhimurium 
14028S and its isogenic efflux mutants. 
 Determine the mechanism which gives rise to the inability of efflux mutants to 
form competent biofilms. 
 Investigate the utility of efflux inhibitors as anti-biofilm agents in Salmonella.
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CHAPTER TWO: 
MATERIALS & METHODS
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2  Materials and Methods 
2.1  Bacterial strains, growth, storage and identification 
2.1.1 Strains used 
This project used a variety of isogenic strains with specific efflux pumps inactivated 
derived from S. Typhimurium 14028S. A number of these have been previously 
described (Nishino et al., 2006), whilst others were constructed during this project. 
S. Typhimurium 14028S was used as the wild-type in the project as it has previously 
been characterised, genome sequenced and readily forms a biofilm on a variety of 
surfaces (Jarvik et al. 2010). Full strain details are shown in Table 2.1. 
2.1.2 Growth and storage of bacteria 
Salmonella strains were kept at -20°C on Protect™ beads (Technical Service 
Consultants Ltd., U.K.) for long-term storage. All strains were resuscitated from 
beads on Luria-Bertani (LB) agar plates (Sigma-Aldrich Ltd., U.K.) containing 
appropriate antibiotics where necessary and incubated at 37°C for 24 hours. Plates 
were stored at 4°C for up to two weeks. Overnight broth cultures were grown by 
inoculating a single colony into an appropriate volume of LB broth (Sigma-Aldrich 
Ltd., U.K.) again containing appropriate antibiotics where needed and incubated 
overnight at 37°C with shaking (200 rpm). 
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Table 2.1 Strains used in this study 
Lab. ref. 
no.  
Strain Description Reference 
L133 SL1344 ramRA::aph Mutant lacking functional RamRA (Bailey et al. 2008) 
L354 SL1344 Wild-type Salmonella Typhimurium ATCC 
L644 SL1344 ΔacrB SL1344 lacking a functional AcrB This study 
L722 14028S ramA::aph 14028S lacking functional RamA Courtesy of V. Der Streaten 
L723 14028S soxS::tet 14028S lacking functional SoxS Courtesy of V. Der Streaten 
L724 14028S ramA:aph, soxS::tet 14028S lacking functional RamA and SoxS Courtesy of V. Der Streaten 
L725 14028S marA::cat 14028S lacking functional MarA Courtesy of V. Der Streaten 
L726 14028S ramA::aph, marA::cat 14028S lacking functional MarA and RamA Courtesy of V. Der Streaten 
L727 14028S marA::cat, soxS::tet 14028S lacking functional MarA and SoxS Courtesy of V. Der Streaten 
L728 
14028S ramA::aph, marA::cat, 
soxS::tet 
14028S lacking functional RamA, MarA and SoxS Courtesy of V. Der Streaten 
L742 SL1344 ΔtolC SL1344 lacking a functional TolC This study 
L786 
SL1344 ramRA::aph + pTrc 
hisA::ramA 
SL1344 containing inducible ramA on a plasmid Courtesy of V. Der Streaten 
L828 14028S SL1344 Salmonella Typhimurium ATCC 
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Lab. ref. 
no.  
Strain Description Reference 
L829 14028S tolC::cat 14028S lacking functional TolC (Nishino et al. 2006) 
L830 14028S acrB::aph 14028S lacking functional AcrB (Nishino et al. 2006) 
L832 14028S acrD::aph Mutant lacking functional AcrD (Nishino et al. 2006) 
L833 14028S acrEF::aph Mutant lacking functional AcrEF (Nishino et al. 2006) 
L834 14028S mdtABC::aph Mutant lacking functional MdtABC (Nishino et al. 2006) 
L835 14028S mdsABC::aph Mutant lacking functional MdsABC (Nishino et al. 2006) 
L836 14028S emrAB::aph Mutant lacking functional EmrAB (Nishino et al. 2006) 
L837 14028S mdfA::aph Mutant lacking functional MdfA (Nishino et al. 2006) 
L838 14028S mdtK::aph Mutant lacking functional MdtK (Nishino et al. 2006) 
L839 14028S macAB::aph Mutant lacking functional MacAB (Nishino et al. 2006) 
L884 SL1344 acrA::aph SL1344 lacking functional AcrA (Blair et al. 2009) 
L973 14028S tolC::cat +pWKS30-tolC TolC mutant complemented with plasmid containing tolC This study 
L974 14028S acrB::aph +pWKS30-acrB AcrB mutant complemented with plasmid containing acrB This study 
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Lab. ref. 
no.  
Strain Description Reference 
L1019 SL1344+pUA66pacpP-gfp SL1344 with plasmid containing gfp gene This study 
L1204 14028S+pUA66pacpP-gfp 14028S with plasmid containing gfp gene This study 
L1271 14028S acrA::aph 14028S lacking functional AcrA This study 
L1303 14028S ramRA::aph 14028S lacking functional RamRA This study 
L1305 14028S tolC::cat, ramRA::aph  14028S lacking functional TolC and RamRA This study 
L1494 SL1344 ompC::aph SL1344 lacking a functional OmpC Courtesy of A. Lawler 
L1496 SL1344 ompF::aph SL1344 lacking a functional OmpF Courtesy of A. Lawler 
L1506 14028S ΔtolC, ΔramA 14028S lacking a functional TolC and RamA This study 
L1507 14028S ΔtolC, ΔramA, marA::aph 14028S lacking a functional TolC, RamA and MarA This study 
L1508 14028S ΔtolC, ΔramA, ΔsoxS 14028S lacking a functional TolC, RamA and SoxS This study 
L1509 
14028S ΔtolC, ΔramA, ΔsoxS, 
marA::aph 
14028S lacking a functional TolC, RamA, SoxS and MarA This study 
L1511 14028S ramA::cat 14028S lacking functional RamA This study 
L1561 14028S envZ::Tn5 14028S lacking a functional EnvZ This study 
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Lab. ref. 
no.  
Strain Description Reference 
L1562 14028s tolC::cat, envZ::Tn5 
14028S lacking a functional TolC and EnvZ inactivated by 
P22 transduced from transposon library 
This study 
L1563 14028S ompR::aph 14028S lacking a functional OmpR This study 
L1564 14028S tolC::cat, ompR::aph 14028S lacking a functional TolC and OmpR This study 
L1575 14028S tolC::cat, envZ::Tn5 
14028S lacking a functional TolC and EnvZ isolated from 
transposon screen 
This study 
L1581 14028S tolC::cat, ybaJ::Tn5 
14028S lacking a functional TolC and YbaJ isolated from 
transposon screen 
This study 
L1582 14028S + pMW82-ramA 
14028S harbouring a plasmid with the promoter region of 
ramA fused to gfp 
This study 
L1583 14028S tolC::cat + pMW82-ramA 
14028S lacking a functional TolC harbouring a plasmid with 
the promoter region of ramA fused to gfp 
This study 
L1584 14028S acrB::aph + pMW82-ramA 
14028S lacking a functional AcrB harbouring a plasmid with 
the promoter region of ramA fused to gfp 
This study 
L1585 14028S + pMW82-marA 
14028S harbouring a plasmid with the promoter region of 
marA fused to gfp 
This study 
L1586 14028S tolC::cat + pMW82-marA 
14028S lacking a functional TolC harbouring a plasmid with 
the promoter region of marA fused to gfp 
This study 
L1587 14028S acrB::aph + pMW82-marA 
14028S lacking a functional AcrB harbouring a plasmid with 
the promoter region of marA fused to gfp 
This study 
L1588 14028S+ pMW82-soxS 
14028S harbouring a plasmid with the promoter region of 
soxS fused to gfp 
This study 
L1589 14028S::cat + pMW82-soxS 
14028S lacking a functional TolC harbouring a plasmid with 
the promoter region of soxS fused to gfp 
This study 
47 
 
Lab. ref. 
no.  
Strain Description Reference 
L1590 14028S acrB::aph + pMW82-soxS 
14028S lacking a functional AcrB harbouring a plasmid with 
the promoter region of soxS fused to gfp 
This study 
N/A 14028S tolC::cat + Tn5 14028S lacking a functional TolC transposon library This study 
N/A 14028S acrB::aph + Tn5 14028S lacking a functional AcrB transposon library This study 
N/A 14028S emrAB::cat + Tn5 14028S lacking a functional EmrAB transposon library This study 
N/A 14028S mdtK::cat + Tn5 14028S lacking a functional MdtK transposon library This study 
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2.1.3 Phenotypic identification of strains 
Gram staining was used to ensure all strains cultured were Gram negative rods, to 
further identify the strains, all bacteria were grown on xylose lysine deoxycholate 
(XLD) agar (Sigma-Aldrich Ltd., U.K.). Salmonella were presumptively identified as 
colonies with black spots in the centre indicating hydrogen sulphite production and a 
colour change of agar from red to pink indicating xylose fermentation, two 
characteristic features of Salmonella. Analytical profile index (API) tests (Biomérieux) 
were also used to definitively identify all strains as Salmonella. The numerical code 
obtained from an API reaction of each strain was analysed using the interpretive 
criteria at https://apiweb.biomerieux.com. 
2.1.4 Primer design and genotypic identification 
Primers were used to amplify specific DNA fragments for various applications 
including sequencing, measuring gene expression, complementation, gene 
inactivation and over-expression (Table 2.2). Primers were designed using the 
PRIMER v 2.0 software package (Science and Educational Software, Cambridge, 
U.K.) and made by Invitrogen Life Technologies (Germany) and diluted with sterile 
distilled water to a concentration of 100 µM and stored at -20°C. When required, 
primers were diluted with sterile distilled water to a 25 µM working stock and stored 
at -20°C. The details of all primers used in this study with their applications are 
shown in Table 2.2. 
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Table 2.2 Primers used in this study 
Primer Sequence Description 
16S-RTF CCT CAG CAC ATT GAC GTT AC 16S qRT-PCR forward primer 
16S-RTR TTC CTC CAG ATC TCT ACG CA 16S qRT-PCR reverse primer 
acrA-checkF ACA TCC AGG ATG TGT TGT CG acrA mutant check forward primer 
acrA-checkR CAA TCG TCG GAT ATT GCG CT acrA mutant check reverse primer 
acrB-checkF GGA TCA CAC CTT ATT GCC AG acrB mutant check forward primer 
acrB-checkR TTA ACA GTG ATC GTC GGT CG acrB mutant check reverse primer 
acrD-checkF AAT TGT GCG TGA AGC GGT acrD mutant check forward primer 
acrD-checkR GCT ACA GCG CCA TAG TAA acrD mutant check reverse primer 
acrF-checkF CCG ACG TTA CCG TAG ATG AA acrF mutant check forward primer 
acrF-checkR GTG GTA AGC AAT GCA ACT GG acrF mutant check reverse primer 
bcsA-RTF TGC AGG ACG GTA ACG ATA TG bcsA qRT-PCR forward primer 
bcsA-RTR ATC TTC CGT CAC CGT CTC AA bcsA qRT-PCR reverse primer 
bcsB-RTF AAT CAC CGA TGA TAG CGC TC bcsB qRT-PCR forward primer 
bcsB-RTR TGC ACC AAC AGA TCG ATA CG bcsB qRT-PCR reverse primer 
bcsC-RTF AGC AGT GGA TAA CAC CGA CA bcsC qRT-PCR forward primer 
bcsC-RTR TTA CCG CTA TCC ATA CGC AG bcsC qRT-PCR reverse primer 
bcsZ-RTF GCG ATA TCT GGA TGG CAT GG bcsZ qRT-PCR forward primer 
bcsZ-RTR CGG CAC ATT CAG GAC CTC TT bcsZ qRT-PCR reverse primer 
csgA-RTF AGC ATT CGC AGC AAT CGT AG csgA qRT-PCR forward primer 
csgA-RTR TTA GCG TTC CAC TGG TCG AT csgA qRT-PCR reverse primer 
csgB-RTF ATC AGG CGG CCA TTA TTG GT csgB qRT-PCR forward primer 
csgB-RTR TAC TGG CAT CGT TGG CAT TG csgB qRT-PCR reverse primer 
csgC-RTF AAT TCT CTC TGT GCG CGA CG csgC qRT-PCR forward primer 
csgC-RTF GCA GTG ATT GTC CGT CCG AA csgC qRT-PCR reverse primer 
csgD-RTF GGT ATT CTG CGT GGC GAA TG csgD qRT-PCR forward primer 
csgD-RTR AGT AAT GCG GAC TCG GTG CT csgD qRT-PCR reverse primer 
csgE-RTF ACG CTA TCT GAC CTG GAT TG csgE qRT-PCR forward primer 
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Primer Sequence Description 
csgE-RTR CGT TAT GGT GAT CCA GCT TC csgE qRT-PCR reverse primer 
csgF-RTF GAC GTT CCA GTT CGC TAA TC csgF qRT-PCR forward primer 
csgF-RTR ATC GTT GGT CAC CAT ACG TC csgF qRT-PCR reverse primer 
csgG-RTF CTG GAA CGA CAA GGC TTA CA csgG qRT-PCR forward primer 
csgG-RTR TGA TCC AGC TGA TAC TGC GT csgG qRT-PCR reverse primer 
envZ-checkF GTC ACA GAG CGC ACT TCA GA envZ mutant check forward primer 
envZ-checkR CTC TCG CGA TAA GCT GAT GA envZ mutant check reverse primer 
macA-checkF AAT ACA GCC GGC GCT ATC TT macAB mutant check forward primer 
macB-checkR GAC GTC AGC AAG ATT ACT CC macAB mutant check reverse primer 
mdfA-checkF TTC TTA CAG TGG CTG CTT GG mdfK mutant check forward primer 
mdfA-checkR CAC CTG CAG CAG ACC ATA TT mdfK mutant check reverse primer 
mdsB-checkF GCA GGA TAT CGA ATA CCG GA mdsABC mutant check forward primer 
mdsB-checkR AGG ATC TTC ACG CTC GTC AA mdsABC mutant check reverse primer 
mdtB-checkF GCG CTG GTC GTC ATG ATT AT mdtABC mutant check forward primer 
mdtB-chackR CTG GCA TAC GAT GAC GAT TG mdtK mutant check reverse primer 
mdtK-checkF GTG ATG ATC GTC CTG TGG AA mdtK mutant check forward primer 
mdtK-checkR ATA GCG GTA ACC ACA GCC AT mdtABC mutant check reverse primer 
ompR-checkF CTG TCG ATA TTG CGC ACA CG ompR mutant check forward primer 
ompR-checkR TAA TTG CTG CGC CAT CTG GT ompR mutant check reverse primer 
ramA- checkF CCA TGC GAT AAG CTG TCT CA ramA mutant check forward primer 
ramA-checkR GCG CGC TGG AAT ATT ATG TC ramA mutant check reverse primer 
ramA KOF 
ATC AGC CGT TAC GTA TTG ATG ATA TTG 
CCC GTC ATG CGG G 
Forward primer with homology to ramA and to 
aph/cat cassette to use with pKD3 or pKD4 
ramA KOR 
GCA GGT TGA ACG TGC GGG TAA AAA TGC 
GCG TAA AGG TTT G 
Reverse primer with homology to ramA and to 
aph/cat cassette to use with pKD3 or pKD4 
RATE F GAA CTT TTG CTG AGT TGA AGG ATC A 
RATE forward primer to create transposon 
insertion site sequencing template 
RATE R ATG GCT CAT AAC ACC CCT TGT ATT A 
RATE reverse primer to create transposon 
insertion site sequencing template 
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Primer Sequence Description 
Tn5 F ACC TAC AAC AAA GCT CTC ATC AAC C 
Tn5 specific forward primer for transposon 
insertion sire sequencing 
Tn5 R GCA ATG TAA CAT CAG AGA TTT TGA G 
Tn5 specific reverse primer for transposon 
insertion sire sequencing 
tolC-checkF CTT CTA TCA TGC CGG CGA CC tolC mutant check forward primer 
tolC-checkR CGC TTG CTG GCA CTG ACC TT tolC mutant check reverse primer 
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The genotypes of mutant strains were verified as carrying the expected specific 
disruptions in genes of interest by polymerase chain reaction (PCR). Bacterial cells 
were lysed to release DNA by boiling a single colony re-suspended in 100 µl of sterile 
distilled water (SDW) for 10 minutes and immediately placed on ice. This DNA lysate 
was used as a template for a PCR using specific primers homologous to the 
upstream and downstream regions of the genes of interest (Table 2.2) using the 
volumes below: 
 22.5 µl ReddyMix™ PCR Buffer (Thermo Scienctific) 
 0.75 µl upstream primer 
 0.75 µl downstream primer 
 1 µl DNA lysate 
PCR parameters varied upon size of expected amplimer and annealing temperature 
of the primers but a typical PCR cycle for a product of around 1kb is as follows: 
 95°C   5 minute   Initial denature 
 95°C  30 seconds  Denature  
 51°C*  30 seconds  Annealing 
 72°C  1 minute*  Extension 
 72°C  10 minutes  Final Extension 
*Variable parameters – annealing temperature is dependent upon GC content of 
primers. Extension time dependent upon amplimer size, typically 1 minute per 
kilobase. 
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1% agarose gels were supplemented with 5 µl of Midori Green (Nippon Genetics, 
Germany) per 100 ml of agarose to separate PCR amplimers. 5 µl of each reaction 
along with the appropriate DNA marker (often Hyperladder I (Bioline, U.K.)) were 
electrophoresed at 100 V for 1 hour. Agarose gels were visualised using a G:Box UV 
transilluminator and Genesys software (Syngene, U.K.) (Figure 2.1).  
If the correct amplimer size was seen Sanger sequencing was used to ensure the 
amplimer obtained contains the partial sequence of the gene of interest as well as 
either the correct inactivation cassette (typically aph or cat) or deletion of a section of 
the gene (for Δ strains). The sequencing reactions were set up as follows: 
 *ng of DNA template (* Amount of template required for a successful 
sequencing reaction depends upon the nature of the template and if 
sequencing from PCR the size of the PCR amplimer – Table 2.3) 
 3.2 pM of either upstream OR downstream primer  
 Nuclease free water up to 10 µl. 
Sequencing reactions were carried out by the Functional Genomics Laboratory 
(Biosciences, University of Birmingham). 
2.2 Mutant construction 
To create new mutants with specific genes inactivated, a recombinase mediated 
insertion of a resistance cassette was used. 
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Figure 2.1 A typical 1% agarose gel electrophoresed at 100 V for approximately 1 hour  
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Table 2.3 Types and quantities of DNA template required for an efficient Sanger sequencing reaction 
 
DNA Template Amplimer size Quantity required 
PCR Amplimer 100 – 200 bp  1-3 ng 
200 – 500 bp  3-10 ng 
500 – 1000 bp 5-10 ng 
1000 – 2000 bp 10-40 ng 
>2000 bp 40-100 ng 
Single-stranded DNA N/A 50-100 ng 
Double-stranded DNA N/A 200-500 ng 
Bacterial genomic DNA N/A 2-3 µg 
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A 5 ml culture of S. Typhimurium SL1344 harbouring pSIM18 (full list of plasmids –
Table 2.4), a plasmid carrying the gamma, beta and exo recombinase genes (Chan 
et al. 2007), was incubated overnight at 30°C with shaking in the presence of 150 
µg/ml of hygromycin (Sigma-Aldrich Ltd., U.K.). 4 ml of this culture was then used to 
inoculate 100 ml of fresh LB broth containing 150 µg/ml of hygromycin and incubated 
at 30°C with shaking until an optical density at 600 nm of 0.3 was achieved. Cells 
were heat shocked in a water bath at 42°C for 15 minutes and cooled immediately on 
ice for 5 minutes. Cells were harvested by centrifugation at 3,000 x g at 4°C for 10 
minutes. Supernatant was discarded and cells re-suspended in 45 ml of sterile ice 
cold water. Cells were again harvested and the pellet re-suspended as above but in 
1.5 ml of ice cold water. Cells were then washed five times by harvesting cells in a 
microcentrifuge at 10,000 x g for 2 minutes and re-suspended again in 1.5 ml of ice 
cold water after each centrifugation. The final pellets were re-suspended in 100 µl of 
ice cold water. Primers with 20 bp of homology to a resistance cassette (either aph or 
cat genes from pKD4 or pKD3 containing kanamycin or chloramphenicol resistance) 
and 40 bp of homology to the gene to be inactivated were used to amplify a product 
via PCR to be inserted into the gene to be inactivated. 40 µl of the competent cells 
were electroporated with 3-5 µg of the PCR amplimer in pre cooled 2 mm 
electrocuvettes (Geneflow, U.K.) at 2.5 kV. The cells were recovered in 400 µl of 
SOC media and incubated at 37°C for 2 hours. Cells were then spread onto agar 
supplemented with appropriate antibiotic and incubated for up to 48 hours at 37°C. 
Candidate colonies were verified by PCR using primers flanking the target gene and 
products sequenced to ensure the correct insertion of the resistance cassette.   
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Table 2.4 Plasmids used in this study 
 Plasmid  Resistance  Reference 
Gene 
inactivation 
plasmids 
pSIM18 Heat inducible recombineering vector hygromycin/ampicillin (Lee and Liu 2009) 
pKD3 
Template plasmid for gene disruption containing cat cassette 
for chloramphenicol resistance flanked by FRT sites 
ampicillin/chloroamphenicol 
(Datsenko and Wanner 
2000) 
pKD4 
Template plasmid for gene disruption containing aph 
cassette for kanamycin resistance flanked by FRT sites 
ampicillin/kanamycin 
(Datsenko and Wanner 
2000) 
pCP20 
Temperature sensitive vector containing flp (flipase) to 
remove antibiotic resistance cassettes at the FRT sites 
ampicillin 
(Cherepanov and 
Wackernagel 1995) 
Over-
expression 
plasmids 
pTrc 
High-level expression vector template inducible upon 
addition of IPTG 
ampicillin (Life technologies, UK) 
pTrc ramA 
High-level expression vector containing ramA inducible upon 
addition of IPTG 
ampicillin Courtesy of Vito Ricci 
pTrc marA 
High-level expression vector containing marA inducible upon 
addition of IPTG 
ampicillin Courtesy of Vito Ricci 
pTrc soxS 
High-level expression vector containing soxS inducible upon 
addition of IPTG 
ampicillin Courtesy of Vito Ricci 
pWKS30 Low copy number expression vector template ampicillin (Wang and Kushner 1991) 
pWKS30 acrB Low copy number expression vector containing acrB ampicillin Courtesy of James Wootton 
pWKS30 tolC Low copy number expression vector containing tolC ampicillin Courtesy of James Wootton 
gfp reporter 
plasmids 
pMW82 
Medium copy expression vector with promotorless gfp (green 
fluorescence protein) gene  
ampicillin (Bumann and Valdivia 2007) 
pMW82-ramA 
Medium copy expression vector containing gfp (green 
fluorescence protein) gene fused to ramA promoter 
ampicillin (Lawler et al. 2013) 
pMW82-marA 
Medium copy expression vector containing gfp (green 
fluorescence protein) gene fused to marA promoter 
ampicillin Courtesy of Vito Ricci 
pMW82-soxS 
Medium copy expression vector containing gfp (green 
fluorescence protein) gene fused to soxS promoter 
ampicillin Courtesy of Vito Ricci 
58 
 
2.3 P22 transduction 
Transduction with bacteriophage P22 was used to transfer specific insertion 
mutations between different strains of Salmonella. Transduction was used when 
transferring mutation between different strains of S. Typhimurium (i.e. from SL1344 to 
14028S), to create multiple inactivations and to ensure any new inactivations created 
by the pSIM protocol (section 2.2) are in a ‘clean’ background.  
A 10 ml culture of desired strain containing the inactivation of interest was grown 
overnight in LB broth at 37°C with shaking (200 rpm). 50 µl of this overnight culture 
was used to inoculate 5 ml of fresh LB broth supplemented with 500 µl of 
100 mM MgSO4 and 50 µl of 500 mM CaCl2 and incubated for 30 minutes at 37°C 
with shaking (200 rpm). 5 µl of P22 phage stock was added to this culture and 
incubated overnight at 37°C with shaking (200 rpm). 1 ml of chloroform was added to 
the overnight culture. Mixed thoroughly by vortexing and pelleted via centrifugation at 
3,000 x g and 4°C for 10 minutes. The supernatant (only the upper liquid layer) was 
transferred to a glass bijou and 200 µl of chloroform added and mixed by vortexing 
briefly. This phage was then kept at 4°C until required.  
A 10 ml culture of the recipient strains were grown overnight in LB broth at 37°C with 
shaking (200 rpm). A pellet was obtained by centrifugation at 2,500 x g at room 
temperature for 10 minutes. The supernatant was discarded and the pellet 
re-suspended in 1 ml of LB broth containing 10 mM MgSO4 and 5 Mm CaCl2. 
Transduction reactions were set up by dispensing 100 µl aliquots of cell suspension 
and adding a volume of P22 phage (containing packaged DNA with desired 
markers), ranging between 0 and 100 µl, to each sample. These reactions were 
incubated at 37°C for 15 minutes. 100 µl of sodium citrate and 1 ml of LB broth were 
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then added to chelate divalent cations and incubated at 37°C for 45 minutes. To 
select for transductants, 100 µl from each transduction reaction was spread onto LB 
plates supplemented with appropriate antibiotics and incubated overnight (or 48 
hours if required) at 37°C. Any colonies obtained were purity plated onto appropriate 
antibiotic and transferred mutation verified by PCR and sequencing. 
2.4 Removal of resistance cassettes 
Resistance cassettes were removed from selected mutant strains to allow 
transduction of additional mutant alleles harbouring the same resistance cassettes to 
create strains with two or more mutations. Competent cells of the strains harbouring 
the resistance cassettes to be removed were made by harvesting 10 ml of a 
mid-logarithmic culture grown in LB broth via centrifugation at 4°C and 2,250 x g for 
10 minutes before the resulting supernatant was discarded. Pellets were then 
re-suspended in 10 ml of ice cold 15% glycerol. This centrifugation and 
re-suspension step was repeated. Suspensions were harvested again and 
re-suspended in a final volume of 1 ml of 15% glycerol. Competent cells can be used 
immediately or stored at -80°C until required. 45 µl of competent cells were then 
electroporated at 2.5 kV for 5 ms with 1 ng of the plasmid pCP20 (Cherepanov and 
Wackernagel 1995), and recovered in 1 ml of SOC for one hour at 30°C with shaking 
(200 rpm). 200 µl of recovered cells were plated onto LB agar plates containing 
50 µg/ml of ampicillin and incubated for up to 48 hours at 30°C. Candidate colonies 
were verified via PCR for loss of resistance cassette and by patching onto LB agar 
containing appropriate antibiotics. Successful colonies were used to inoculate 10 ml 
of antibiotic free LB broth and incubated overnight at 43°C with shaking (200 rpm) to 
allow for loss of the plasmid as pCP20 carries a temperature sensitive origin of 
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replication. A loopful of culture was streaked onto LB agar and incubated at 37°C 
overnight. Candidate strains were then patched onto LB agar supplemented with 
ampicillin and tested for susceptibility (to ensure plasmid has been cured) and 
kanamycin/chloramphenicol susceptibility (to ensure loss of resistance cassette). 
2.5 Plasmid purification, construction and transformation 
2.5.1 Plasmid purification 
Plasmids were isolated from strains to over-express genes of interest, allow 
complementation and to introduce fluorescent reporter proteins for imaging. Plasmid 
DNA was harvested using the QIAprep® Spin Cell Mini Kit (QIAGEN) as follows. 
10 ml overnight cultures in LB broth of strains of interest (containing plasmids) were 
incubated and pellets harvested by centrifugation for 10 minutes at 2,250 x g. Pellets 
were re-suspended in 250 µl of buffer P1 (QIAGEN) and transferred to a 
microcentrifuge tube. 250 µl of buffer P2 (QIAGEN) was then added and the tube 
was immediately mixed by inversion to ensure the solution was mixed thoroughly. 
This was followed by addition of 350 µl of buffer N3 (QIAGEN) and again the tubes 
were immediately mixed by inversion. The tubes were centrifuged at 4,500 x g in a 
table-top centrifuge for 10 minutes and the supernatants transferred to spin columns 
using a pipette. Spin columns were placed in clean microcentrifuge tubes and 
centrifuged again for 1 minute at 4,500 x g and the flow-through discarded. Columns 
were washed with 500 µl of buffer PB (QIAGEN), centrifuged for 1 minute and the 
flow-through discarded. Columns were again washed by adding 750 µl of buffer PE 
(QIAGEN), centrifuged for 1 minute and the flow-through discarded before being 
centrifuged for an additional minute to remove residual wash buffer. Columns were 
placed into clean microcentrifuge tubes and plasmid DNA eluted by adding 50 µl of 
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buffer EB (QIAGEN) and centrifuging for 1 minute. The resulting plasmid DNA was 
analysed by agarose gel electrophoresis using a 1% agarose gel. The plasmid DNA 
was quantified by analysing gel images using Gene Tools (Syngene, U.K.). Plasmid 
DNA was stored at -20°C. 
2.5.2 Plasmid transformation 
Competent cells of recipient strains were prepared (see section 2.4) and chilled on 
ice until transformation. 50 µl of competent cells and around 1 ng of plasmid DNA 
were added to a microcentrifuge tube and chilled on ice for 20 minutes. Suspensions 
were transferred to a 2 mm electrocuvette and electroporated immediately with 
2.5 kV for 5 ms. Cells were recovered by adding 950 µl of SOC media and incubated 
at 37°C with shaking (200 rpm) for 1.5 hours. Two volumes of the recovered cells 
(100 and 200 µl) were spread onto LB agar containing appropriate antibiotics and 
incubated overnight at 37°C. Colonies obtained were verified by purity plating on LB 
agar supplemented with appropriate antibiotics and plasmid purification (as in section 
2.5.1) to ensure plasmid has been successful inserted.  
2.6 Growth Kinetics  
To determine whether any of the mutants studied had a growth deficit which could 
impact on their ability to form a biofilm, growth kinetics of each were investigated. 
Overnight cultures of strains were diluted 1 in 25 in fresh pre-warmed LB broth 
without salt. For each strain two biological and two technical replicates were used. A 
96 well microtitre tray was inoculated with 100 µl of this bacterial suspension and 
incubated at 30°C with intermittent agitation. The optical density at 600 nm was 
measured every 10 minutes for 16 hours using a FLUOstar OPTIMA (BMG, U.K.). 
Results were analysed by plotting average values for each strain on a logarithmic 
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graph and calculating standard deviations to use as error bars. Generation times 
were also calculated using the logarithmic growth phase of the line graph and the 
following equation; 
g =           T ln2                         (where g is generation [doubling] time and T is time) 
      ln (ODend/ODstart)  
Values which appeared different to the parent strain were evaluated for significance 
at defined time points using a students ‘t’ test. 
2.7 Antimicrobial susceptibility testing  
Antimicrobial susceptibility testing was used to define the impact of gene inactivation 
and as another method to verify the phenotype of all mutant strains. The agar 
doubling dilution method was used to determine the minimum inhibitory concentration 
(MIC) of antimicrobials according to the method of the British Society of Antimicrobial 
Chemotherapy (Andrews 2007). Antibiotic stocks were prepared and diluted and 
labelled universal tubes and Petri dishes were prepared for each final test 
concentration of each antibiotic required. The appropriate volume of antibiotic stock 
was added to a universal to give the desired concentration when added to 20 ml of 
molten iso-sensitest agar (using a dilution table – Table 2.5). A perifill peristaltic 
pump was set up aseptically and used to dispense 20 ml of molten agar into the 
universals containing the antibiotics, swirled and poured into the corresponding Petri 
dish. Two antibiotic free Petri dishes were also set up to become a ‘start’ and ‘finish’ 
plate to act as inoculation controls. The agar plates were left on the bench to set for 
15 minutes before being dried at 50°C. 100 µl of overnight LB broth cultures were 
diluted in 10 ml of sterile LB broth to give approximately 107 cfu/ml.  
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Table 2.5 Antibiotic stocks required to prepare final antibiotic concentrations in 20 ml of agar 
 Final concentration of antibiotic in 20 ml of agar 
Final required 
concentration 
1024 512 256 128 64 32 
Volume of 10,000 µg/ml 
stock required 
2048 1024 512 256 128 64 
Final required 
concentration 
16 8 4 2 1  
Volume of 1,000 µg/ml 
stock required 
320 160 80 40 20  
Final required 
concentration 
0.5 0.25 0.12 0.06   
Volume of 100 µg/ml 
stock required 
100 50 25 13   
Final required 
concentration 
0.03 0.015 0.008    
Volume of 10 µg/ml  
stock required 
 
60 30 15    
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From this bacterial suspension, 100 µl was added to the wells of a 21 or 100 pin 
template. All agar plates were inoculated using a multipoint inoculator with 1 µl of the 
diluted suspension to give a final inocula of ~104 cfu starting with the ‘start’ plate and 
finishing with the ‘finish’ plate. Inoculated agar plates were incubated overnight at 
37°C. Plates were read by first ensuring that all strains grew on the antibiotic free 
‘start’ and ‘finish’ plates. The lowest concentration of an antibiotic at which the each 
strain showed no growth was recorded and defined as the minimum inhibitory 
concentration (MIC) of that drug against the relevant strain. 
2.8 Metabolomics 
In parallel with this project a metabolomics investigation was used to explore the 
hypothesis that AcrAB-TolC may export metabolites whose accumulation is toxic and 
deleterious to biofilm formation, differences in intracellular metabolites present within 
L828 (wild-type) and L830 (acrB::aph) were investigated. The results from this work 
were made available for interrogation in this project; the methodology was briefly as 
follows:  
Six replicate cultures (25 ml, defined MOPS minimal media) were grown to 
logarithmic phase (OD600 of 0.7) after incubation with shaking (170 rpm) at 37°C. 
Ten ml of each culture was withdrawn and metabolites quenched by adding the 
sample to 10 ml of -46°C 60% methanol (+ 70 mM HEPES). Cells were then 
harvested by centrifugation at 3250 x g at  -4°C. The supernatant was discarded and 
cell pellets stored at -80°C overnight. The pellets were then re-suspended in 5ml of -
46°C 60% methanol (+ 70 mM HEPES) and the OD (600 nm) measured for each and 
additional -46°C 60% methanol (+ 70 mM HEPES) added to standardize the 
concentration of metabolites before being harvested again. Supernatants were 
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discarded again and pellets stored at -80°C until metabolite extraction. Metabolite 
extraction and analysis by mass spectrometry was completed by the functional 
genomics unit (School of Biosciences, University of Birmingham) according to their 
protocols. Analysis of metabolites present and differences between samples used a 
principal component analysis, Benjamini Hochberg correction for removal of false 
positives and calibration of the experimental data against mass results for known 
metabolites. All bioinformatic analysis was in collaboration with the group of Dr Mark 
Viant (School of Biosciences, University of Birmingham). 
2.9 Biofilm formation assays 
A variety of different assays were used to evaluate formation of biofilms over time, in 
different media, on various materials, at liquid air interfaces and under different flow 
conditions. 
2.9.1 Optimising the crystal violet biofilm formation assay 
A simple, high throughput biofilm formation assay to allow screening of large 
numbers of strains or inhibitors was used as follows; overnight broths were diluted in 
5 ml of appropriate media to an optical density at 600 nm of 0.1. A 200 µl (or 500 µl) 
aliquot of this dilution was dispensed into a well of a microtitre tray. The pattern of 
inoculation of the microtitre tray was recorded. A number of variables were assessed 
when defining optimum conditions: 
 24 (inoculated with 500 µl of bacterial suspension rather than 200 µl) or 96 
well microtitre trays were used 
 Temperature was altered between 30°C and 37°C 
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 Different media was used – LB broth, MOPS minimal media (Teknova, USA) 
and M9 minimal media 
 Varying concentrations of NaCl were added to the media 
 Gentle agitation or static incubation 
 Time – biofilms were analysed between 24 and 96 hours of growth. 
Once the desired incubation time had ended biofilms were washed in sterile distilled 
water to remove unattached cells. Next, 200 µl of 1% crystal violet was added to the 
wells and incubated for 15 minutes at room temperature to stain the cells associated 
with the biofilm. The crystal violet was removed from the wells which were washed 
again using sterile distilled water. The crystal violet retained was solubilised by 
addition of 200 µl of 70% ethanol. The OD (600 nm) of each well was then measured 
using a FLUOstar OPTIMA (BMG labtech). At least two biological replicates of each 
strain and four technical replicates of each were used in a run, repeat runs were 
included before final analysis of data. Average biofilm formation for each strain was 
determined and plotted on a bar chart, as well as standard deviations and values 
used as error bars. Differences between strains or addition of inhibitors was analysed 
with the students ‘t’ test.  
2.9.2 Biofilm formation assay with EIs 
An assay was developed to observe the effects of different efflux inhibitors (EIs) on 
the formation of biofilms. The EIs used in this study were carbonyl cyanide m-
chlorophenylhydrazone (CCCP), chlorpromazine (CPZ) and phenyl-arginine-β-
naphthylamide (PAβN), each thought to have a different mechanism of action. CCCP 
abolishes the proton motive force (Pages et al. 2005) which provides the energy 
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used for the majority of MDR efflux systems (with ABC transporters being the 
exception). CPZ has been shown to stop serotonin uptake in human cells and also 
inhibits bacterial efflux and is thought to work via inducing ramA and repressing acrB 
(Bailey et al. 2008). PAβN is a substrate and acts as a competitive inhibitor of AcrAB-
TolC (Lomovskaya et al. 2001). All wells of a 96 well MTT were filled with 50 µl of 
appropriate media. 50 µl of EI (at twice the desired highest final concentration) was 
added to each well of column one and mixed by pipetting up and down gently. 50 µl 
of this solution was removed from column 1 and transferred to column 2, this 
doubling dilution was repeated across the MTT leaving column 12 free from EI. 
Overnight broths were diluted with appropriate broth to an optical density at 600 nm 
of 0.1. 50 µl of this suspension was then used to inoculate appropriate rows of the 
MTT. Each MTT was then incubated for 48 hours at 30°C with gentle agitation. 
Biofilms were stained and analysed (see section 2.9.1). 
2.9.3 Biofilm formation assay with exogenous polyamine 
This assay was used to observe the effects of exogenous polyamines on the ability of 
Salmonella to form biofilms. Polyamines have been linked with biofilm formation in 
Yersinia pestis (Patel et al. 2006) and were also identified as over-accumulated 
within L830 (acrB::aph) relative to L828 (wild-type) in metabolic experiments carried 
out in this laboratory. Polyamines used were; acetyl-spermidine, cadaverine, 
putrescine and spermidine. 
100 mM stocks of the appropriate polyamine were prepared in broth and each row of 
a 96 well MTT was loaded with 100 µl of a different concentration of polyamine (each 
at twice the final desired concentration), i.e. row 1 – 20 mM, row 2 – 2 mM, row 3 – 
0.2 mM etc. Overnight broths cultures prepared in LB broth of desired bacterial 
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strains were diluted in sterile LB broth without salt to an optical density at 600 nm of 
0.2 and 100 µl used to inoculate appropriate wells of the MTT. Broth controls 
(containing no bacteria) and polyamine controls (containing bacteria but no 
polyamine) were included. Two biological and two technical repeats were used for 
each strain. MTTs were incubated at 30°C for 48 hours with gentle agitation. Biofilms 
were stained and analysed (see section 2.9.1). 
2.9.4 Membrane stress biofilm formation assay 
Membrane stress two component systems have been shown to evoke repression of 
biofilm related genes (Jubelin et al. 2005). An assay to artificially stress the bacterial 
membrane through changes in osmolarity and pH of the extracellular environment 
was used to assess whether a membrane stress response was relevant to biofilm 
repression in the efflux mutants. 10 ml overnight cultures were diluted to an OD (600 
nm) of 0.1 in LB broth without salt adjusted to appropriate pH levels and LB broth 
without salt supplemented with 20% glucose. Two biological and four technical 
replicates were used for each strain or pH level. A 200 µl aliquot of these dilutions 
were dispensed into the wells of a 96 well MTT and incubated at 30°C for 48 hours. 
Biofilms were stained and analysed (see section 2.9.1). 
2.9.5 Formation of floating biofilm mats 
10 ml overnight cultures grown in LB broth were diluted to an OD (600 nm) of 0.1 in 
LB broth without salt. 1 ml of this bacterial suspension was transferred into 
appropriate wells of a 24 well MTT. The MTT was incubated statically, at room 
temperature for 5 days. By incubating in this manner floating biofilm mats were 
formed on the surface of the liquid and easily removed with sterile tweezers allowing 
intact biofilms to be harvested for further analysis. 
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2.9.6 Transwell biofilm assay 
A transwell assay was used to assess if the mutants’ ability to form a biofilm can be 
rescued by the presence of wild-type supernatant. Transwell plates 
(ThermoScientific, U.K.) were used to co-incubate both wild-type and mutant 
separated by a permeable membrane to allow wild-type supernatant (but not 
wild-type cells) into the well where the mutant cells are forming a biofilm. 10 ml 
overnight cultures were prepared of both wild-type and efflux mutant strains in LB 
broth, these cultures were diluted to an optical density at 600 nm of 0.1 in fresh LB 
broth without salt. 600 µl of mutant bacterial suspension was transferred into the 
bottom well and 100 µl of wild-type suspension into the top well (Figure 2.2). Control 
wells were also set with wild-type suspension in both top and bottom wells. Transwell 
plates were then incubated at 30°C for 48 hours with gentle agitation. Top wells were 
removed from the transwell plate and planktonic culture from the bottom well 
discarded. Biofilms formed in the bottom well were stained with 1 ml of 1% crystal 
violet and incubated at room temperature for 15 minutes. Any unbound dye was 
removed from the wells and washed with sterile distilled water. Bound dye was 
solubilised with 1 ml of 70% ethanol. The optical density at 600 nm was measured on 
a FLUOstar, averages plotted on a bar chart and standard deviation calculated. 
Statistically significant differences were calculated using a student’s t test with p<0.05 
as the threshold.   
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Figure 2.2 Schematic cross section diagram of a Transwell co-incubation well showing where wild-type and mutant 
suspensions were incubated, the positioning of the semi-permeable membrane that allows supernatant from with well to 
permeate and the location of the biofilm growth that was quantified via crystal violet staining. 
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2.9.7 Biofilm co-incubation assay 
In an attempt to determine whether the efflux mutants’ could be incorporated into a 
biofilm when grown with the wild-type strain, direct co-incubation experiments were 
used. 10 ml overnight cultures were diluted to an optical density at 600nm of 0.1 in 
LB broth without salt. Two biological and four technical replicates of each strain were 
tested. 1 ml of bacterial suspension was used to inoculate control wells containing 
only one strain and the co-incubation wells were inoculated with 0.5 ml of each strain 
(Figure 2.3). The strains were also incubated in isolation to ensure that all strains 
were viable under assay conditions, after a 96 hour incubation period a mat of biofilm 
floating on the surface of the media should be visible. The viable count of the 
planktonic culture (to ensure the co-incubated strains were able to grow to a similar 
cfu/ml) and the biofilm mat of each well were calculated after 24, 48, 72 and 96 hour 
incubation periods for planktonic cfu/ml and 96 hours for biofilm mat. This was 
achieved for the planktonic culture by diluting 20 µl of culture from the well in 180 µl 
sterile PBS. For the biofilm mat, the mat was extracted with sterile tweezers and 
transferred into 1 ml of sterile PBS in a microcentrifuge tube and sonicated on ice 
four times at 30 seconds. Both the planktonic and biofilm mat suspensions were then 
further double diluted along a 96 well microtitre tray so 12 dilutions were made. Each 
dilution was used to aliquot three, 20 µl spots onto an LB agar plate supplemented 
with appropriate antibiotic. Co-incubation bacterial dilutions were plated onto both 
antibiotic free LB agar plates and either 25 µg/ml chloramphenicol LB agar plates 
(L829 (tolC::cat)) or 50 µg/ml kanamycin LB plates (L830 (acrB::aph)). Only the 
mutant strains could grow on the antibiotic agar plate so colony counts from antibiotic 
agar plates were taken to represent mutant numbers 
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Figure 2.3 Co-incubation biofilm assay 24 well microtitre tray template showing pattern of inoculation for wild-type and mutant 
bacterial suspensions including media quality controls, all strain incubated alone to ensure planktonic growth is consistent and 
both co-incubation tests. 
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The wild-type count was calculated by subtracting the mutant count (i.e. the count on 
the antibiotic agar plate) from the total count (i.e. the count on the antibiotic free LB 
agar plate). Data was analysed by plotting average cfu/ml on a logarithmic graph and 
standard deviations calculated.  
2.9.8 Microfluidic flow cell biofilm assay 
A Bioflux (Fluxion, US) was used to visualise the effect to the biofilm phenotype 
under flow conditions. To prime the flow cells with media, 200 µl of LB broth without 
salt was added to the inner circle of the output wells of a 48 well Bioflux flow cell 
plate (Fluxion, US) (Figure 2.4). A Bioflux manifold (Fluxion, US) was attached to the 
48 well plate along with the relevant Bioflux tubes. The Bioflux software was used to 
select media (LB broth), temperature (20°C) and flow rate (5 dynes). The required 
wells were selected on the software to start the flow and flow stopped after 5 
minutes. Any residual media was removed, apart from the media in the inner pockets 
of the inlet and outlet wells. Overnight cultures diluted in fresh LB broth without salt 
were diluted to an optical density at 600 nm of 0.1 and the flow channels were 
inoculated by transferring 50 µl of this bacterial suspension to the output wells. To 
balance the flow cell, 50 µl of fresh LB broth without salt was added to the inlet well. 
The bacteria were then introduced into the flow channel at 3 dynes for approximately 
3 seconds until the bacterial cells reach the start of the flow cell. This can be seen by 
placing the plate onto a LTSi-1000 inverted microscope (Labtech, US) so that the 
neck of the flow cell is in field, once cells can be seen the flow must be stopped to 
ensure the sterility of the serpentine (tubing leading up to the inlet well). Even 
coverage of the bacterial cells in the flow channel needs to be observed before allow 
the bacteria to attach at 30°C for 3 hours. 
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Figure 2.4 High-throughput biofilm flow cell system (A) Bioflux system set up consisting of pneumatic pump attached to a 
manifold via tubing which is placed on top of a 48 well Bioflux plate and an inverted microscope. (B) Diagram of a 48 well 
Bioflus plate showing 24 inlet and 24 outlet well connected by 24 independent flow cells. (C) Cross-section diagram of one 
inlet-flow cell-outlet set up with annotation showing fresh and spent medium, biofilm growth and where the pneumatic pressure 
is placed. (D) Two microfluidoc flow cells; black circles represent fresh medium in the inlet wells and the black line shows the 
path of the media through the serpentine then the flow cell and in the outlet well (Benoit et al. 2010). 
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Once bacterial cells have attached 1 ml of fresh LB broth without salt was added to 
the inlet well and flow rate set at 0.3 dynes for 16 hours. Camera images can be 
taken at various intervals at x10, x20 and x40 magnification. Estimation of areas of 
flow cells covered used the Bioflux EZ software (Labtech, U.K) and triplicate flow cells 
were measured multiple times to give average values for coverage in defined areas 
which were then compared between strains or treatments. 
2.10 Visualisation and quantification of biofilm matrix components 
2.10.1 Scanning electron microscopy 
5 ml overnight cultures in universal tubes were incubated at 37°C overnight with 
shaking (200 rpm) before addition of a 10 mm square glass cover slip at 30°C for 48 
hours to allow a biofilm to form on the surface of the cover slip. The cover slip was 
removed and submerged in a primary fixative of 2.5% gluteraldehyde in phosphate 
buffer. Subsequent dehydration and mounting steps were carried out at the Centre 
for Electron Microscopy, University of Birmingham. Dehydration of samples was 
achieved by using a graded ethanol series as follows;  
 70% ethanol for 15 minutes (twice) 
 90% ethanol for 15 minutes (twice) 
 100% ethanol for 15 minutes (twice) 
 100% dried ethanol with molecular sieve for 15 minutes (twice) 
The samples were then dried in a Polaron E3000 CPD critical point drier (Quorum 
Technologies Ltd, U.K.). Samples were mounted on stubs and sputter coated with 
platinum in an EMScope SC500 sputter coater (Quorum Technologies Ltd, U.K.). 
76 
 
Scanning electron microscopy images were viewed at a variety of magnifications on 
a Philips XL30 FEG ESEM (FEI, U.S.A.).  
2.10.2 Quantitative Congo red staining 
To assess production of the aggregated amyloid fibre, curli a dye called Congo red 
was used. Strains were streaked onto LB agar plates without salt and incubated at 
30°C overnight. Bacterial suspensions were then made by harvesting a 1 cm patch of 
bacterial growth from a densely inoculated section of the plate in 5 ml of PBS and 
optical density at 600 nm measured. All samples were corrected to the lowest OD 
obtained by diluting with PBS. 500 µl of each bacterial suspension was added to 500 
µl of a 20,000 µg/ml Congo red solution and left to stain for 20 minutes. Pellets were 
obtained by centrifugation at 13,000 rpm for 5 minutes, washed with 1 ml of sterile 
distilled water and harvested again. The pellets were then re-suspended in 200 µl of 
PBS and the optical density at 492 nm and fluorescence (Ex 492, Em 600) measured 
in a FluoSTAR OPTIMA (BMG, U.K.). 
2.10.3 Congo red agar 
The presence of curli proteins on the surface of the outer membrane of strains of 
interest were detected by diluting overnight cultures of strains of interest grown in LB 
broth to a final dilution of 1:10,000 in sterile PBS. 5 µl of this final cell suspension was 
dispensed onto LB agar without salt supplemented with 40 µg/ml of Congo red 
(Sigma-Aldrich Ltd., U.K.). Red, dry and rough colonies were observed for strains 
producing both curli and cellulose. Pink colonies were observed for strains producing 
cellulose but no curli. Smooth and white colonies were observed for strains producing 
neither curli or cellulose (Jonas et al., 2007).  
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2.10.4 Calcoflour agar 
The presence of cellulose in the extracellular matrix was detected (see section 
2.10.3) using 200 µg/ml of Calcofluor (fluorescence brightener 28 - Sigma-Aldrich 
Ltd., U.K.) in the agar instead of 40 µg/ml of Congo Red. Agars plates were 
visualised on a UV transilluminator and difference in fluorescence levels compared to 
wild-type under ultra violet indicates differing phenotypic cellulose expression.  
2.11 Cell surface hydrophobicity and aggregative ability 
2.11.1 Settle assay 
Any changes in cellular hydrophobicity which allows aggregative ability could impact 
the ability of strains to form a biofilm, settle assays were used to measure this. 10 ml 
LB without salt broths were incubated overnight with shaking (150 rpm) and the 
following morning placed on a laboratory bench around a Bunsen burner. Three 
biological replicates and two technical replicates of each strain were used. A 100 µl 
sample was taken from immediately below the surface of each overnight broth, at 0 
hours, two hours, four hours, six hours and 24 hours, and the optical density at 600 
nm measured. The data was then analysed by converting each hourly optical density 
reading to a percentage of the initial optical density (at time 0) and the average of the 
six replicates plotted on a bar graph. Standard deviations were measured and used 
as error bars and any differences to wild-type analysed using the students ‘t’ test. 
2.11.2 Salt aggregation test 
Bacterial cell aggregation can also be measured by observing the lowest 
concentration of a salt solution required to induce aggregation (Ljungh and Wadstrom 
1982). A 4 M stock of (NH4)2SO4 was prepared in phosphate buffered saline (PBS) 
and the pH of the solution adjusted to 6.8. The 4 M stock was double diluted in sterile 
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PBS to create a range of concentrations from 4 M to 0.002 M. Overnight cultures 
were diluted to an optical density at 600 nm of 0.8 in PBS. 50 µl of bacterial 
suspension was transferred onto a microscope slide and mixed with 50 µl of 4 M 
(NH4) 2SO4. This was repeated for each concentration of (NH4) 2SO4. The 
microscope slides were gently rocked for 2 minutes and left on the bench for 1 hour. 
A visual reading was taken against a black background with a light microscope. Cell 
surface hydrophobicity was quantified by using the lowest (NH4) 2SO4 concentration 
needed for aggregation to be seen as the salt aggregation test (SAT) value. The 
lower the SAT value the greater the cell surface hydrophobicity of the bacterial cell.  
2.12 Membrane component preparations 
2.12.1 Lipopolysaccharide preparation 
To determine whether disruption of efflux pumps altered lipopolysaccharide (LPS) 
production, LPS was prepared and analysed. A 5 ml of culture of bacterial strains of 
interest were grown in LB broth at 37°C overnight with shaking (200 rpm). The optical 
density of the overnight culture were measure at 600 nm, ideally the overnight 
cultures will have reached an optical density at 600nm of 3.5 or higher. 250 µl of the 
overnight culture was dispensed into a microcentrifuge tube and pelleted via 
centrifugation at 14,000 x g for 10 minutes. All supernatant was discarded and pellet 
re-suspended in cracking buffer (SDS-Page loading buffer), the volume of which is 
calculated by multiplying the optical density at 600nm of the overnight culture by 25 
(e.g if the optical density at 600 nm of the overnight culture is 4, then 100 µl of 
cracking buffer would be used to re-suspend the pellet). This suspension was then 
boiled for 4 minutes and frozen at -80°C for 5 minutes. The frozen lysates were then 
defrosted quickly and boiled again for 4 minutes. Pellets were again obtained via 
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centrifugation in a microcentrifuge at 14,000 x g for 2 minutes. Around 80 µl of the 
supernatant was discarded and 5 µl of 5 mg/ml of Proteinase K to digest any protein 
(A 5 ml/mg stock of Proteinase K was prepared by diluting a 20 mg/ml stock 1 in 4 
with cracking buffer). This mixture was incubated at 60°C for 1 hour and then heated 
to 95°C for 5 minutes. 4 µl of loading buffer was added to 10 µl of LPS sample 
heated to 95°C for 5 minutes and then loaded onto a 10% Bis-Tris Bolt™ gel (Life 
Technologies, U.K.) and electrophoresed at 80 V for around 1 hour. Bis-Tris Bolt™ 
gels were stained using SimplyBlue™ SafeStain (Life Technologies, U.K.) (see 
section 2.12.4). 
2.12.2 Outer membrane protein preparation 
3 ml overnight cultures of strains were prepared in LB broth and incubated at 37°C 
with shaking (200 rpm). 50 ml of pre-warmed LB  broth without salt was inoculated 
with a 4% inoculums of the overnight culture and incubated at 30°C until mid to late 
logarithmic phase is reached (an optical density at 600 nm of 0.7-1.0 for Salmonella). 
Around 25 ml of this culture was transferred to a sterile universal tube and pelleted 
via centrifugation at 3000 x g at 4 °C for 15 minutes. The supernatant was discarded 
and the remainder of the culture transferred on top of the pellet and centrifugation 
repeated. The supernatant was once again discarded and the pellet was 
re-suspended in 10 ml of ice cold sterile PBS to wash cells. Pellets were again 
obtained via centrifugation at 3000 x g at 4°C for 10 minutes. Samples were kept on 
ice between steps. The supernatent was once again discarded and pellet 
re-suspended in 1 ml of ice cold sterile PBS, the sample was then transferred to a 
sterile glass bijou tube and stored at -20°C overnight. The following day samples 
were thawed on ice and sonicated with a Soniprep 150 microprobe (Sanyo, Japan) 
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four times at 30 seconds with a 30 second rest on ice. Sample was then transferred 
to a labelled ice cold microcentrifuge tube and pelleted via centrifugation at 5,000 x g 
at 4°C for 5 minutes. The supernatant was discarded and the pellet was 
re-suspended by vortexing in 200 µl of a 2% sarcosyl solution and incubated at room 
temperature for 30 minutes. The sample was once again pelleted via centrifugation at 
10,000 x g at room temperature for 30 minutes. The supernatant was again 
discarded and pellet air dried for 15 minutes to ensure the pellet is completely dry. 
The dry pellet was re-suspended by vortexing in 50 µl of sterile PBS. The sample 
was peletted via centrifugation in a microcentrifuge at room temperature at 10,000 x 
g for 10 minutes to wash off any remaining sarcosyl. The supernatant was discared 
for the final time and the pellet re-suspended in 50 µl of sterile PBS and can be 
stored at -20°C prior to estimating the amount of protein present (see section 2.12.3) 
and analysing on a 10% Bis-tris Bolt™ gel (see section 2.12.4). 
2.12.3 Bradford assay for protein quantification 
A set of 5 bovine serum albumin (BSA) (Sigma, U.K.) standards were prepared; 0.1, 
0.2,0.3, 0.4 and 0.5 mg/ml. Transfer 20 µl of each standard into clean microcentrifuge 
tubes and add 1 ml of Bradford reagent (Sigma, U.K.) (Bradford 1976). Samples 
were incubated at room temperature for 5 minutes. A no protein control (1 ml of 
Bradford regent and 20 µl of water) in a cuvette was used to calibrate a 
spectrophotometer at 595 nm. Each sample was transferred to a cuvette and optical 
density at 595 nm was then measured in a spectrophotometer and plotted on a graph 
of optical density against BSA concentration (Figure 2.5) on Microsoft Excel 2010 
(Microsoft, USA). A line of best fit was added to the graph and equation of the 
straight line calculated.  
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Figure 2.5 A representative Bradford assay standard curve for protein quantification using standards of Bovine Serum 
Albumin (BSA)of 10, 20, 30, 40 and 50 µg/ml and corresponding optical density values at 595 nm plotted on a line graph. Line 
of best fit and equation of a straight line calculated using Microsoft Excel 2010 (Microsoft, US) and equation rearranged and 
annotated to allow estimation of unknown protein samples from their optical density value. 
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20 µl of the protein sample to be quantified was added to 1 ml of Bradford reagent in 
a cuvette and optical density at 595 nm measured on a spectrophotometer. To 
calculate the quantity of protein in the sample put the optical density obtained into the 
equation of the line of best fit from the graph. Each protein preparation was diluted 
the match the protein sample of the lowest concentration before being analysed on a 
10% Bis-tris Bolt gel (see section 2.12.4) 
2.12.4 OMP/LPS gel staining 
OMP and LPS Bolt™ gels were stained with SimplyBlue™ SafeStain (Invitrogen, 
U.K.). Gels were transferred into a square petri dish and washed with 100 ml of 
Ultrapure water with gentle agitation for 5 minutes. This wash step was repeated a 
further 2 times. The gel was then stained with 20 ml of SimplyBlue SafeStain for 1 
hour with gentle agitation. The stain was then removed and washed with 100 ml of 
Ultra pure water with gentle agitation for 1 hour. Gels were visualised on a 
transilluminator with a white light converter.  
2.13 Gene expression analysis 
Expression of genes thought to be relevant to biofilm formation was measured under 
various conditions.  
2.13.1 RNA preparation from stationary phase planktonic cells 
10 ml cultures in LB broth were prepared for strains of interest and incubated 
overnight at 37°C. These cultures were the used to inoculate 50 ml of fresh LB 
without salt broth in 250 ml glass flasks and incubated at 30°C for 6 hours with 
shaking (200 rpm) to attempt resemble conditions used for biofilm formation. 4 ml of 
each suspension was added to 1 ml of ice cold 5% phenol, 95% ethanol and stood 
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on ice for 30 minutes. The Promega ‘SV40 total RNA kit’ protocol was then followed 
according to the manufacturer’s instructions. After incubation on ice for 30 minutes, 
pellets were obtained by centrifugation at 4°C (2,250 x g, 10 minutes) and the 
supernatant discarded. The resulting pellets were re-suspended in residual 
supernatant and transferred to a 1.5 ml microcentrifuge tube. Pellets again were 
obtained via centrifugation in a table top centrifuge at 14,000 x g and the supernatant 
discarded. Pellets were re-suspended using 100 µl of TE buffer containing 50 mg/ml 
lysozyme and incubated at room temperature for 5 minutes. 75 µl of lysis reagent 
(Promega, U.K.) was added and samples were mixed by inversion followed by 
addition of 350 µl of RNA dilution buffer (Promega, U.K.) and again mixed well by 
inversion. Samples were heated at 70°C for 3 minutes, mixed by vortexing and 
centrifuged at 4,500 x g in a table-top centrifuge. The supernatant (containing RNA) 
was transferred to a clean microcentrifuge tube. 200 µl of 100% ethanol was added 
to the supernatant, mixed and transferred to spin columns (Promega, U.K.). Columns 
were centrifuged for 30 seconds, then washed with 600 µl wash buffer (Promega, 
U.K.) and centrifuged for 30 seconds. DNAse mix was prepared (using reagents 
supplied with kit, Promega, U.K.): 5 µl 90 mM MnCl2, 40 µl DNAse core buffer and 5 
µl DNAse. 50 µl of this DNAse mix was added to each spin column and incubated at 
room temperature for 15 minutes. The reaction was stopped by adding 200 µl of 
DNAse stop buffer (from kit) and centrifuged for 30 seconds. Columns were washed 
with 600 µl wash buffer, centrifuged and the eluate discarded. Columns were washed 
again with 250 µl of wash buffer and centrifuged. Columns were transferred into 
sterile microcentrifuge tubes and 100 µl of RNAse-free distilled water was added and 
allowed to stand for 1 minute. Columns were centrifuged at 4,500 x g for 2 minutes to 
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elute RNA before being discarded. Three, 3 µl aliquots of RNA were retained and the 
rest of the RNA stored at -80°C. One aliquot was used as a template for a PCR used 
to ensure there was no DNA contamination, if DNA was present RNA samples were 
again treated with DNase. A second aliquot was analysed by agarose gel 
electrophoresis and a third analysed by a NanoDrop spectrophotometer (NanoDrop 
Technologies, USA) to quantify total RNA and estimate protein and organic 
compound contamination. Figure 2.6 shows a typical RNA preparation 
electrophoresed for approximately 1 hour on a 1% agarose gel at 100 V.  
2.13.2 cDNA synthesis 
The RNA prepared using (see section 2.13.1) was used as a template from which to 
synthesise cDNA. The following component solutions were added together in a 
microcentrifuge tube for each reaction: 
 1 µl of 50 ng/µl of random primers (Life Technologies, U.K.) 
 1 µl of 10 mM dNTP mix (Life Technologies, U.K.) 
 500 ng of RNA 
 Sterile distilled water to 13 µl. 
This mixture was heated at 65°C for 5 minutes and incubated for 1 minute on ice and 
centrifuged to collect the contents of the tubes and the following components added: 
 4 µl of 5x First-strand buffer (Life Technologies, U.K.) 
 1 µl of 0.1 M DTT (Life Technologies, U.K.) 
 1 µl of RNaseOUT (Life Technologies, U.K.) 
 1 µl of SuperScript III RT (220 units/µl) (Life Technologies, U.K.). 
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Figure 2.6 A typical RNA preparation separated by electrophoreses for 1 hour on a 1% agarose gel at 100 V. 
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The contents of the tube were mixed by gently pipetting up and down. They were 
then incubated at 25°C for five minutes followed by 50°C for one hour. The 
SuperScript III enzyme was then inactivated by heating to 70°C for 15 minutes. cDNA 
was stored at -20°C until required. 
2.13.3 Comparative reverse transcriptase PCR (cRT-PCR) 
cRT-PCR was used to compare expression of different genes between strains or 
conditions (Eaves et al. 2004).  
cRT-PCR mixtures  contained the following components in a microcentrifuge tube: 
 45 µl of PCR Mastermix (ABgene®, U.K.) 
 1.5 µl of forward primer 
 1.5 µl of reverse primer  
 2 µl of cDNA (as made in section 2.13.2) 
Two technical replicates of cDNA were used from three biological replicates of RNA 
(six replicates in total). All primers were used at a concentration of 25 µM. To avoid 
saturation of reactions and ensure final product concentrations were a reflection of 
initial template concentrations cDNA was used at a 1:10 dilution (of original cDNA 
obtained) except when using 16SrRNA primers where a 1:1000 dilution was used. 
The dilutions needed to avoid reaction saturation were experimentally determined for 
each gene using cDNA dilutions before ‘test’ reactions were completed. All reactions 
were completed in a PCR machine with appropriate PCR conditions: 
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 95°C 5 minutes   
 95°C 30 seconds 
 ??°C* 30 seconds  x 30 
 72°C ??* seconds 
 72°C 10 minutes   
*Appropriate annealing temperature or extension times were used according to 
specific primers/amplimers. 
Successful PCR amplification was verified by agarose gel electrophoresis and bands 
quantified using GeneTools (SynGene, U.K.) with Hyperladder I (Bioine, U.K.) as a 
standard. Average values for each gene/condition were calculated and normalised to 
the corresponding 16S values. Normalised data was plotted on a bar chart, standard 
deviation calculated and any variation between the data measured for statistical 
significance using a student’s ‘t’ test. Differences with a p<0.05 were considered as 
significant. 
2.14 Expression of global regulators of efflux using fluorescent markers 
To determine whether the stress response regulators marA, ramA, soxS and rob 
showed differences in i) temporal and ii) spatial expression between wild-type and 
efflux mutants a set of promoter gfp reporter constructs were used. Reporter 
constructs were previously constructed in pMW82 and included the promoter of each 
gene cloned upstream of an unstable gfp (Table 2.4) (Lawler et al. 2013). Each 
plasmid was electroporated into competent cells (section 2.4).  
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2.14.1 Temporal expression of global regulators in wild-type and efflux mutants 
Overnight cultures prepared in 10 ml of LB broth containing 50 µg/ml of ampicillin (to 
retain the reporter plasmid) were used to inoculate fresh 5 ml of LB broth without salt 
again containing 50 µg.ml of ampicillin 1:100. Expression of each gene in the wild-
type and efflux mutants was determined by monitoring fluorescence (Ex 492, Em 520 
nm) in a FLUOstar OPTIMA. Three biological and three technical replicates of each 
strain were used and 100 µl aliquots transferred to black 96 well microtitre trays. 
Fluorescence was then measure every 180 seconds for 16 hours whilst being 
incubated at 30°C. 
2.14.2 Spatial expression of global regulators in wild-type and efflux mutants 
Overnight cultures and bacterial dilutions were prepared as in section 2.14.1. Congo 
red agar assay was used as in section 2.10.3 with the addition of the Congo red agar 
being supplemented with 50 µg/ml ampicillin to ensure the plasmid is retained. Plates 
were incubated as in section 2.10.3. Colonies were observed under both light 
microscopy to see Congo red morphology (indicating the spatial expression of curli 
within the colony) and fluorescence microscopy (to observe spatial expression of 
ramA, marA, soxS and rob) using a SM2 400 (Nikon, U.K.). 
2.15 Induction assay 
To identify whether efflux mutants differed in their ability to respond to inducers of 
marA, ramA, soxS and rob a high throughput fluorescence induction assay was used 
to measure the gfp expression of gfp reporter plasmids (section 2.14 and Table 2.3). 
Fresh pre-warmed broth was inoculated with a 4% inoculum of an overnight culture 
and supplemented with appropriate antibiotic. Cultures were incubated at appropriate 
temperature with shaking until an OD 600 of 0.9 was reached. Stocks of appropriate 
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inducer at 100 x final required concentration were prepared. 10 µl of inducer stock 
was added to 990 µl of cells. Also 10 µl of inducer solvent was added to 990 µl of 
cells as an un-induced control. 100 µl aliquots of un-induced and induced cultures 
were loaded into a black 96 well MTT. Fluorescence intensities (Ex 492, Em 520) 
were measured every 180 seconds for 5 hours. Three biological and three technical 
repeats were used for each strain, an average taken and standard deviation 
calculated. 
2.16 Transposon mutagenesis to identify curli ‘rescue’ mutants 
Transposon mutagenesis was used to create libraries of mutants in S. Typhimurium 
14028S with efflux pump mutations (Figure 2.7). This method allowed the libraries to 
be screened for mutants with the ability to produce curli and in theory form a biofilm. 
If the reason for the efflux mutants’ biofilm/curli defect is over-expression of a 
gene/protein that is repressing curli genes this approach could identify the gene 
responsible. 
2.16.1 Creating a random transposon library 
To create transposon libraries either the EZ-Tn5TM<DHFR-1>Tnp TransposomeTM or 
the EZ-Tn5TM<KAN-2>Tnp TransposomeTM Kits (Epicentre® Biotechnologies, U.S.A.) 
were used. This allowed versatility in choosing selective markers and avoided conflict 
with those used in the efflux pump mutant construction. Competent cells of the 
recipient strain were made as in section 2.4. 1 µl of transposome was electroporated 
with 50 µl of competent cells at 2.5 kV in a two mm electrocuvette. Cells were 
recovered by the addition of 1 ml of SOC medium and incubated at 37°C for 30-60 
minutes. Transposon mutants were selected on appropriate antibiotic plates (either 
50 µg/ml of kanamycin or 50 µg/ml of trimethoprim).  
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Figure 2.7 Diagram of the transposon mutagenesis protocol showing electroporation, 
recovery of transformed cells, Congo red screening, subsequent Congo red 
phenotypic testing, crystal violet biofilm formation assay and sequencing of 
transposon insertion site. 
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All transposon mutant colonies were collected on a loop, re-suspended in 20% 
glycerol and stored at -20°C until screening. 
2.16.2 Identifying curli ‘rescue mutants’ on Congo red agar 
Transposon libraries of efflux mutants were diluted to approximately 1000 cfu/ml and 
100 µl aliquots of this dilution spread onto LB agar containing appropriate antibiotics 
(either 50 µg/ml of kanamycin or 50 µg/ml of trimethoprim) and incubated overnight at 
37°C. Colonies obtained were then replica plated with velveteen squares onto LB 
agar without salt supplemented with 40 µg/ml of Congo red and incubated at 30°C for 
48 hours. Plates were visualised and any colonies displaying a red and rough 
morphology were selected and purity plated. These ‘rescue’ candidates were verified 
as still containing the expected efflux mutation. Congo red agar assays were used to 
verify the candidates ability to produce curli (section 2.10.3) and crystal violet biofilm 
assays to see if ‘curli rescue’ correlated to ‘biofilm rescue’ (section 2.9.1). 
2.16.3 DNA sequencing of transposon insertion site 
Bacterial lysates (section 2.1.4) of candidate transposon mutants were used as a 
template for a single primer PCR using a primer specific for the Tn5 transposon DNA 
(Table 2.2). An extended PCR programme was performed to amplify specific and 
non-specific fragments using the PCR parameters as follows (Karlyshev et al. 2000): 
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95°C 5 minutes 
95°C 30 seconds 
55°C 30 seconds  x 30 
72°C 3 minutes 
95°C 30 seconds 
30°C 30 seconds  x 30 
72°C 2 minutes 
95°C 3- seconds 
55°C 30 seconds  x 30 
72°C 2 minutes 
The resulting PCR amplimers were then used as a template for DNA sequencing 
(see section 2.1.4 and Table 2.3), again using a nested primer specific to the Tn5 
transposon. The resulting sequence was analysed using Chromas software 
(Tecchnelysium. U.K.) and aligned against the Tn5 transposon sequence to identify 
the junction with chromosomal sequence. Insert sites were identified using the Basic 
Local Alignment Search Tool (http://blast.ncbi.nlm.nih.gov). 
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CHAPTER THREE: 
BASELINE RESULTS 
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3  Optimisation of biofilm models, test conditions and strain selection 
3.1 Introduction 
The main focus of this project was initially the AcrAB-TolC efflux pump (Table 1.2) as 
an exemplar and the best studied efflux system in Salmonella and E. coli. Whilst 
there was a panel of efflux mutants available at the start of this project (Nishino et al, 
2006) there was no acrA mutant in the culture collection. A mutant lacking acrA was 
recently found to have a distinct phenotype to acrB or tolC mutants (Blair et al. 2009). 
Therefore an isogenic acrA mutant in S. Typhimurium 14028S needed to be 
constructed. S. Typhimurium 14028S was chosen as the model parent strain as it 
has a full genome sequence (Jarvik et al. 2010), is widely used as a model S. 
Typhimurium and will readily form biofilms in vitro. 
All the strains used in the project needed to be verified genotypically by PCR to 
confirm the presence of the expected genetic mutations and growth kinetics analysed 
to ensure the various efflux mutants did not possess any growth defect which may 
influence their ability to form a biofilm. 
A wide range of different experimental protocols to study biofilm formation have been 
described in the literature. The crystal violet microtitre assay was used a relatively 
rapid, inexpensive and semi high throughput assay to routinely monitor biofilm 
formation in this project. A number of variables (media, temperature, time) needed to 
be investigated to define standard conditions under which different mutants or 
treatments could be assessed. 
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3.2 Strain verification 
Before being used in any experiment, all strains were phenotypically examined by 
Gram staining, plating onto XLD agar and API 20E biochemical tests to verify strains 
were Salmonella. Genetic disruptions in mutant strains were verified by PCR and 
sequencing. All results from these tests were consistent with that expected for each 
strain.  
3.3 Inactivation of acrA 
Recently a mutant with a specific disruption of acrA by insertion of the aph 
kanamycin resistance gene was created in Salmonella Typhimurium SL1344 (Blair et 
al. 2009). This mutant acrA allele was transferred into 14028S (L828) by transduction 
using bacteriophage P22. Colonies were obtained on selective agar (50 µg/ml 
kanamycin) for all transduction reactions. Two colonies were chosen, purity plated 
onto LB supplemented with kanamycin and XLD agar and subjected to an API20E 
biochemical test to ensure the transductants obtained were Salmonella. Specific 
PCR using primers flanking acrA ensured the transductants carried the correct 
mutation (Figure 3.1). These candidates were named L1270 and L1271, in 
subsequent experiments L1271 was the acrA::aph mutant used. 
3.4 Growth kinetics 
Growth kinetics were monitored over 16 hours for L828 (wild-type), L829 (tolC::cat), 
L830 (acrB::aph), L832 (acrD::cat), L833 (acrEF::cat), L834 (mdtABC::cat), L835 
(mdsABC::cat), L836 (emrAB::cat), L837 (mdfA::cat), L838 (mdtK::cat) and L839 
(macAB::cat). Growth kinetics were carried out at 30°C and in LB broth without salt to 
mimic conditions used in the biofilm formation assays. All mutants displayed similar 
growth pattern to wild-type over the duration of the experiment (Figure 3.2).  
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Figure 3.1 PCR verification of 14028S (acrA::aph) transductants candidates 1 and 2 
A PCR verification using primers homologous to both acrA and the aph cassette. B 
PCR verification using primers within acrA upstream and downstream of the aph 
cassette.
97 
 
Figure 3.2 A Growth kinetics and B generation times of L828 (wild-type), L829 
(tolC::cat), L830 (acrB::aph), L832 (acrD::cat), L833 (acrEF::cat), L834 
(mdtABC::cat), L835 (mdsABC::cat), L836 (emrAB::cat), L837 (mdfA::cat), L838 
(mdtK::cat) and L839 (macAB::cat). 
. 
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There was no statistically significant difference of the generation times of the efflux 
mutants when compared to wild-type with the exception of L837 (mdfA::cat) which 
had an average generation time of 203 minutes compared to the 112 minutes 
generation time of wild-type. A comparison of the final OD value achieved by all 
strains showed no significant difference for any of the mutants compared to wild-type. 
3.5 Optimisation of the Crystal Violet biofilm assay 
Formation of competent biofilms depends upon the media used (Figure 3.3). L828 
(wild-type) formed most biofilm in LB without salt, followed by minimal media and 
least biofilm in LB broth with salt. L829 (tolC::cat) in contrast formed most biofilm in 
minimal media followed by LB without salt and again least in normal LB media. L830 
(acrB::aph) formed relatively poor biofilms in all media conditions. 
Various temperatures were also tested to establish the optimum temperature at 
which Salmonella will biofilm, it was found that L828 (wild-type), L829 (tolC:cat) and 
L830 (acrB::aph) all formed more biofilm at 30°C when compared to 37°C. 
Subsequently, all biofilm assays were performed at 30°C in LB without salt and on 96 
well polystyrene microtitre trays to allow for high throughput. 
3.6 Biofilm assay of all efflux mutants  
All efflux mutants tested (Figure 3.4) were compromised in their ability to form 
biofilms when grown in LB broth without salt except for L1271 (acrA::aph) which 
biofilms to wild-type levels. L829 (tolC::cat) the only strain without a functional outer 
membrane channel for the majority of the efflux system is the most compromised at 
forming a biofilm, forming around six fold less biofilm than wild-type.  
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Figure 3.3 Optimisation of the crystal violet biofilm assay A Crystal violet biofilm 
assay of L828 (wild-type) with two representative efflux mutants L829 (tolC::cat) and 
L830 (acrB::aph) with various media; Minimal, LB and LB without salt. B Crystal violet 
biofilm assay of L828 (wild-type), L829 (tolC::cat) and L830 (acrB::aph) in LB without 
salt at 30°C and 37°C. Statistical significance between strains and temperatures are 
calculated using a student’s t test (p<0.05) and indicated with an asterisk. 
B 
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Figure 3.4 Crystal violet biofilm assay of L828 (wild-type) and all MDR efflux mutants of S. Typhimurium. White bar - L828 (wild-
type); orange bar - outer membrane porin mutant, L829 (tolC::cat); green bars - RND efflux mutants; purple bars - MFS efflux 
mutants; blue bar - MATE mutant; yellow bar - ABC transporter mutant. Statistically significant differences between L828 (wild-type) 
and efflux mutants are calculated using a student’s t test (p<0.05) and indicated with an asterisk. 
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L830 (acrB::aph), L833 (acrEF::cat) L835 (mdsABC:cat), L836 (emrAB::cat), L837 
(mdfA::cat) and L838 (mdtK::cat)  have slightly better biofilm phenotype forming 
around three fold less biofilm than wild-type. L832 (acrD::cat), L834 (mdtABC::cat) 
and L839 (macAB::cat) are the least affected but still only form around half of the 
amount of biofilm formed by wild-type.  
3.7 Biofilm ‘mat’ formation 
Whilst S. Typhimurium form a biofilm at the air-liquid interface in a 96 well microtitre 
tray it has recently been shown that they will form a ‘mat’ of biofilm on the surface of 
the liquid if incubated statically in a 24 well microtitre tray (Romling and Rohde 1999). 
The trend observed in the crystal violet biofilm assay is also observed when using the 
‘floating mat model’ of biofilm formation. Only L828 (wild-type) forms a biofilm mat on 
the surface of the media after 3 days. The panel of ten efflux mutants did not produce 
a floating mat of biofilm even when left for 5 days. 
3.8 Biofilm flow cell model 
To ensure the defect seen is not just a static biofilm phenomenon, L828 (wild-type), 
L829 (tolC::cat) and L830 (acrB::aph) were incubated at room temperature within a 
flow cell with LB broth without salt flowing through the cell at around 0.3 dynes. The 
reason for using a flow biofilm model was to try and replicate some real life biofilm 
situations as biofilm will form in waterways, stream and under flow on medical 
devices. The cells were allowed to adhere for 3 hours on the flow cell before the flow 
was started and again only L828 (wild-type) formed a mature three dimensional 
biofilm. L829 (tolC::cat) and L830 (acrB::aph) although cells have initially adhered 
during the 3 hour seeding incubation no further maturation has occurred (Figure 3.5). 
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Figure 3.5 A Phase contrast microscopy images using x 40 objective of L828 (wild-
type), L829 (tolC::cat) and L830 (acrB::aph) forming a biofilm under flow conditions 
under 0.3 dynes using a Bioflux pneumatic pump and 48 well plate system. Black bar 
depicts a 5 µm scale.  
B Average biofilm coverage of the microfluidic flow cell quantified using the Bioflux 
EZ software. Statistically significant differences in biofilm formation in comparison to 
their parent strain are indicated by an asterisk (p<0.05). 
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3.9 Discussion 
Before any phenotypic characterisation was carried out, an isogenic acrA::aph 
mutant was constructed to complete the panel of S. Typhimurium 14028S efflux 
mutants. A similar mutant made in S. Typhimurium SL1344 had a distinct phenotype 
from acrB or tolC mutants, warranting investigation of the impact of acrA on biofilm 
formation. Initial baseline experiments showed that inactivation of efflux pumps of 
S. Typhimurium did not have an adverse effect on the growth kinetics and in 
particular the generation time of the bacteria. Growth kinetics were carried out at 
30°C and in LB without salt, in optimal biofilm conditions. This shows that the biofilm 
defect observed in these efflux mutants is specific and is not a result of any generic 
growth defect.  
Various biofilm formation conditions were tested to elucidate the optimal conditions 
for S. Typhimurium biofilm formation in vitro. When comparing biofilm assays 
incubated in minimal media, LB and LB without salt, the optimal media for biofilm 
formation by the wild-type was LB without salt. The presence of salt in media reduces 
the cell surface hydrophobicity of the bacteria and decreases the cells ability to 
aggregate and adhere to a surface reducing the amount of biofilm formed (Kuntiya et 
al., 2005; Giaoris et al, 2005). Therefore removing salt from the media helps the 
bacteria to form a more competent mature biofilm, but still providing rich nutrition for 
the bacterial cells. Two temperatures were also tested for optimal biofilm formation, 
30°C (a temperature used widely in the literature for in vitro Salmonella biofilm 
assays) and 37°C (optimal temperature for Salmonella planktonic growth). L828 
(wild-type), L829 (tolC::cat) and L830 (acrB::aph) mutants all formed more biofilm at 
30°C than 37°C. Although Salmonella grows best at 37°C as it is mammalian body 
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temperature, in this context it will invade cells and biofilm formation may not be 
important. However, environmentally Salmonella will tend to exist in a biofilm, 
therefore lower temperatures are conducive to induction of the biofilm mode of 
growth (Giaoris et al, 2005).  
Efflux mutants first observed to have a biofilm defect carried defined a single genetic 
inactivation of components of the well characterised AcrAB-TolC system. L829 
(tolC::cat) and L830 (acrB::aph) have a significant biofilm defect however L1271 
(acrA::aph) forms a biofilm as well as L828 (wild-type). A complete panel of efflux 
mutants representing all the other efflux systems in Salmonella were tested and all 
were found to have a significant biofilm defect in various laboratory biofilm models 
(Baugh et al, 2012). This is a surprising observation as many of the efflux pumps 
have overlapping substrate specificity (Nishino et al. 2006; Nishino et al. 2009) and 
when individual efflux systems are inactivated other systems can compensate for the 
loss. Also some of these efflux systems are cryptic under laboratory conditions 
therefore it seems surprising that they should have such a striking effect upon the 
ability of S. Typhimuirum to form a biofilm. 
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CHAPTER FOUR: 
HYPOTHESIS ONE – 
EXPORT OF A BIOFILM FACTOR
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4 Hypothesis One – AcrAB-TolC exports a crucial biofilm factor 
4.1 Background 
AcrAB-TolC has been well characterised, is known to have a wide substrate 
specificity and can efflux various antibiotics, dyes, detergents, solvents and peptides. 
Knowing this I hypothesised that AcrAB-TolC may be either exporting a molecule 
essential for biofilm formation or a metabolite that inhibits biofilm formation if it 
remains intracellular. Various assays were used to investigate whether an exported 
substrate of AcrAB-TolC is required to form a biofilm. 
4.2 Transwell biofilm assay of wild-type with efflux mutants 
Transwell assays were used to grow wild-type and mutant strains in the wells of a 24 
well microtitre tray with contiguous media separated by a membrane which prevents 
bacteria but not solute movement. Co-incubation of mutants with a mid-logarithmic 
phase culture of L828 (wild-type) showed no ability to restore or improve the ability of 
L829 (tolC::cat) or L830 (acrB::aph) to form biofilms (Figure 4.1). When the 
experiment was repeated with an overnight, stationary phase culture of L828 (wild-
type) as the supernatant ‘donor’ again no rescue of the ability of the mutants to form 
biofilms was observed, conversely biofilm formation was inhibited to some degree 
(Figure 4.1). This experiment indicates that no soluble factor exported by AcrAB-TolC 
by the wild-type strain during logarithmic growth or in stationary phase is able to 
restore biofilm formation in mutants lacking a functional acrB or tolC.  
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Figure 4.1 Transwell biofilm assay of L828 (wild-type) with L829 (tolC::cat) or L830 (acrB::aph). A  Co-incubation of L829 
(tolC::cat) and L830 (acrB::aph) with L828 (wild-type) – wells inoculated with wild-type and mutant simultaneously B Co-
incubation of L829 (tolC::cat) and L830 (acrB::aph) with a stationary phase culture of L828 (wild-type). Statistically significant 
differences in biofilm formation compared to L828 (wild-type) exposed to the same conditions as the mutant tested were 
analysed using a student’s t test and indicated with an asterisk (p<0.05). 
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4.3 Biofilm co-incubation assay 
The biofilm mat assay was used as another way to investigate whether the wild-type 
strain (L828) could complement the mutants’ biofilm defect. Biofilm mats formed on 
the surface of all co-incubated wells of 24 well microtitre trays, the mats were 
removed and disrupted to release individual cells and wild-type and mutant cells 
enumerated by viable counting. Although mutant strains were able to grow well 
planktonically in competition with L828 (wild-type) when co-incubated, the mutants 
were unable to form a mat biofilm or intergrate into the wild-type biofilm (Figure 4.2). 
L829 (tolC::cat) cannot associate with wild-type biofilm to any degree and L830 
(acrB::aph) cells comprised only 1 in 106 of the total biofilm formed. 
4.4 Metabolomics 
Data from a metabolomics experiment comparing metabolites present within the acrB 
mutant were analysed to look for differences which may suggest molecules exported 
by AcrB that impact on biofilm formation. Approximately 750 peaks representing 
distinct metabolites were detected by mass spectrometry from all samples and the 
principle component analysis (PCA) indicated that mutant and wild-type replicates 
separated into two distinct clusters (one replicate from the wild-type was a consistent 
outlier, analysis was repeated with and without this sample, little differences to 
overall results ensued). Approximately 1.5% of the peaks were significantly different 
in abundance between the wild-type and mutant samples. Of the metabolites which 
could be assigned an identity the metabolite with the greatest difference between the 
two strains was spermidine which was found to be in the mutant samples at levels 33 
fold higher than the wild-type and was the metabolite responsible for the majority of 
the discrimination of the samples by the PCA (Table 4.1 and Figure 4.3) 
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Figure 4.2 A Diagrammatic representation of the inoculation pattern of the co-incubation mat biofilm assay and viable count 
enumeration of L828 (wild-type), L829 (tolC::cat) and L830 (acrB::aph) of B planktonic liquid and C proportion of mixed strain biofilm 
comprised of mutant cells. Statistically significant differences in cfu/ml compared to L828 (wild-type) at each time point in panel B 
were analysed using a student’s t test and indicated with an asterisk (p<0.05).  
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Table 4.1 Metabolites identified with different abundance from within L828 (wild-type) 
and L830 (acrB::aph) cells 
 
Figure 4.3 Principle component analysis (PCA) of samples from showing separation 
of replicates. The circled sample consistently has an outlier, analysis was repeated 
with and without this sample   
mz Metabolite Change 
mutant/wild-type 
P value 
146.1651 Spermidine 33.7421 0.002867 
171.0417 Dihydrocoumarin plus others 0.549924 0.148721 
156.0421 Valine, betaine, etc 0.247751 0.388728 
221.0361 Xanthan 1.66932 0.001798 
352.2246 steroid/alkaloid 0.156018 0.350022 
183.0781 Diisopropyl phosphate plus 
fatty acid 
1.393881 0.019276 
424.2822 ['Myxalamid B'] 0.661969 0.034707 
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4.5 Biofilm formation with addition of exogenous polyamines 
As the metabolimics data suggested excess accumulation of spermidine within efflux 
mutants the impact of adding exogenous polyamines on biofilm formation was 
analysed. The addition of exogenous polyamines to crystal violet biofilm assays had 
no effect on biofilm formation by L828 (wild-type), L829 (tolC::cat) or L830 
(acrB::aph), the polyamines neither hindered nor rescued biofilm formation of wild-
type or mutants (Figure 4.4).  
4.6 Biofilm formation assay with exogenous indole, tryptophan and casamino 
acids 
Recent work has suggested that amino acid metabolism is increased in biofilm 
formation and that indole can regulate efflux pump regulation (Hamilton et al. 2009; 
Nikaido et al. 2011). Biofilm assays with the addition of either exogenous tryptophan 
or casamino acids showed no impact on biofilm rescue of the mutants biofilm defect. 
Increasing the concentration of exogenous indole seems to have a negative effect of 
biofilm formation. (Figure 4.5). 
4.7 Discussion 
The hypothesis examined in this chapter investigated whether inactivation of AcrAB-
TolC prevents export of a substrate of the pump which promotes biofilm formation. 
Both the transwell and co-incubation assays suggest that this is an unlikely 
explanation for the defect of mutant strains as the presence of wild-type biofilms were 
unable to rescue the biofilm phenotype of the tolC and acrB mutants, either in trans 
or when directly co-incubated. 
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Figure 4.4 Crystal violet biofilm formation assay of L828 (wild-type), L829 (tolC::cat) 
and L830 (acrB::aph) with addition of increasing concentrations of three different 
polyamines putrescine (A), cadaverine (B) and spermidine (C). 
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Figure 4.5 Crystal violet biofilm formation assay of L828 (wild-type), L829 (tolC::cat) 
and L830 (acrB::aph) with addition of exogenous casamino acids (A), tryptophan (B) 
and indole (C) 
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The second part of this hypothesis considered the idea that by inactivating AcrAB-
TolC, a toxic metabolite accumulates in the bacterial cell that inhibits the cells ability 
to live at high density. Metabolomics data showed that spermidine (or another closely 
related polyamine) accumulated in the cell in the absence of a functional AcrB, 
polyamines have also been linked with biofilm formation in a number of different 
bacteria (Karatan et al. 2005; Patel et al. 2006; Lee et al. 2009). However the 
addition of spermidine, cadaverine or putrescine had no significant effect on the 
biofilm formation of either wild-type or the mutant strains. If a polyamine(s) was 
accumulating to toxic levels within the mutant strains it may have been expected that 
addition of exogenous polyamines would inhibit wild-type biofilm formation. After 
these experiments were completed with the acrB and tolC mutants it was observed 
that a much wider panel of efflux mutants showed a biofilm defect (Section 3.6). 
Some of the efflux systems lacking in this panel of mutants are considered cryptic 
under laboratory conditions and there are no known substrates common to all the 
MDR efflux systems in Salmonella. These data further suggest it is unlikely a biofilm 
promoting substrate is exported. In conclusion it appears unlikely that direct export of 
a biofilm relevant solute can account for the biofilm defect of efflux mutants. 
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5 Hypothesis Two – Inactivation of AcrAB-TolC impacts upon cell surface 
hydrophobicity 
5.1 Background 
Removal of large membrane proteins from both the inner and outer membrane of 
Gram negative bacteria has the potential to create instability of the cell envelope. The 
second hypothesis investigated if a potential membrane change impacts upon the 
cells surface hydrophobicity and ultimately the cells ability to aggregate to surfaces 
and each other.  
5.2 Settle assay 
The settle assay suggested that the mutants are not compromised in their ability to 
aggregate in comparison to the wild-type (Figure 5.1), if anything the mutants 
aggregated slightly more than the wild-type, in particular L830 (acrB::aph) however 
changes were not statistically significant (Baugh et al. 2013).  
5.3 Salt aggregation test 
L828 (wild-type) and L830 (acrB::aph) both showed a similar ability to aggregate; the 
lowest ammonium sulphate molarity causing aggregation was 2 M (Figure 5.2). L829 
(tolC::cat) again demonstrated a higher aggregation ability as the lowest ammonium 
sulphate molarity required to cause aggregation was 1 M, however at only one 
dilution difference the results are not conclusive (Baugh et al. 2013). 
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Figure 5.1 Settle assay of L828 (wild-type), L829 (tolC::cat) and L830 (acrB::aph). Statistically significant differences in cfu/ml 
compared to L828 (wild-type) at each time point were analysed using a student’s t test and indicated with an asterisk (p<0.05).  
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Figure 5.2 Salt aggregation test images of L828 (wild-type), L829 (tolC::cat) and L830 (acrB::aph) in 1M and 2M ammonium 
sulphate. Presence of a white precipitate indicates bacterial aggregation.
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5.4 LPS preparation 
A crude LPS preparation method was used to extract LPS from L828 (wild-type), 
L829 (tolC::cat) and L830 (acrB::aph) to determine if there were any change in LPS 
pattern resulting from inactivating tolC or acrB. No difference in the band pattern was 
observed between wild-type and mutants when the LPS preparations were run on an 
SDS-PAGE gel (Figure 5.3). 
5.5 Discussion 
The second hypothesis considered the idea that deletion of large membrane proteins 
(AcrB and TolC) physically altered the properties of the bacterial cell envelope and 
perhaps disrupted the ability of the bacteria to aggregate with each other or to a 
surface. All assays that tested either aggregation, hydrophobicity or membrane 
structure suggest there is no defect in the tolC and acrB mutants cell surface 
hydrophobicity or ability to aggregate. These data suggest that the reason for the 
mutants biofilm defect is not a decreased ability to aggregate. This conclusion is 
consistent with chemical inactivation of AcrAB-TolC with various EIs where L828 
(wild-type) is inhibited in its ability to form biofilms but still has a physically intact 
efflux system.  
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Figure 5.3 Analysis of LPS preparations of L828 (wild-type), L829 (tolC::cat) and L830 (acrB::aph) separated on 12% SDS PAGE 
gel by electrophoresis 
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6 Hypothesis three – Inactivation of components of AcrAB-TolC alters 
expression of biofilm related genes or proteins  
6.1  Background 
Many genes are involved in the efficient biofilm formation of Salmonella; two csg 
operons encoding curli proteins, the bsc operon encoding cellulose biosynthesis, 
bapA encoding a membrane protein involved in pellicle formation and many other 
genes that regulate the expression of these crucial biofilm genes. csgD is the master 
biofilm regulator gene in Salmonella and is involved in the up-regulation of csgBA 
(curli structural subunits), bscABCD (cellulose biosynthesis) and bapA (pellicle 
formation). Curli and cellulose expression was investigated in this chapter as they are 
the two major components of the Salmonella biofilm extracellular matrix.  
6.2 Characterisation of extra cellular matrix components of tolC and acrB 
mutants 
6.2.1 Scanning Electron microscopy 
In order to determine whether efflux pump mutants were unable to adhere to 
surfaces at all or were adherent but unable to form a biofilm, cultures were incubated 
on glass slides (submersed in LB without salt for 48 hours) before being fixed for 
SEM. Images obtained from the SEM showed L828 (wild-type) forming a complex 
three dimensional biofilm where you can see clearly the extracellular matrix as well 
as some spherical structures putatively identified as outer membrane vesicles 
(OMVs) (Figure 6.1). Images of L829 (tolC::cat) and L830 (acrB::aph) showed no 
multicellular communities only individual bacterial cell. 
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Figure 6.1 Scanning electron microscopy images of L828 (wild-type), L829 (tolC::cat) and L830 (acrB::aph) at 20,000, 40,000 and 
100,000 X magnification. 
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The outer membrane of L829 (tolC::cat) appeared relatively smooth with no curli 
structures or OMVs whereas L830 (acrB::aph) appeared to have no curli but did have 
OMVs associated with the bacterial outer membrane.  
6.2.2 Transcriptomic and phenotypic cellulose characterisation  
Production of cellulose can be phenotypically characterised by plating strains out 
onto LB agar without salt and supplemented with 200 µg/ml of Calcofluor which 
fluoresces under UV light when bound to cellulose. This method showed no 
disruption of cellulose production for any of the mutants (Figure 6.2). Comparative 
RT-PCR confirmed this observation showing no significant difference in the genetic 
expression of the bcsABCZ cellulose biosynthesis operon in either L829 (tolC::cat) or 
L830 (acrB::aph) (Figure 6.3). 
6.2.3 Transcriptomic and phenotypic curli characterisation  
Curli production was visualised on Congo red agar by examining morphological 
appearance. L828 (wild-type) showed a red and rough morphology indicating the 
presence of curli in contrast to L829 (tolC::cat) and L830 (acrB::aph) which presented 
with a pink and smooth morphology indicating the absence of curli (Figure 6.4). This 
trend was also confirmed by staining a bacterial suspension with Congo red and 
measuring both the absorbance and fluorescence stained cells (Figure 6.4). 
To ascertain if this curli repression was occurring at the transcriptional level, RNA 
was isolated from L828 (wild-type), L829 (tolC:cat), L830 (acrB::aph) and L1271 
(acrA::aph) and cDNA synthsised which was used as the template for cRT-PCR of 
the genes within both curli operons. Expression of all curli genes were significantly 
down regulated in both L829 (tolC::cat) and L830 (acrB::aph) (Figure 6.5).   
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Figure 6.2 Images taken under UV light to assess cellulose expression of L828 (wild-
type), L829 (tolC::cat) and L830 (acrB::aph) using Calcofluor staining. 
 
Figure 6.3 Cellulose synthesis gene expression of L828 (wild-type), L829 (tolC::cat) 
and L830 (acrB::aph) using comparative RT-PCR. Statistically significant differences 
in cellulose expression in comparison to L828 (wild-type) are indicated by an asterisk 
(p<0.05). 
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Figure 6.4 Phenotypic curli expression of L828 (wild-type), L829 (tolC::cat) and L830 
(acrB::aph) using various Congo red assays and quantification; Congo red agar 
morphologies (A), Congo red staining of bacterial suspension (B) quantified by both 
optical density (C) and fluorescence (D) In panels C and D Statistically significant 
differences in curli expression in comparison to L828 (wild-type) are indicated by an 
asterisk (p<0.05). 
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Figure 6.5 RNA preparation of L828 (wild-type), L829 (tolC::cat), L830 (acrB::aph) and L1271 (acrA::aph) grown to stationary 
phase in LB without salt broth at 30°C. 5 µl of RNA preparation was mixed with 1 µl of DNA loading buffer, loaded onto a 1% 
agarose gel along with DNA marker Hyperladder I and separated by electrophoresis at 100 V for 1 hour. 
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The master regulator, csgD, was down regulated 10 fold for both mutants. The three 
genes required for efficient assembly and translocation of the structural subunits 
were also all down regulated to varying degrees; csgE was down regulated 2 and 4 
fold in the acrB and tolC mutants respectively, csgF was down regulated by 1.5 fold 
in both mutants and csgG down regulated by 5 and 10 fold in the acrB and tolC 
mutants respectively (Figure 6.6 and Figure 6.7) (Baugh et al. 2013). 
6.3 Curli is down-regulated in all multidrug resistance efflux mutants 
Congo red agar revealed that the entire panel of efflux mutants tested for biofilm 
formation (section 3.6) were lacking curli on the surface of their outer membrane 
(Figure 6.8). cRT-PCR of csgB (the major structural curli subunit) and csgD (the 
mastor curli regulator) confirmed that this repression was occurring at the mRNA 
level as in the L829 (tolC:cat) and L830 (acrB::aph) (Figure 6.9). Both genes were 
significantly down-regulated in L829 (tolC::cat) and all five RND efflux mutants; L830 
(acrB::aph), L832 (acrD::cat), L833 (acrEF::cat), L834 (mdtABC::cat) and L835 
(mdsABC::cat). csgB expression was down-regulated in the four mutants belonging 
to the MFS, MATE and ABC efflux families; L836 (emrAB::cat), L837 (mdfA::cat), 
L838 (mdtK::cat) and L839 (macAB::cat) however csgD expression remains 
unchanged. 
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Figure 6.6 cRT-PCR of csgG with L828 (wild-type), L829 (tolC::cat), L830 (acrB::aph) and L1271 (acrB::aph) cDNA 
(synthesised from RNA in Figure 6.5). 5 µl of each cRT-PCR sample was loaded onto a 1% agarose gel and electrophoresed 
at 100 V for 1 hour. 
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Figure 6.7 Gene expression of genes in both curli operons of L828 (wild-type), L829 
(tolC::cat) and L830 (acrB::aph) using comparative RT-PCR on A bar chart. 
Statistically significant differences in gene expression in comparison to L828 (wild-
type) are indicated by an asterisk (p<0.05).and B a heat map of transcription of the 
two curli loci.  
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Figure 6.8 Congo red morpholgies of L828 (wild-type), L832 (acrD:cat), L833 (acrEF:cat), L834 (mdtABC::cat), L835 
(mdsABC::cat), L836 (emrAB::cat), L837 (mdfA::cat), L838 (mdtK;:cat) and L839 (macAB::cat) showing absence of curli by the 
pink and smooth morphology in all efflux mutants. 
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Figure 6.9 Gene expression of csgB and csgD in L828 (wild-type), L832 (acrD:cat), L833 (acrEF:cat), L834 (mdtABC::cat), 
L835 (mdsABC::cat), L836 (emrAB::cat), L837 (mdfA::cat), L838 (mdtK;:cat) and L839 (macAB::cat) using comparative RT-
PCR. Statistically significant differences gene expression in comparison to L828 (wild-type) are indicated by an asterisk 
(p<0.05). 
.
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6.4 Discussion 
SEM images showed L828 (wild-type) Salmonella forming a mature biofilm and the 
two efflux mutants, L829 (tolC::cat) and L830 (acrB::aph) adhering as individual cells 
but not forming three dimensional biofilms as the wild-type does. Phenotypic and 
genotypic characterisation of cellulose showed no significant difference between 
wild-type and the two efflux mutants. However, there is a significant difference in 
Congo red morphology between wild-type (red, dry and rough) and the two mutants 
(smooth and pink) suggesting curli is not expressed in the mutants and this is 
confirmed by cRT-PCR of both curli operons. Further investigation into expression of 
curli of the entire panel of MDR efflux mutant revealed all mutants lack curli and the 
repression is at the transcriptional level. Both mutants were significantly down 
regulated although the error is large for the csgD expression of wild-type. This could 
be explained by csgD being a phase variable gene, meaning the gene is either 
turned on or off (Grantcharova et al. 2009), if a much larger proportion of the 
population have csgD turned ‘on’ but there is still a subset with csgD turned ‘off’ the 
error will appear large.  
This chapter suggests that repression of curli seen in efflux mutants is the 
mechanism underpinning the observed biofilm defect. It also confirms the mechanism 
is regulatory and the this third hypothesis is most likely to be correct.  
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7 Global regulators of AcrAB-TolC repress curli synthesis 
7.1 Background 
Chapter 6 shows that the link between inactivation of efflux and inhibition of biofilm 
formation is due to repression of both curli operons. This suggests that there is a 
regulatory switch being invoked upon inactivation of efflux components that directly 
or indirectly represses curli. There are a known group of inducible transcriptional 
regulators belonging to the AraC family in Salmonella that have previously been 
identified as being able to control expression of AcrAB-TolC; ramA, marA and soxS. 
In this chapter these regulators were investigated to elucidate if they play a role in 
curli expression in S. Typhimuirum.  
7.2 Inactivation of acrA has no effect on biofilm formation or curli expression  
Genetic inactivation of both tolC or acrB creates a biofilm defect via repression of 
both curli operons, however inactivation of acrA does not have an effect on biofilm 
formation or curli expression and the acrA mutant can biofilm to wild-type levels 
(Figure 7.1). Previous transcriptomic data from our laboratory has shown that 
inactivation of tolC or acrB results in greatly increased expression of ramA (Webber 
et al. 2009), however inactivation of acrA has no effect on levels of ramA (Bailey et 
al. 2010). Furthermore, transcriptomic data for an S. Typhimurium wild-type carrying 
a plasmid that results in over-expression of ramA showed that curli expression was 
down regulated in response to over expression of ramA (Bailey et al. 2010).
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Figure 7.1 Crystal violet biofilm assay and Congo red morphologies of L828 (wild-type), L829 (tolC::cat), L830 (acrB::aph) and 
L1271 (acrA::aph). Statistically significant differences in biofilm formation in comparison to L828 (wild-type) are indicated by an 
asterisk (p<0.05). 
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7.3 Spatial expression of ramA, marA and soxS inversely correlates to curli 
expression 
To visualise the expression of ramA, marA and soxS, the promoter region of each 
gene was cloned into the gfp reporter plasmid pMW82. The construct was then 
electroporated into L828 (wild-type), L829 (tolC::cat) and L830 (acrB::aph). The 
strains harbouring these plasmids were plated onto Congo red plates so curli 
expression could be visualised as well as ramA, marA and soxS expression using 
fluorescence microscopy.  
The inverse correlation between ramA/marA expression and curli expression is 
visually quite striking (Figure 7.2). The leading edge of the colony is not expressing 
curli, shown by the pink and smooth morphology, presumably as the outer most part 
of the colony is still growing and therefore not reached stationary phase yet which is 
when curli is expression is most apparent. The centre of the colony presents with a 
red and rough morphology indicating curli expression. The corresponding wild-type 
colonies harbouring ramA and marA gfp reporter plamsids under fluorescence 
microscopy show very high expression of both ramA and marA at the leading edge of 
the colony where curli is not expressed and much less throughout the colony where 
curli is expressed. Again this inverse correlation is seen in the both efflux mutants, 
Congo red morphology is pink and smooth throughout the colony, indicated absence 
of curli, which again correlated with high levels of ramA and marA expression seen 
across the whole colony.  
The correlation between absence of curli and high soxS expression is less obvious, 
perhaps because soxS is not expressed at the same kind of levels as ramA and 
marA.   
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Figure 7.2 Congo red morphologies and fluorescence images of L828 (wild-type), 
L829 (tolC::cat) and L830 (acrB::aph) containing gfp reporter plasmids for ramA, 
marA and soxS.  
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However, there is still an increase in soxS expression in both L829 (tolC::cat) and 
L830 (acrB::aph) throughout the colony, but the ring of fluorescence indicated high 
expression at the leading edge of the colony seen with ramA and marA expression is 
absent.  
7.4 Addition of efflux inhibitor increases ramA expression and decreases 
biofilm formation in wild-type S. Typhimurium 
ramA can be induced in a dose dependent manner using the efflux inhibitor, PAβN. 
PAβN is a competitive inhibitor of RND efflux pumps, and has a particularly strong 
affinity for AcrB (Lomovskaya et al. 2001), thus triggering ramA, one of the global 
regulators of acrB, to become up regulated. Upon increasing concentrations of 
PAβN, ramA expression increased in a dose dependent manner (Figure 7.3). There 
is again a striking inverse correlation with biofilm formation, as ramA begins to be up 
regulated, biofilm formation decreases and again upon increasing concentrations of 
PAβN decreases in a dose dependent manner.  
7.5 Artificial over-expression of the global regulators; ramA, marA and soxS 
represses curli expression 
Given the link seen in the transcriptomic data between inactivation of tolC or acrB, 
subsequent over-expression of ramA and further repression of curli genes and up 
regulation of regulators in association with efflux inhibitor exposure, I investigated the 
impact of over expression of ramA, marA and soxS on biofilm formation by wild-type 
S. Typhimurium. The pTrc expression vector was used to over-express ramA, marA 
or soxS in wild-type S. Typhimurium. Over-expression of all three regulators 
decreased biofilm formation significantly in a static crystal violet biofilm assay upon 
induction with 1 mM IPTG (Figure 7.4) 
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Figure 7.3 Crystal violet biofilm assay of L828 (wild-type) (blue bars) and ramA induction assay upon addition of increasing 
concentrations of the efflux inhibitor, PAβN (red line). Statistically significant decreases in biofilm formation and increases 
gene expression in comparison to absence of PAβN are indicated by a blue and red asterisk respectively (p<0.05).
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Figure 7.4 Crystal violet biofilm assay of L828 (wild-type) harbouring pTrc-marA, pTrc-soxS or pTrc-ramA; both uninduced 
(blue bars) and upon induction with 1mM IPTG (red bars). Statistically significant differences in biofilm formation of strains with 
induced regulators in comparison to uninduced are indicated by an asterisk (p<0.05). 
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Furthermore, over-expression of these three regulators also induces a curli defect 
supporting the transcriptomic data of the ramA over expressing wild-type and 
supporting the idea that the regulators prevent biofilm formation by repression curli 
expression. 
7.6 Inactivation of global regulators in a tolC mutant does not rescue biofilm 
formation 
To investigate whether over-expression of ramA, marA or soxS is the mechanism by 
which loss of efflux activity results in curli repression, various combinations of 
regulator inactivation mutations were transduced into L829 (tolC::cat) (the mutant 
with the most significant biofilm defect) and biofilm formation quantified to establish if 
the biofilm defect of the tolC mutant can be rescued. Inactivation of either ramA or 
marA alone evoked no defect in biofilm formation, inactivation of marA had a slight 
but significant increase in biofilm formation in S. Typhimurium 14028S (Figure 7.5). 
However, inactivation of soxS resulted in a significant decrease in biofilm formation. 
Inactivating multiple regulators in the same strain had no effect on biofilm formation 
apart from in the marA/soxS double mutant where biofilm formation was slightly yet 
significantly decreased. When inactivating these same regulators in the tolC::cat 
background it again had no impact on biofilm formation (Figure 7.6). Deletion of 
multiple global regulators was required as there is functional redundancy between 
them and if one is inactivated the other two are over-expressed in response 
(Figure 7.7). All mutation combinations tested were again not able to rescue the 
biofilm defect of the tolC mutant (Figure 7.6). 
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Figure 7.5 Biofilm formation of L828 (wild-type) and single, double and triple inactivation mutations in ramA, marA and soxS. 
Statistically significant differences in biofilm formation in comparison to L828 (wild-type) are indicated by an asterisk (p<0.05).  
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Figure 7.6 Crystal violet biofilm assay of wild-type S. Typhimurium and mutants lacking various combinations of tolC, ramA, 
marA and soxS. Statistically significant differences in biofilm formation in comparison to L828 (wild-type) are indicated by an 
asterisk (p<0.05).  
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Figure 7.7 Compensatory gene expression of global regulators of AcrAB-TolC upon inactivation of a single regulator showing 
functional redundancy of ramA, marA and soxS in S. Typhimurium (courtesy of Amelia Lawler). 
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7.7 Discussion 
The global regulators of AcrAB-TolC, ramA, marA and soxS can all negatively 
regulate curli expression and therefore biofilm formation revealing a novel role for 
these proteins. The mechanism for this is likely to be repression occurring either 
directly or indirectly via csgD as this is the major biofilm regulator in Salmonella. 
These three regulators are known transcriptional activators and increase expression 
by binding upstream of the target gene to allow for more efficient transcription, they 
are not known to directly repress any members of their regulons therefore the 
negative regulation of curli is likely to be indirect. There are also no obvious 
mar/sox/ram boxes (the sequence where these regulators bind) around the csg 
operons. Efflux inhibitors, such as PAβN used in the assay in this chapter, can also 
induce these regulators as well as repress biofilm formation, and the dose dependent 
correlation between induction of ramA and repression of biofilm formation is striking. 
It is currently unclear how these regulators influence curli expression and no known 
genes belonging to all these regulons is known to repress curli. However, inactivation 
of these regulators in a tolC mutant does not rescue the ability to form a biofilm. As 
there is redundancy between the three regulators and over expression of each 
regulator leads to a biofilm defect all three genes were inactivated. This did not 
rescue efflux but this may be as inactivation of four separate genes may have a 
negative effect on the physiology of the cell.  
Following this very specific approach to try and rescue efflux mutants’ ability to form a 
biofilm, a broader, more unbiased approach needed to be taken to identify regulators 
blocking biofilm formation. Therefore a random transposon library of the mutants was 
created and screened for restoration of curli expression.  
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8 Transposon mutagenesis to rescue biofilm defect of efflux mutants 
8.1 Background 
As inactivation of ramA, marA, soxS or combinations thereof did not rescue curli 
repression and biofilm defect in the tolC mutant, a literature search was carried out to 
identify all genes known to regulate curli expression in Salmonella and E. coli (Figure 
8.1). However, this literature search highlighted that curli regulation is highly complex 
and involves many different genes, proteins, small RNAs and signalling molecules 
which can act to promote or repress curli expression. Therefore a generalised, 
unbiased approach was required to identify genes responsible for curli repression in 
efflux mutants. If the curli repression was mediated via a gene or protein that is over-
expressed in the efflux mutants then a transposon screen should identify the gene(s) 
or protein(s) involved.  
8.2 Transposon mutagenesis 
A literature search showed no previously established method for using a transposon 
library to screen for changes in curli phenotype, therefore a method needed to be 
established (Figure 8.2). The EZ-Tn5™ <KAN-2> and EZ-Tn5™<DHFR-1> Insertion 
Kits (Epicentre® Biotechnologies – Madison, U.S.) were used to randomly insert a 
transposon around the genome giving rise to either a library of kanamycin resistant 
(EZ-Tn5™ <KAN-2>) or trimethoprim resistant mutants (EZ-Tn5™<DHFR-1>). 
Electrocompetent cells (as in section 2.4) of efflux mutants of interest were prepared 
by glycerol re-suspension on ice to ensure a high electroporation efficiency and 
insertion of the transposon introduced into the bacterial cell by electroporation (as In 
section 2.2). 
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Figure 8.1 Complex regulation of curli operons using literature for both Salmonella and E. coli. (Vidal et al. 1998; Adams and 
McLean 1999; Brown et al. 2001; Batchelor et al. 2005; Jonas et al. 2007; Troxell et al. 2007; Lee et al. 2009; Sommerfeldt et 
al. 2009; Holmqvist et al. 2010; Tagliabue et al. 2010; Monteiro et al. 2011). 
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Figure 8.2 Diagram of method devised for transposon insertion, screening and 
sequencing.  
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Libraries were then plated onto LB agar supplemented with the appropriate antibiotic. 
Drug free control plates were also used to assess the total number if viable cells. All 
colonies were harvested and stored at -20°C in 50% glyercol. For screening, each 
transposon library was diluted to around 1000 cfu/ml and 100 µl aliquots spread onto 
LB agar plates supplemented with the appropriate antibiotic to ensure all colonies 
obtained were harbouring the transposon within their genome. Colonies obtained 
were replica plated onto LB agar without salt supplemented with 40 µg/ml of Congo 
red (Figure 8.3). As curli positive/negative phenotypes are easily distinguishable on 
Congo red plates, any rescue of curli could be detected by the morphology of the 
colonies; red, dry and rough for curli positive and pink and smooth for curli negative. 
L828 (wild-type) was used as a curli positive control and L829 (tolC::cat) was used as 
a curli negative control. Any potential curli rescue mutants were re-streaked onto 
Congo red to ensure a curli positive phenotype (Figure 8.4) and subsequently purity 
plated onto LB supplemented with the appropriate antibiotic. 
The rescue candidates then underwent genotypic characterisation. Firstly, the 
original efflux mutation that the strain was harbouring was checked by PCR to ensure 
the strain is correct. Secondly, the transposon insert site needed to be identified to 
establish the insert site. The EZ-Tn5™ <KAN-2> and EZ-Tn5™<DHFR-1>; Insertion 
kits claim Sanger sequencing can be successful directly from a genomic DNA 
preparation as a template. However this method failed to work reliably with the 
candidates in this study with only one attempt being successful. As an alternative 
method for sequencing transposon insertion sites named RATE (Rapid Amplification 
of Transposon Ends) that uses a PCR amplimer as the sequencing template 
(Karlyshev et al. 2000).  
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Figure 8.3 Replica plate of L829 (tolC::cat) transposon library onto Congo red agar 
to distinguish between different curli phenotypes. 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.4 Congo red agar streak plates of a curli negative strain, L829 (tolC::cat), 
and a transpsoson mutant where curli expression has been restored. 
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RATE PCR uses a single primer homologous to the transposon and a non-specific 
PCR to create both the specific and non-specific amplimers (Figure 8.5). The initial 
amplimers were then sequenced with a second, transposon specific nested primer to 
ensure sequencing of the specific RATE amplimers only. Sequences were compared 
against the transposon sequence and the junction identified. Insert sites were 
identified by comparing the chromosomal sequence against the S. Typhimurium 
14028S genome using the BLAST algorithm. Specific primers flanking the genes 
identified from sequencing were designed and specific PCRs used as another check 
to ensure the transposon has been inserted within that gene (Figure 8.6). 
8.3 Inactivation of various genes rescues curli/biofilm defect in efflux mutants 
A candidate efflux mutant representing each class of efflux pump were chosen to 
determine if curli rescue could be achieved by inactivation of genes with the Tn5 
transposon. The mutants chosen were; L829 (tolC::cat) – outer membrane porin, 
L830 (acrB::aph) – RND transporter, L836 (emrAB::cat) – MFS transporter and L838 
(mdtK::cat) – MATE transporter. Transposon libraries were successfully created and 
colonies screened for each strain were approximately; 4000 colonies (15 curli 
positive) for L829 (tolC::cat), 3500 colonies (five curli positive) for L830 (acrB::aph), 
3000 colonies (seven curli positive) for L836 (emrAB::cat) and 3700 colonies (six curli 
positive) for L838 (mdtK::aph). Some tranpososon insertions may be intergenic 
therefore not inactivating any gene, some genes are unable to be viably inactivation 
as they are essential and there is a possibility that the same gene has the transposon 
inserted into the same gene multiple times. 
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Figure 8.5 RATE PCR amplimers of various strains harbouring Tn5 were separated alongside Hyperladder I (Bioline) on a 1% 
agarose gel at 100 V for 1 hour.  
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Figure 8.6 PCR using envZ flanking primers and electrophoresed on a 1% agarose gel for 1 hour at 100 V revealing two out of 
the three curli positive candidates obtained in the second transposon screen as envZ::Tn5 mutants.  
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For full coverage of the S. Typhimurium genome, containing around 4,500 genes, it 
would be ideal to screen around 10,000 colonies. Crystal violet biofilm assays were 
carried out for all curli positive candidates to observe their biofilm phenotype in a 
static laboratory model (Figure 8.7). Three out of the four selected efflux mutants had 
a fully rescued curli and biofilm phenotype; L829 (tolC::cat), L836 (emrAB::cat) and 
L838 (mdtK::cat). The insert sites that brought about full curli and biofilm rescue were 
all within the genes envZ (in L829 (tolC::cat)), yjcC (in L836 (emrAB::cat)) and ybaJ 
(in L838 (mdtK::cat)).  
Other genes identified as having a positive effect on the efflux mutants ability to 
express curli and form a biofilm are alaRS (in L830 (acrB::aph)), accA (in L830 
(acrB::aph)) and xapA (in L836 (emrAB::cat)).  
8.4 Discussion 
Successful transposon libraries were created for four efflux mutants harbouring 
mutations in efflux genes belonging to varying efflux families. Also a high throughput 
screen for curli rescue has been developed that allowed us to identify curli 
phenotypes of thousands of colonies at once. The Congo red agar plates used to 
assess the curli phenotype of the strains was highly successful and curli rescue 
candidates were isolated for each efflux mutant screened. The curli positive 
candidates did for the most part correlated with an increase in biofilm formation in 
relation to the parent strain, however not all candidates biofilm ability rescued to wild-
type levels. The biofilm defect phenotype seen in the efflux mutants was rescued in 
all but one, L830 (acrB::aph). In the three remaining mutants the biofilm and curli 
phenotypes were rescued fully to wild-type levels by transposon insertion.  
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Figure 8.7 Crystal violet biofilm formation assays of L829 (tolC::cat), L830 (acrB::aph), L836 (emrAB::cat) and L838 
(mdtK::cat) transposon library curli positive strains. Location of the transposon is stated where known. Statistically significant 
differences in biofilm formation in comparison to parent strains are indicated by an asterisk (p<0.05).  
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The genes inactivated for this rescue to occur were different in all three cases, envZ 
to rescue tolC, yjcC to rescue emrAB and ybaJ to rescue mdtK. All the ‘rescue’ genes 
identified are not known to interact or be part of the same regulatory network 
suggesting that repression of curli in the different efflux mutants is mediated by 
different mechanisms, or that all these genes contribute to the same pathway in a 
currently unknown way. 
yjcC is a diguanylate cyclase also known to be important in biofilm repression (Rouf 
et al. 2011), and when inactivated is known to enhance biofilm formation in 
S. Typhimuirum (Kim and Wei 2009). yjcC expression is dependent upon SoxS 
(Huang et al. 2013) which is a global regulator of AcrAB-TolC (Chapter 7) and upon 
artificial over-expression represses curli expression and induces a biofilm defect.  
ybaJ is important in biofilm formation and control of aggregation and motility (Barrios 
et al. 2006). It is a suggested antitoxin in a toxin-antitoxin complex with Hha (Garcia-
Contreras et al. 2008); an osmolarity- and temperature-dependent global modulator 
of toxin alpha-hemolysin synthesis (Mourino et al. 1996; Nieto et al. 2002) and ybaJ 
expression. It is located only 496 base pairs downstream of the acrB, the gene that 
encodes for the major efflux pump of S. Typhimuirum. In a parallel project this 
ybaJ::Tn5 mutation was transduced into the acrB mutant to see if this gene is 
responsible for the acrB mutant’s biofilm defect. However, biofilm formation and curli 
expression of the acrB mutant was not rescued upon introduction of the ybaJ 
mutation. The positioning of ybaJ could be important in the intermediate rescue 
phenotype caused when inactivated ybaJ in the tolC mutant. Inactivation of tolC is 
known to induce expression of global regulators of AcrAB-TolC, which in turn induces 
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expression of acrB, this up-regulation of acrB could cause up-regulation of genes 
downstream of it due to transcriptional carry through. This mechanism would also 
work for the phenotype seen in the ramA, marA and soxS over expressing strains. 
This hypothesis would need to be further investigated to confirm or rule out its 
validity. 
envZ is part of a two component system (envZ/ompR) that recognises environmental 
changes in pH and osmolarity and changes expression of many stress response 
genes as a result (Prigent-Combaret et al. 1999), csgD (master curli regulator) being 
one of them. As envZ rescues the ability of the tolC mutant to form a biofilm and was 
already on our list of genes known to control csgD (the master curli regulator) and is 
a membrane bound protein (therefore located in the same part of the cell as efflux 
proteins) we decided to investigate further into the potential link between efflux and 
biofilm formation and the contribution of membrane stress. 
Other genes found to have a positive effect on the biofilm formation of the efflux 
mutants were accA, alaRS (inactivation increased biofilm formation of acrB mutant) 
and xapA (inactivation increased biofilm formation of emrAB mutant). Although these 
increases were significant they were only slight. 
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CHAPTER NINE: 
BIOFILM/CURLI RESCUE OF tolC 
MUTANT VIA INACTIVATION OF 
envZ 
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9 Biofilm and curli rescue of tolC mutant via inactivation of envZ 
9.1 Background 
Transposon screening of L829 (tolC::cat) identified that inactivation of envZ, one part 
of a two component regulatory system (with ompR), rescued the ability of the strain to 
express curli and subsequently form a biofilm. The EnvZ/OmpR two component 
system is important in regulating a response to membrane stress. EnvZ is an inner 
membrane bound protein and detects changes in the cells environment such as 
osmolarity and pH and relays this message to by phosporylating OmpR and 
subsequently promotes or represses expression of it’s effector genes (Cai and 
Inouye 2002; Parkinson 2003). ompC and ompF are the two main effector genes, the 
expression of which depends upon the ratio of phosphorylated and unphosphorylated 
OmpR. A reduced level of phosphorylated OmpR favours ompF transcription and an 
elevated level of phosphorylated OmpR allows activation of ompC transcription and 
repression of ompF (Parkinson 2003). 
9.2 L829 (tolC::cat) transposon screen reveals two groups of rescue mutants 
An initial transposon library screen of over 4,000 L829 (tolC::cat) Tn5 colonies was 
carried out on Congo red plates exposing 15 curli positive colonies (as in Figure 8.3). 
All 15 colonies were purity plated and checked again for curli rescue of which all 
candidates possessed the red, dry and rough morphology in strains expressing curli. 
To observe if ‘curli rescue’ translated to ‘biofilm rescue’ a crystal violet biofilm assay 
was carried out for these strains and revealed two classes of rescue candidates; ‘full 
rescue’ and ‘intermediate rescue’ candidates (Figure 9.1). The ‘full rescue’ mutants 
were able to produce the same level of biofilm in the standard crystal violet biofilm 
assay as L828 (wild-type).  
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Figure 9.1 Crystal violet biofilm assay of L828 (wild-type), L829 (tolC::cat) and a representative of two different rescue 
candidates isolated from the transposon screen; the ‘full rescue’ envZ::Tn5 and ‘partial rescue’ ybaJ::Tn5 mutations. 
Statistically significant differences in biofilm formation are indicated by an asterisk in comparison to L828 (wild-type) or 
comparing the two bars below the ends of the black lines (p<0.05). 
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This suggests that the transposon mutagenesis procedure had released all 
repression of the curli operons seen in tolC mutant or over-expression of curli via an 
unrelated pathway had overridden the tolC mutant’s curli repression. Sequencing of 
the transposon insertion site was carried out by RATE PCR (Figure 9.2) and Sanger 
sequencing. All four candidates exhibiting the ‘full rescue’ biofilm phenotype had the 
transposon insertion site in the same location. The transposon was inserted 935 
base pains from the start codon of envZ (Figure 9.3) inhibiting translation of the last 
200 amino acids of the 451 amino acid protein causing disruption of nearly half the 
gene. envZ is one part of a two component system involved in sensing membrane 
stress and known to regulate curli synthesis (Jubelin et al. 2005). The ‘intermediate 
rescue’ mutants all harboured the transposon between base pair 170 and 171 of a 
375 base pair gene, ybaJ, a known biofilm regulator (Barrios et al. 2006). The 
inserted transposon was inserted within the 57th amino acid, inhibiting translation of 
69 amino acids, over half of the proteins primary structure would be affected. The 
identical insert sites suggest clonal expression of the two separate events. 
The envZ::Tn5 mutation was transduced using P22 phage into a ‘clean’ L829 
(tolC::cat) background to observe the biofilm phenotype. However, this ‘re-
transduced’ strain, L1562 (tolC::cat, envZ::Tn5), was unable to form a biofilm as the 
strain isolated from the transposon library (Figure 9.4).  
To determine if loss of envZ function could rescue other mutants the envZ::Tn5 
mutation was transduced into L828 (wild-type) and the entire panel of efflux mutants.  
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Figure 9.2 Single primer RATE PCR used as a template for Sanger sequencing of the transposon insertion site, 5 µl of each 
reaction was run on a 1% agarose gel and along with DNA marker, Hyperladder I and electrophoresed at 100 V for 1 hour. 
The ladder pattern observed is a mixture of specific transposon fragments and non specific DNA fragments due to the PCR 
parameters used.
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Figure 9.3 A Sanger sequencing output from Chromas of L829 (tolC::cat) transposon 
mutant candidate 3. B Sanger sequencing read out of candidate 3 transposon 
insertion site showing regions of homology with both Tn5 transposon sequence and 
envZ and C A diagrammatic representation of where the transposon has been 
inserted within the envZ/ompR locus. 
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Figure 9.4 Crystal violet biofilm assay of L828 (wild-type), L829 (tolC::cat), L1561 (envZ::Tn5) and L1562 (tolC::cat, 
envZ::Tn5). Statistically significant differences in biofilm formation in comparison to L828 (wild-type) are indicated by an 
asterisk (p<0.05). 
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The envZ::Tn5 mutation alone reduced the biofilm formation in comparison to L828 
(wild-type) slightly but significantly. Transduction of the envZ::Tn5 mutation into any 
of the other efflux mutants saw no rescue of biofilm formation (Figure 9.5). 
9.3 Artificial membrane stress decreases biofilm formation in S. Typhimurium 
Membrane stress can be artificially induced upon the exogenous addition of 20% 
sucrose or increasing the pH of the broth (Wood 1999) To investigate the hypothesis 
that EnvZ/OmpR is being activated in the tolC mutants in response to a membrane 
stress and repressing curli, L828 (wild-type) was artificially stressed to attempt to 
replicate the phenotype. Both types of stimuli caused a defect in biofilm formation of 
both L828 (wild-type) and L829 (tolC::cat) (Figure 9.6). 20% sucrose caused 
L828 (wild-type) to form six times less biofilm and L829 (tolC::cat) to form around 
three times less biofilm. A statistically significant difference in biofilm formation was 
seen at pH 7.5 for L828 (wild-type) and pH 8 for L829 (tolC::cat). As L828 (wild-type) 
biofilm formation can be disrupted upon artificial membrane stress it suggests that 
the membrane stress seen in the tolC mutant is not caused by an accumulation of a 
metabolite inducing a regulatory cascade but a physical membrane stress.  
9.4 Inactivation of ompR does not rescue biofilm formation  
EnvZ acts as a membrane stress sensor protein that interacts with its partner 
response protein OmpR which directly promotes or represses expression of target 
genes. ompR was inactivated in the tolC mutant to observe if this also resulted in 
rescue of biofilm formation. Inactivation of ompR in L829 (tolC::cat) did not have any 
impact on biofilm formation, relative to L829 (tolC::cat), inactivation of ompR alone 
decreased biofilm formation four fold in comparison to L828 (wild-type) (Figure 9.7). 
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Figure 9.5 Crystal violet biofilm assay of L828 (wild-type), L830 (acrB::aph), L832 (acrD::cat), L833 (acrEF::cat), L834 
(mdtABC::cat), L835 (mdsABC::cat), L836 (emrAB::cat), L837 (mdfA::cat), L838 (mdtK::cat) and L839 (macAB::cat) with and 
without the envZ::Tn5 mutation. Statistically significant differences in biofilm formation in comparison to L828 (wild-type) are 
indicated by an asterisk (p<0.05). 
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Figure 9.6 Crystal violet biofilm assay showing artificial membrane stress of 
L828 (wild-type) and L829 (tolC::cat) under membrane stress caused by exogenous 
addition of sucrose and increasing pH. Statistically significant differences in biofilm 
formation in comparison to their parent strain are indicated by an asterisk (p<0.05). 
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Figure 9.7 Crystal violet biofilm assay of L828 (wild-type), L829 (tolC::cat), L1563 (ompR::aph) and L1564 (tolC::cat, 
ompR::aph) showing no rescue of the tolC biofilm phenotype upon inactivation of ompR. Statistically significant differences in 
biofilm formation in comparison to their parent strain are indicated by an asterisk (p<0.05). 
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These results suggest that either curli repression in the tolC mutant is not occurring 
via ompR (the usual regulation pathway from envZ) or that rescue of the tolC mutant 
by inactivation of envZ requires ompR to be in a particular state in order to release 
the transcriptional repression on the curli operons.  
9.5 Outer membrane protein preparation shows no difference in OMP profile 
As an alternative way to investigate the contribution of OmpR, the balance of 
OmpC/OmpF expression was investigated as this is sensitive to the state of OmpR. 
An outer membrane protein preparation was electrophoresed on a Bolt™ Bis-Tris 4-
12% gel for to assess if there is a difference in the OMP profile of L829 (tolC::cat) 
and L1575 (tolC::cat, envZ::Tn5) in comparison to L828 (wild-type) (Figure 9.8). This 
information can give us an insight to the activity of OmpR, as depending on the state 
OmpR is in (i.e. polymerised or phosphorylated) the OMP profile will change. OmpC 
was the predominantly expressed porin protein which is seen expressed at similar 
levels throughout the strains tested, with the exception of L1494 (ompC::aph) which 
expresses OmpF but no OmpC. The unchanged OMP profile suggests that OmpR 
activity remains unchanged in L829 (tolC::cat) and L1575 (tolC::cat, envZ::Tn5).  
9.6 Inactivation of envZ in different strain of S. Typhimurium lacking a 
functional TolC also rescues biofilm formation above wild-type levels 
A different strain of S. Typhimurium (SL1344) lacking a functional TolC or AcrB has 
the same relative biofilm defect observed in the wild-type used in this project 
(S. Typhimurium14028S) although it intrinsically is a poorer biofilm forming strain.  
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Figure 9.8 Outer membrane protein preparation of L828 (wild-type), L829 (tolC::cat), L1494 (ompC::aph), L1496 (ompF::aph), 
L1563 (ompR::aph), L1564 (tolC::cat, ompR::aph), L1575 (tolC::cat, envZ::Tn5) showing the OMP profiles of biofilm deficient 
and rescued strains to be unchanged. 
173 
 
To see if this rescue is strain specific envZ was inactivated via P22 transduction in 
S. Typhimurium SL1344, a crystal violet biofilm assay of SL1344 (ΔtolC, envZ::Tn5) 
along side the wild-type and ΔtolC show a huge increase in biofilm formation 
compared to both ΔtolC and wild-type (Figure 9.9). Unlike the 14028S tolC::cat 
transposon library rescue mutant which was rescued up to L828 (wild-type 14028S) 
biofilm levels, the L1565 (SL1344 ΔtolC, envZ::Tn5) rescue mutant biofilms at six 
times the L354 (SL1344 wild-type) levels. 
9.7 Discussion 
The curli repression and biofilm defect seen in L829 (tolC::cat) is rescuable via 
inactivation of the osmolarity sensor envZ, located in the inner membrane. The 
envZ::Tn5 mutation did not rescue any of the other efflux mutants suggesting that the 
efflux and curli link is not completely generic. The tolC mutant was chosen for study 
as it is the most affected mutant due to inactivation of the one outer membrane porin 
effects multiple efflux systems. 
To determine if induction of a membrane stress response in L828 (wild-type) can 
replicate the defect in L829 (tolC::cat) an artificial membrane stress assay was 
carried out. The results showed that artificial membrane stress (induced either by 
addition of exogenous 20% sucrose or increasing pH of the media) confers a biofilm 
defect in both L828 (wild-type) and L829 (tolC::cat). L828 (wild-type) was more 
susceptible to the increase in pH of the broth than L829 (tolC:cat) possibly because 
this strain is already under physical membrane stress. Inactivation of tolC has also 
recently been implicated in induction of at least five different stress response systems 
including, BaeRS and CpxARP (Rosner and Martin 2013). 
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Figure 9.9 A crystal violet biofilm assay showing a different strain of S. Typhimurium SL1344, SL1344 (ΔtolC) and SL1344 
(ΔtolC, envZ::Tn5). S. Typhimurium wild-type 14028S (the wild-type used throughout this project) is included as a point of 
reference. Statistically significant differences in biofilm formation in comparison to wild-type SL1344 are indicated by an 
asterisk (p<0.05).  
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EnvZ is known to regulate genes via OmpR, however inactivation of ompR in the 
tolC::cat mutant did not rescue biofilm or curli expression as inactivation of envZ did. 
This however does not mean that EnvZ is not working via OmpR in this situation as 
OmpR has various configurations (i.e. monomer, polymer and phosphorylated) and 
each of these configurations can regulate the EnvZ/OmpR regulon in different ways. 
Depending upon the configuration of OmpR the expression of OmpA, OmpC and 
OmpF differ, the OMP preparation I performed showed no variation in the expression 
of these three proteins between the tolC::cat and tolC::cat, envZ::Tn5 mutants 
suggesting inactivation of envZ is not having an effect upon the configuration of 
OmpR or at least not that results in a known regulatory output in relation to Omp 
expression. Whilst EnvZ is thought to be highly specific for OmpR (Siryaporn and 
Goulian 2008) it is possible EnvZ is regulating curli expression via a different, novel 
pathway.  
To investigate the EnvZ mediated biofilm and curli expression rescue seen in 
S. Typhimurium 14028S was strain specific, the envZ::Tn5 mutation was transduced 
into another S. Typhimuirum tolC mutant in the SL1344 background with a biofilm 
defect, L742 (SL1344 ΔtolC). Not only did inactivation of envZ in L742 (ΔtolC) 
increase biofilm formation this was to six times above the level of the parent L354 
(SL1344 wild-type). This shows the EnvZ inactivation can resuce a tolC mediated 
biofilm defect in various strains and in SL1344 can promote biofilm formation above 
the level of the parent considerably.  
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CHAPTER TEN: 
CHEMICAL INACTIVATION OF 
EFFLUX CAUSES A BIOFILM 
DEFECT IN A RANGE OF 
SPECIES 
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10 Chemical Inactivation of efflux causes a biofilm defect in a range of 
species 
10.1 Exogenous addition of efflux inhibitors induces a biofilm defect of L828 
(wild-type) in the crystal violet biofilm assay 
To see if the biofilm defect can be induced via chemical efflux inhibition, addition of 
three different efflux inhibitors with various mechanisms of action were added 
exogenously to a crystal violet biofilm assay. PAβN, CCCP and CPZ all cause a 
biofilm defect in L828 (wild-type), the concentrations required to cause an anti-biofilm 
effect are all below minimum inhibitory concentration (Figure 10.1). The most 
effective EI for preventing L828 (wild-type) from forming a biofilm was CCCP where 
the effect was seen at 1 µg/ml of exogenous CCCP. Both PAβN and CPZ seem to 
have similar efficiencies, where the start of the dose dependent anti-biofilm effect 
was at 32 µg/ml and 64 µg/ml respectively. There was a small but significant effect 
with 2 and 8 µg/ml of CPZ but the dose dependent effect not seen until 64 µg/ml of 
CPZ (Baugh et al. 2012).  
10.2 Efflux inhibitors also induce a biofilm defect in wild-type S. aureus, 
E. coli and P. aeruginosa 
To assess whether chemical inhibition of efflux using efflux inhibitor compounds has 
impact as an anti-biofilm approach in other bacterial species we evaluated the ability 
of the same three inhibitors used with S. Typhimurium (section 10.1); CPZ, CCCP 
and PAβN to prevent biofilm formation by representative strains of E. coli (NCTC 
MG1655), P. aeruginosa (NCTC PA01) and S. aureus (NCTC 8532) (Baugh et al. 
2013). 
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Figure 10.1 Crystal violet biofilm assays of L828 (wild-type) with increasing 
concentrations of exogenous efflux inhibitor A PAβN, B CCCP or C CPZ. Statistically 
significant differences in biofilm formation in comparison to absence of efflux inhibitor 
are indicated by an asterisk (p<0.05). Minimum inhibitory concentration of L828 (wild-
type) to each efflux inhibitor marked by a black bar. 
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These particular species were chosen as they are the source of biofilm related 
infections either in the food industry or hospital setting (Archer et al. 2011; Joo and 
Otto 2012; Romling and Balsalobre 2012). These inhibitors act in different ways; 
disruption of the proton motive force, competitive substrate of the pump or 
transcriptional repression) therefore we hypothesise that any anti-biofilm effect 
common to all species investigated is due to inhibition of efflux and not specific 
effects of the inhibitors themselves. The crystal violet biofilm assay shows all three 
inhibitors significantly reduced the biofilm formed (p<0.05) by all three species 
however inhibitor concentrations that provoked the greatest effect varied between 
species (Figure 10.2). The most susceptible strain to CCCP was S. aureus with 2 
mg/L causing a 5 fold reduction in biofilm formation; PAβN had the greatest impact 
on E. coli with 16 mg/L preventing formation of a normal biofilm. P. aeruginosa was 
least susceptible to the inhibitors with 128 mg/L of CCCP and 512 mg/L of the other 
inhibitors needed to prevent biofilm formation. Irrespective of the species, biofilm 
inhibitory concentrations were all below the MIC of each compound under the test 
conditions demonstrating a specific anti-biofilm effect rather than a generalised 
growth inhibition.  
10.3 The same efflux inhibitor dependent biofilm defect was seen under flow 
conditions 
After an initial attachment period, efflux inhibitors were added to the appropriate 
media and flowed over the cells that have initially attached to the flow cell to observe 
if a mature biofilm can develop in the presence of efflux inhibitors. All efflux inhibitors 
repressed all strains ability to form a mature biofilm under flow conditions. Bacterial 
coverage in the flow cell by S. aureus and biofilm formation was severely reduced or 
180 
 
absent after addition of CCCP (4 mg/L, resulted in a 6-fold reduction in coverage of 
the flow cell), CPZ (64 mg/L, resulted in a 6-fold reduction in coverage of the flow 
cell) and PAβN (64 mg/L, resulted in a 500 fold reduction in coverage of the flow cell) 
(Figure 10.3). All all EIs were effective against all species under flow conditions, 
representative phase contrast microscopy images show this inhibition for wild-type 
P. aeruginosa, S. aureus, S. Typhimurium and E. coli incubated alone and with 
appropriate concentrations of CCCP, i.e. below the MIC of the specific strain but 
within the range where an anti-biofilm effect is seen in the crystal violet biofilm assays 
(Figure 10.4) (Baugh et al. 2013). 
10.4 The mechanism controlling the biofilm defect of L828 (wild-type) with 
efflux inhibitors is repression of curli genes 
Phenotypic studies of L828 (wild-type) curli production with EI were difficult as Congo 
red, the dye used to stain curli, is exported by the efflux pumps addition of an EI into 
the agar prevented the bacteria from growing properly as Congo red is toxic at high 
concentrations. Therefore, comparative RT-PCR was used to investigate whether 
addition of efflux inhibitors induce the same curli repression as genetic efflux 
inactivation. Both csgB, the major structural curli subunit and csgD, the master curli 
regulator were down-regulated upon addition of 32 and 64 µg/ml of PAβN (Figure 
10.5). 
10.5 Discussion  
Chemical inactivation of efflux in S. Typhimurium 14028S causes a biofilm defect in 
both static and flow conditions. Three different efflux inhibitors with various 
mechanisms of action were used to ensure any effect seen was not an artefact the 
efflux inhibitor but was in fact an effect of stopping the efflux pump from working.  
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Figure 10.2 Crystal violet biofilm assays of S. aureus, E. coli, P. aeruginosa with various sub MIC concentrations of the three 
efflux inhibitors, CCCP, PAβN and CPZ. Statistically significant differences in biofilm formation in comparison to their parent 
strain are indicated by an asterisk (p<0.05).  
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Figure 10.3 Percentage of flow cell covered by biofilm of F77 (S. aureus wild-type) with and without efflux inhibitors (64 µg/ml 
CPZ, 1 µg/ml CCCP and 64 µg/ml PAβN) after 16 hours under a flow rate of 0.3 dynes. Statistically significant differences in 
biofilm formation in comparison to F77 (S. aureus wild-type) without efflux inhibitor are indicated by an asterisk (p<0.05). 
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Figure 10.4 Phase contrast microscopy images (x10 magnification) of P. aeruginosa, 
S. aureus, S. Typhimurium and E. coli biofilms after 16 hours incubation under flow 
conditions. with and without appropriate concentrations of CCCP for the specific 
strain. Concentrations of CCCP used; P. aeruginosa – 64 µg/ml, S. aureus – 1 µg/ml, 
S. Typhimurium – 2 µg/ml and E. coli – 4 µg/ml. 
184 
 
Figure 10.5 L828 (wild-type) mRNA expression of csgB and csgD with exogenous addition of 32 and 64 µg/ml of PAβN. 
Statistically significant differences in gene expression of wild-type compared to absence of efflux inhibitor are indicated by an 
asterisk (p<0.05). 
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The three EIs all caused an anti-biofilm effect well below the MIC level, this shows 
that the EIs are acting as anti-biofilm agents and the biofilm defect in not due to the 
EI acting as an antimicrobial and preventing growth. Each EI worked to varying 
degrees with CCCP being most effective followed by PAβN then CPZ. This could 
make sense as CCCP abolishes the proton motive force (Pages et al. 2005) so will 
effect eight out of the nine multidrug efflux pumps in Salmonella (Nishino et al. 2003). 
PAβN is a known substrate of RND pumps and may have an effect on up to five of 
the nine MDR pumps (Lomovskaya et al. 2001). CPZ is thought to be a 
transcriptional repressor of global regulators of certain pumps (Bailey et al. 2008). 
To see if this biofilm defect caused by addition of EIs is Salmonella specific, EIs were 
added to crystal violet static biofilm assays of S. aureus, E. coli and P. aeruginosa. 
All three EIs caused an anti biofilm effect for all three species to varying degrees; 
CCCP was most effective against S. aureus biofilms, CCCP and PAβN worked best 
against E. coli biofilms and CCCP was most effective by far against P. aeruginosa 
biofilms. All EIs also had an anti-biofilm effect on all species under flow conditions, 
where cells were incubated without EI for around 3 hours to initially attach to the flow 
cell after which EI was added to see if a mature biofilm could be prevented from 
forming.  
EIs have previously been shown to decrease biofilm formation in 
Pseudomonas putida (P. putida) and S. aureus, the EIs used in that study were 
thioridazine, 1-(1-naphtylmethyl)-piperazine (NMP) and PAβN (Kvist et al. 2008). A 
direct comparison that can be drawn from this study is the effect of PAβN against 
prevention formation of S. aureus.biofilms. Kvist et al showed that 20 µg/ml of PAβN 
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reduced  the amount of biofilm formed by around 60%, this study substantiates this 
finding as we showed that both 16 and 32 µg/ml of PAβN reduces biofilm formation to 
60% of the non EI control. Another comparison we can draw from the Kvist study is 
the use of phenothiazines as EIs, the Kvist study used thioridazine which is in the 
same class of drugs as the chlorpromazine used in this study. 20 µg/ml of 
thioridazine caused a decrease in biofilm formation causing S. aureus to form 30% of 
biofilm formed by the no EI control, in our study 32 µg/ml of chlorpromazine had a 
very similar effect where biofilm formation of S. aureus decreased to around 40%.  
The use of EIs in a clinical setting could be a therapeautic avenue although two of 
the EIs used in this study, CCCP and PAβN, are toxic to humans due to them 
affecting the efflux pumps in human cells. However, chlorpromazine is part of a group 
of drugs called phenothiazines which are already used in medicine as anti-
psychotics, so there is a possibility that these type of drugs could be used 
therapeutically as a classic antimicrobial and ant-biofilm drug either alone or in 
conjunction with an antibiotic. Another use of EIs could be impregnated medical 
biomaterials such as catheters, joint prostheses and pacemakers to prevent the 
formation of biofilms on the surface of these devices which are sources of human 
infection. 
The ability of EIs to repress curli expression is also another line of evidence for the 
mechanism linking efflux and biofilm formation being regulatory and a result of loss of 
efflux function. 
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CHAPTER ELEVEN: 
OVERALL DISCUSSION 
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11 Overall discussion 
11.1 Genetic inactivation of multidrug resistant efflux pumps causes a biofilm 
defect 
The initial findings of this project identified a link between multidrug resistance efflux 
pumps and biofilm formation in Salmonella. This finding was corroborated by 
anothyer study by Kvist et al with E. coli, K. pneumonia, P. putida and S. aureus 
(Kvist et al. 2008). The work in our laboratory showed that genetic inactivation of the 
individual components of the major efflux system of Salmonella, AcrAB-TolC, creates 
a biofilm defect in a simple static crystal violet biofilm assay. The Kvist study showed 
both genetic and chemical inactivation of efflux pumps of a variety of species creates 
a biofilm defect, but did not propose a mechanism for the phenotype observed or 
investigate the input of deletion of multiple pumps per species.  
Further investigation into which MDR efflux pumps are involved in biofilm formation 
highlighted that inactivation of all nine MDR efflux pumps known to be present in 
Salmonella created a biofilm defect to varying degrees. The nine MDR efflux pumps 
in Salmonella belong to four different efflux families; five RND, two MFS, one MATE 
and one ABC. This shows that the biofilm defect we see is not specific to a single 
efflux pump or indeed a single class of efflux pump, no previous consistent phrnotype 
has been attributed to loss of all efflux systems. 
Various biofilm assays were tested and optimised, and the biofilm defect was seen in 
all assays with both static and flowing media. The flow cell biofilm model was 
important as many ‘real-world’ biofilms will form and mature under flow conditions 
both in the environment such as waterways and in human disease such as on 
catheters.  
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11.2 Three different hypotheses were investigated 
Three different hypotheses were formulated; AcrAB-TolC exports a crucial biofilm 
factor, inactivation of AcrAB-TolC impacts upon cell surface hydrophobicity and 
inactivation of components of AcrAB-TolC alters  expression off biofilm related genes 
or proteins. Experiments were chosen and designed to investigate each hypothesis. 
The first hypothesis, that AcrAB-TolC exports a crucial biofilm factor, was tested by 
using various co-incubation assays to assess if presence of the wild-type cells could 
rescue the tolC and acrB mutants’ ability to form a biofilm. Transwell assays, where 
wild-type and mutant cells were separated with a semi-permeable membrane which 
allows solutes through but restricts movement of the cells, showed no rescue of 
either tolC or the acrB mutants. Both wild-type mid-logarithmic phase and stationary 
phase cultures were used as the metabolites excreted can vary depending upon the 
growth phase of the bacteria. Another co-incubation biofilm assay used involves the 
formation of wild-type biofilm mats which grow on the surface of the media and 
enumerating the number of acrB or tolC mutant cells that are incorporated in the 
biofilm mat. Again, this co-incubation assay showed that presence of wild-type cells 
were not able to rescue the ability of the either the tolC or acrB mutants’ to form a 
biofilm. Metabolomics data revealed differences between the accumulated 
metabolomic profile of wild-type cells and the acrB mutant, the biggest difference 
seen is the accumulation of the polyamine, spermidine. Polyamines have previously 
been shown to be an essential metabolite in the formation of biofilms of Yersinia 
pestis (Patel et al. 2006). To assess if lack of export of polyamines prevents the tolC 
or acrB mutants’ ability to biofilm, various concentrations of spermidine, acetyl-
spermidine cadaverine and putrescine were added exogenously to the simple crystal 
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violet biofilm assay. Addition of any of the polyamines did not positively affect either 
mutant’s ability to form a biofilm. If accumulation of polyamines is occurring to toxic 
levels when cells are residing within a biofilm then exogenous addition of polyamines 
would not answer this question. However, you might see that exogenous addition of 
polyamines have a negative effect on wild-type biofilm formation, which is not seen. 
These assays suggest that polyamines are not involved in the link between MDR 
efflux and biofilm formation but these experiments are not definitive. Another piece of 
evidence to suggest that it is not export or accumulation of a specific metabolite is 
that inactivation of all MDR efflux pumps causes the same biofilm defect, albeit to 
varying degrees, therefore you would expect the other eight efflux pumps to 
compensate. However, inactivation of each efflux system could cause accumulation 
of a different metabolite causing the same biofilm defect mediated by accumulation of 
different substrates although this seems highly unlikely.  
The second hypothesis investigated whether inactivation of AcrAB-TolC causes a 
change in cell surface hydrophobicity or membrane composition which can affect 
cellular aggregation and therefore could impact upon biofilm formation. Various 
aggregation assays were used to test this hypothesis. The simplest assay used was 
the settle assay which measures the speed at which the cells sink to the bottom of a 
tube, this showed no decrease in the aggregation ability of the tolC or acrB mutants 
but in fact it showed a slight increase in the acrB mutant’s ability to aggregate. 
Another simple assay used various concentrations of ammonium sulphate which 
upon addition of a bacterial suspension causes aggregation observed by the 
presence of a white precipitate. The lower the concentration of ammonium sulphate 
required for a precipitate to form the higher the cell surface hydrophobicity. Again, no 
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decrease in cell surface hydrophobicity was seen for either the tolC or acrB mutant 
however, a slight increase was seen for the tolC mutant. The composition of the 
outer membrane was also investigated by isolating both the lipoploysaccharide and 
outer membrane proteins and visualising on a Bis-Tris gel. No apparent differences 
in the banding pattern of the LPS or OMP preparations were seen in the tolC or acrB 
mutants. None of the assays used highlighted a decrease in cell surface 
hydrophobicity of the cell or change in the composition of the outer membrane.  
The final hypothesis tested was that inactivation of components of the AcrAB-TolC 
efflux system changes expression of biofilm related genes or proteins. To test this 
hypothesis we used phenotypic assays to assess the expression of components of 
the Salmonella extracellular matrix, essential for formation of mature biofilms. 
Cellulose, the polysaccharide used to help adhere cells to each other within a biofilm 
was assessed on agar supplemented with Calcofluor, a dye that binds to cellulose 
and fluoresces. No difference was seen between wild-type and the tolC or acrB 
mutants was seen .This was confirmed by cRT-PCR where expression of the mRNA 
of the four genes responsible for cellulose biosynthesis remained unchanged in both 
mutants. The other extracellular matrix component essential for biofilm formation is a 
proteinaceous filament that protrudes from the outer membrane of the cell called 
curli. Agar supplemented with Congo red, a dye used to stain amyloid fibres (curli 
when assembled on the surface of the outer cell membrane is an amyloid fibre) 
(Romling 2005) revealed that both the tolC and acrB did not display the red, dry and 
rough phenotype indicative of strain expressing curli. cRT-PCR confirmed that the 
repression of curli was occurring at the transcriptional level. All genes in both of the 
curli operons, csgBA and csgDEFG in the tolC and acrB mutant were down regulated 
192 
 
in comparison to wild-type. Congo red agar assays and cRT-PCR of csgB and csgD 
exposed curli repression in the entire panel of efflux mutants strongly suggesting that 
the biofilm defect seen in all mutants is due to absence of this essential 
proteinaceous extracellular matrix component. 
11.3 Artificial overexpression of global regulators of AcrAB-TolC also induces 
a biofilm defect 
A previous study found that increase of marA decreases curli expression and 
subsequent biofilm formation (Guinta 2010). This finding led us to hypothesise that 
upon inactivation of efflux pumps, the up-regulation of global regulators of efflux was 
the reason for curli repression and subsequent biofilm formation. Artificial over-
expression of the global regulators of efflux, marA, ramA and soxS inhibits biofilm 
formation by wild-type S. Typhimurium. The spatial expression of the three global 
regulators visualised using a gfp fusion reporter plasmid also correlates with the 
absence of curli visualised on Congo red agar. Various combinations of all three 
regulator genes in the tolC mutant were inactivated, however, rescue of the tolC 
mutant’s ability to biofilm or express curli was not achieved. These data does not 
discount the hypothesis that regulators are the reason for the efflux mutants biofilm 
defect but does not prove it either. 
11.4 Membrane stress response systems are involved in curli repression of 
the tolC mutant 
To further explore the regulatory mechanism controlling the curli repression of the 
genetically inactivated efflux mutants a transposon mutagenesis screen was 
developed and optimised during this study. Transposon libraries in representative 
mutants of various classes of efflux pumps were created and screened on Congo red 
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agar to expose any candidates with curli expression restored. The tolC mutant library 
was investigated in more detail as the tolC mutant’s biofilm formation was most 
effected and any curli or biofilm rescue would perhaps be more noticeable. It was 
discovered that insertion of the transposon into the membrane bound osmolarity 
sensor envZ restores that ability of the tolC mutant to express curli and form a 
biofilm. The envZ::Tn5 mutation was transduced into all other MDR efflux mutants 
and also back into the tolC mutant to investigate if the same mechanism was 
responsible for the curli repression and biofilm defect. None of the other efflux 
mutants formed a biofilm in the crystal violet biofilm assay.  
The envZ mutation was transduced into a tolC mutant of a different strain of 
S. Typhimurium (SL1344) to see if this curli/biofilm rescue was strain specific. 
However, surprisingly the SL1344 tolC/envZ mutant did not just rescue biofilm 
formation to wild-type levels but greatly beyond that of the parent.  
The EnvZ/OmpR two component system is already known to be a regulator of the 
curli operons (Prigent-Combaret et al. 1999) along with two other two component 
systems, CpxA/CpxR and RcsB/RcsC. All three systems respond to changes in the 
environment including pH, osmolarity and membrane stress (Dorel et al. 1999; 
Huang et al. 2006). This response to environmental or membrane stress makes 
sense because if the cell is sensing stress in the environment it is residing in, it would 
not be conducive to the cell to express curli and form a biofilm. Artificial stressing of 
the membrane using sucrose or increasing the of the pH media also reduced biofilm 
formation of the wild-type again supporting membrane stress as the mechanism. 
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Inactivation of tolC in E. coli has recently been implicated in induction of at least five 
different stress response systems including, BaeRS and CpxARP (Rosner and Martin 
2013). The study suggested that accumulation of a metabolite usually exported via 
efflux systems using TolC as their outer membrane porin is detected by these stress 
response genes. However, the metabolite responsible was not found, although 
accumulation of indole, acetate and ethanol were all ruled out (Rosner and Martin 
2013). As accumulation of polyamines within the cell was not ruled as the cause of 
the biofilm defect in the tolC and acrB mutant, it is possible that the metabolite 
responsible could be one of spermidine, acetyl-spermidine, putrescine or cadaverine. 
However, to investigate this hypothesis mutants lacking genes in the polyamine 
biosynthetic pathways would have to be constructed in the tolC mutant background. 
If this hypothesis were correct these double mutants may gain back the ability to 
express curli and form a competent biofilm.   
11.5 Efflux inhibitors cause an anti-biofilm effect in various species 
In addition to genetic inactivation of efflux creating a biofilm defect, chemical efflux 
inhibition using various efflux inhibitor molecules also induces the same defect. Three 
different efflux inhibitors were incubated with wild-type S. Typhimurium at various 
concentrations in a simple crystal violet biofilm assay. PAβN, a competitive inhibitor 
of RND efflux pumps, CCCP, a proton motive force de-coupler, and chlorpromazine 
which down regulates the expression of MDR efflux pumps. All three induced a dose 
dependent biofilm defect in the wild-type strain. This biofilm inhibition was observed 
well below the MIC values for each EI suggesting the inhibition is anti-biofilm in 
nature and that the EIs are not acting as generic antimicrobials. CCCP seems to 
have the biggest effect causing a significant decrease in biofilm formation as low as 1 
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µg/ml which would make sense as CCCP would inactivate eight out of the nine MDR 
efflux pumps, all with the exception of the ABC pump, MacABC, which uses ATP as 
its energy source. PAβN is the next effective EI with the dose dependent effect 
starting at 32 µg/ml, this EI would inhibit up to five of the nine efflux pumps as there 
are five RND MDR pumps known in S. Typhimurium. Chlorpromazine is the least 
effective with the dose dependent effect starting at 64 µg/ml, chlorpromazine is 
thought to act as a transcriptional repressor which would affect just acrAB-tolC. 
Comparitive RT-PCR of csgB, the major structural curli subunit and csgD, the master 
curli regulator, revealed that the reason for the biofilm defect of wild-type S. 
Typhimurium upon addition of PAβN is the down regulation of curli genes. This data 
again suggests that accumulation of a metabolite could be responsible for the curli 
repression seen in the efflux mutants as chemical inhibition of efflux leaves efflux 
pumps in situ but inhibits export of substrates. 
As biofilms are a major clinical problem that are a hugely antibiotic resistant, novel 
anti-biofilm agents are desperately needed. Biofilms are a problem both as a source 
of infection within the body such as P. aeruginosa and B. cepacia (Govan and 
Deretic 1996) in the lungs of cystic fibrosis patients and on medical biomaterials such 
as S. aureus on catheters (Zimmerman et al. 1988), cannulae (Thomas and Morris 
2005) and hip joint prostheses (Lebeaux and Ghigo 2013). Both CCCP and PAβN, as 
with the majority of EIs, are toxic to human cells due to all cells including human cells 
containing efflux pumps. Toxic EIs would be dangerous if administered systemically 
however, chlorpromazine is one of a group of molecules called phenothiazines that 
are already used in human medicine as anti-psychotic drugs. Non-toxic EIs could be 
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used alone or in conjunction with standard antimicrobials to increase the efficacy as 
the antimicrobial will no longer be exported from the cell and will be able to work 
more effectively. EIs could possibly be used to coat medical biomaterials to prevent 
biofilms forming on their surface and subsequently prevent human infections. 
Other species found to be susceptible to efflux inhibitors when forming a biofilm in 
the Kvist study were E. coli, K. pneumonia, P. putida and S. aureus (Kvist et al. 
2008). A variety of other species were also tested in this project including S. aureus, 
E. coli and P. aeruginosa. All three species’ ability to form a biofilm in both flow and 
static models were affected by exogenous addition of all three EIs tested (CCCP, 
PAβN and CPZ) to varying degrees. These data shows that the link between efflux 
and biofilm formation is not specific to Salmonella but seems to be a generic 
phenomenon effecting both Gram negative and Gram positive bacteria. The 
mechanism causing the biofilm defect in each species is unknown, although the 
genes encoding curli are seen throughout various bacterial species however curli is 
not an essential biofilm component in all bacteria (Dueholm et al. 2013). 
11.6 Overall conclusions and future work 
Multidrug resistance efflux and biofilm formation in Salmonella and a variety of other 
species is definitely co-regulated. Both genetic and chemical inactivation of efflux 
pumps, as well as artificial over expression of the pumps results in repression of the 
curli operons and a subsequent biofilm defect. For the tolC mutant the mechanism by 
which curli repression is occurring seems to be via a membrane stress response, 
already known to be responsible for curli regulation. However, whilst EnvZ 
inactivation rescued biofilm formation in the tolC mutant, inactivation of OmpR did 
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not. Further investigation into this mechanism would help develop understanding of 
how and why the bacteria down-regulate biofilm genes when under membrane 
stress. I would liked to have sequenced the genome of the tolC rescue mutant 
obtained from the transposon screen to ensure all mutations were known, as envZ 
does not seem solely responsible for curli and biofilm rescue. The obvious 
explanation is that upon inactivation of the pump the cell accumulates a metabolite 
which is sensed by a stress response gene. If the cell senses that the membrane is 
under stress, it would not be favourable for the bacteria to form a biofilm under those 
conditions.  
A possible clinical application of this project is the use of chemical efflux inhibitors as 
anti-biofilm agents, either administered systemically with or without an antibiotic or 
impregnated into medical biomaterials. Although we know that addition of EIs prevent 
biofilms forming, future work could elucidate if EIs can disrupt already established 
mature biofilms. This information could again have a clinical application for 
disinfection of surfaces or tissues on which biofilms have already formed. 
  
198 
 
Publications associated with this study 
Baugh S., Ekanayaka A.S., Piddock L.J.V. and Webber M.A. (2012) Loss of or 
inhibition of all multidrug resistance efflux pumps of Salmonella enterica serovar 
Typhimurium results in impaired ability to form a biofilm. J Antimicrob Chemother. 
2012 Oct;67(10):2409-17. 
Baugh S, Phillips C.R., Ekanayaka A.S., Piddock L.J.V., Webber M.A. (2013) 
Inhibition of multidrug efflux as a strategy to prevent biofilm formation. J Antimicrob 
Chemother. [In Press]. 
Hanulík V, Chromá M, Webber MA, Uvízl R, Whitehead RN, Baugh S, Htoutou 
Sedláková M, Kolář M. (2012) Detection of Burkholderia cepacia complex strains in 
the University Hospital Olomouc. Klin Mikrobiol Infekc Lek. 2012 Feb;18(1):4-8. 
Hanulik V., Webber M.A., Chroma M, Uvizl R., Holy O., Whitehead R.N., Baugh S., 
Matouskova I., Kolar M. (2013) An outbreak of Burkholderia multivorans beyond 
cystic fibrosis patients. J Hosp Infect. 2013 Jul;84(3):248-51.  
Baugh S. and Piddock L.J.V. (2013) Efflux pumps of Salmonella. In Yu E.W., Zhang 
Q., Brown M.H. (1), Microbial Efflux Pumps: Current Research (pp. 163-173). Norfolk, 
UK: Caister Academic Press (Book Chapter). 
  
199 
 
Poster presentations at international conferences 
Baugh S., Ekanayaka A.S., Piddock L.J.V. and Webber M.A. Chemical Inhibition of 
Multidrug Resistance Efflux Abolishes Biofilm Formation by Salmonella enterica 
serovar Typhimurium. 52nd ICAAC, San Francisco, 2012, poster number C1-674. 
Baugh S., Piddock L.J.V. and Webber M.A. The contribution of AcrAB-TolC to biofilm 
formation in Salmonella enterica serovar Typhimurium. 462nd WE Heraeus Seminar, 
Bremen, 2010.  
Poster presentations at national conferences 
Baugh S., Ekanayaka A.S., Piddock L.J.V. and Webber M.A. Co-ordinated regulation 
of multidrug efflux pumps and biofilm formation in Salmonella Typhimurium involves 
curli biosynthesis and membrane stress SGM, Manchester, 2013. 
Baugh S., Piddock L.J.V. and Webber M.A.  New approaches to targeting bacterial 
infection: Blocking biofilm formation. SET for BRITAIN, London, 2012.  
Baugh S., Ekanayaka A.S., Piddock L.J.V. and Webber M.A. Co-ordinated regulation 
of multidrug efflux pumps and biofilm formation in Salmonella Typhimurium involves 
curli biosynthesis and membrane stress. SfAM Summer Conference, Edinburgh, 
2012 
Baugh S., Piddock L.J.V. and Webber M.A. Inactivation of efflux pumps inhibits 
biofilm formation of S. Typhimurium as a result of curli repression. 5th BSAC, ARM, 
Birmingham, 2011. 
  
200 
 
Oral presentations at international conferences 
Baugh S., Ekanayaka A.S., Piddock L.J.V. and Webber M.A. Multidrug resistance 
efflux pumps are required for curli expression and biofilm formation in Salmonella. 
22nd ECCMID, London, 2012. 
Baugh S., Piddock L.J.V. and Webber M.A.  Control of multidrug efflux pumps and 
biofilm formation in Salmonella. 21st ECCMID, Milan, 2011. 
Oral presentations at national conferences 
Baugh S., Piddock L.J.V. and Webber M.A. Control of multidrug efflux pumps and 
biofilm formation in Salmonella. SfAM Summer Conference, Dublin, 2011. 
Baugh S., Piddock L.J.V. and Webber M.A.  Control of multidrug efflux pumps and 
biofilm formation in Salmonella. Microbiology Symposium, University of Birmingham, 
2011. 
 
201 
 
References 
 
Achtman, M., J. Wain, F. X. Weill, S. Nair, Z. Zhou, V. Sangal, M. G. Krauland, J. L. 
Hale, H. Harbottle, A. Uesbeck, G. Dougan, L. H. Harrison and S. Brisse 
(2012). "Multilocus Sequence Typing as a Replacement for Serotyping in 
Salmonella enterica." PLoS Pathog 8(6): e1002776. 
Adams, J. L. and R. J. McLean (1999). "Impact of rpoS deletion on Escherichia coli 
biofilms." Appl Environ Microbiol 65(9): 4285-7. 
Aires, J. R. and H. Nikaido (2005). "Aminoglycosides are captured from both 
periplasm and cytoplasm by the AcrD multidrug efflux transporter of 
Escherichia coli." J Bacteriol 187(6): 1923-9. 
Amar, S. and X. Han (2003). "The impact of periodontal infection on systemic 
diseases." Med Sci Monit 9(12): RA291-9. 
An, D. and M. R. Parsek (2007). "The promise and peril of transcriptional profiling in 
biofilm communities." Curr Opin Microbiol 10(3): 292-6. 
Andrews, J. M. (2007). "BSAC standardized disc susceptibility testing method 
(version 6)." J Antimicrob Chemother 60(1): 20-41. 
Anon (1999). "Microbiological safety evaluations and recommendations on sprouted 
seeds. National Advisory Committee on Microbiological Criteria for Foods." Int 
J Food Microbiol 52(3): 123-53. 
Anon (2010) "Multistate outbreak of human Salmonella Typhimurium infections 
associated with aquatic frogs - United States, 2009." MMWR Morb Mortal 
Wkly Rep Volume, 1433-6 DOI:  
Archer, G. L. (1978). "Antimicrobial susceptibility and selection of resistance among 
Staphylococcus Epidermidis isolates recovered from patients with infections of 
indwelling foreign devices." Antimicrob Agents Chemother 14(3): 353-9. 
Archer, N. K., M. J. Mazaitis, J. W. Costerton, J. G. Leid, M. E. Powers and M. E. 
Shirtliff (2011). "Staphylococcus aureus biofilms: properties, regulation, and 
roles in human disease." Virulence 2(5): 445-59. 
Bae, J. W., S. K. Rhee, J. R. Park, B. C. Kim and Y. H. Park (2005). "Isolation of 
uncultivated anaerobic thermophiles from compost by supplementing cell 
extract of Geobacillus toebii in enrichment culture medium." Extremophiles 
9(6): 477-85. 
Bailey, A. M., A. Ivens, R. Kingsley, J. L. Cottell, J. Wain and L. J. Piddock (2010). 
"RamA, a member of the AraC/XylS family, influences both virulence and 
efflux in Salmonella enterica serovar Typhimurium." J Bacteriol 192(6): 1607-
16. 
Bailey, A. M., I. T. Paulsen and L. J. Piddock (2008). "RamA confers multidrug 
resistance in Salmonella enterica via increased expression of acrB, which is 
inhibited by chlorpromazine." Antimicrob Agents Chemother 52(10): 3604-11. 
Barnhart, M. M. and M. R. Chapman (2006). "Curli biogenesis and function." Annu 
Rev Microbiol 60: 131-47. 
202 
 
Barrios, A. F., R. Zuo, D. Ren and T. K. Wood (2006). "Hha, YbaJ, and OmpA 
regulate Escherichia coli K12 biofilm formation and conjugation plasmids 
abolish motility." Biotechnol Bioeng 93(1): 188-200. 
Batchelor, E., D. Walthers, L. J. Kenney and M. Goulian (2005). "The Escherichia coli 
CpxA-CpxR envelope stress response system regulates expression of the 
porins ompF and ompC." J Bacteriol 187(16): 5723-31. 
Baucheron, S., S. Tyler, D. Boyd, M. R. Mulvey, E. Chaslus-Dancla and A. 
Cloeckaert (2004). "AcrAB-TolC Directs Efflux-Mediated Multidrug Resistance 
in Salmonella enterica serovar Typhimurium DT104." Antimicrobial Agents and 
Chemotherapy 48(10): 3729-3735. 
Baugh, S., A. S. Ekanayaka, L. J. Piddock and M. A. Webber (2012). "Loss of or 
inhibition of all multidrug resistance efflux pumps of Salmonella enterica 
serovar Typhimurium results in impaired ability to form a biofilm." J Antimicrob 
Chemother. 
Baugh, S., C. R. Phillips, A. S. Ekanayaka, L. J. Piddock and M. A. Webber (2013). 
"Inhibition of multidrug efflux as a strategy to prevent biofilm formation." J 
Antimicrob Chemother: [In Press]. 
Beenken, K. E., P. M. Dunman, F. McAleese, D. Macapagal, E. Murphy, S. J. Projan, 
J. S. Blevins and M. S. Smeltzer (2004). "Global gene expression in 
Staphylococcus aureus biofilms." J Bacteriol 186(14): 4665-84. 
Bender, J. W. and W. T. Hughes (1980). "Fatal Staphylococcus epidermidis sepsis 
following bone marrow transplantation." Johns Hopkins Med J 146(1): 13-5. 
Benoit, M. R., C. G. Conant, C. Ionescu-Zanetti, M. Schwartz and A. Matin (2010). 
"New device for high-throughput viability screening of flow biofilms." Appl 
Environ Microbiol 76(13): 4136-42. 
Bhutta, Z. A. (2006). "Current concepts in the diagnosis and treatment of typhoid 
fever." Bmj 333(7558): 78-82. 
Blair, J. M., R. M. La Ragione, M. J. Woodward and L. J. Piddock (2009). 
"Periplasmic adaptor protein AcrA has a distinct role in the antibiotic 
resistance and virulence of Salmonella enterica serovar Typhimurium." J 
Antimicrob Chemother 64(5): 965-72. 
Blair, J. M. and L. J. Piddock (2009). "Structure, function and inhibition of RND efflux 
pumps in Gram-negative bacteria: an update." Curr Opin Microbiol 12(5): 512-
9. 
Blouse, L. E., G. D. Lathrop, L. N. Kolonel and R. M. Brockett (1978). "Epidemiologic 
features and phage types associated with nosocomial infections caused by 
Staphylococcus epidermidis." Zentralbl Bakteriol Orig A 241(1): 119-35. 
Bouige, P., D. Laurent, L. Piloyan and E. Dassa (2002). "Phylogenetic and functional 
classification of ATP-binding cassette (ABC) systems." Curr Protein Pept Sci 
3(5): 541-59. 
Boyen, F., F. Haesebrouck, D. Maes, F. Van Immerseel, R. Ducatelle and F. 
Pasmans (2008). "Non-typhoidal Salmonella infections in pigs: A closer look at 
epidemiology, pathogenesis and control." Veterinary Microbiology 130(1-2): 1-
19. 
Bradford, M. M. (1976). "A rapid and sensitive method for the quantitation of 
microgram quantities of protein utilizing the principle of protein-dye binding." 
Anal Biochem 72: 248-54. 
203 
 
Branda, S. S., A. Vik, L. Friedman and R. Kolter (2005). "Biofilms: the matrix 
revisited." Trends in Microbiology 13(1): 20-26. 
Brenner, F. W., R. G. Villar, F. J. Angulo, R. Tauxe and B. Swaminathan (2000). 
"Salmonella nomenclature." J Clin Microbiol 38(7): 2465-7. 
Brombacher, E., A. Baratto, C. Dorel and P. Landini (2006). "Gene expression 
regulation by the Curli activator CsgD protein: modulation of cellulose 
biosynthesis and control of negative determinants for microbial adhesion." J 
Bacteriol 188(6): 2027-37. 
Brown, P. K., C. M. Dozois, C. A. Nickerson, A. Zuppardo, J. Terlonge and R. 
Curtiss, 3rd (2001). "MlrA, a novel regulator of curli (AgF) and extracellular 
matrix synthesis by Escherichia coli and Salmonella enterica serovar 
Typhimurium." Mol Microbiol 41(2): 349-63. 
Buchholz, U., H. Bernard, D. Werber, M. M. Bohmer, C. Remschmidt, H. Wilking, Y. 
Delere, M. an der Heiden, C. Adlhoch, J. Dreesman, J. Ehlers, S. Ethelberg, 
M. Faber, C. Frank, G. Fricke, M. Greiner, M. Hohle, S. Ivarsson, U. Jark, M. 
Kirchner, J. Koch, G. Krause, P. Luber, B. Rosner, K. Stark and M. Kuhne 
(2011). "German outbreak of Escherichia coli O104:H4 associated with 
sprouts." N Engl J Med 365(19): 1763-70. 
Buckley, A. M., M. A. Webber, S. Cooles, L. P. Randall, R. M. La Ragione, M. J. 
Woodward and L. J. Piddock (2006). "The AcrAB-TolC efflux system of 
Salmonella enterica serovar Typhimurium plays a role in pathogenesis." Cell 
Microbiol 8(5): 847-56. 
Bumann, D. and R. H. Valdivia (2007). "Identification of host-induced pathogen 
genes by differential fluorescence induction reporter systems." Nat Protoc 
2(4): 770-7. 
Burse, A., H. Weingart and M. S. Ullrich (2004). "The phytoalexin-inducible multidrug 
efflux pump AcrAB contributes to virulence in the fire blight pathogen, Erwinia 
amylovora." Mol Plant Microbe Interact 17(1): 43-54. 
Cabeza, M. L., A. Aguirre, F. C. Soncini and E. G. Vescovi (2007). "Induction of 
RpoS degradation by the two-component system regulator RstA in Salmonella 
enterica." J Bacteriol 189(20): 7335-42. 
Cai, S. J. and M. Inouye (2002). "EnvZ-OmpR interaction and osmoregulation in 
Escherichia coli." J Biol Chem 277(27): 24155-61. 
Callaghan, J. C., J. P. Despres and R. Benvenuto (1961). "A study of the causes of 
60 deaths following total cardiopulmonary bypass." J Thorac Cardiovasc Surg 
42: 489-96. 
Chan, W., N. Costantino, R. Li, S. C. Lee, Q. Su, D. Melvin, D. L. Court and P. Liu 
(2007). "A recombineering based approach for high-throughput conditional 
knockout targeting vector construction." Nucleic Acids Res 35(8): e64. 
Cherepanov, P. P. and W. Wackernagel (1995). "Gene disruption in Escherichia coli: 
TcR and KmR cassettes with the option of Flp-catalyzed excision of the 
antibiotic-resistance determinant." Gene 158(1): 9-14. 
Chubiz, L. M. and C. V. Rao (2011). "Role of the mar-sox-rob regulon in regulating 
outer membrane porin expression." J Bacteriol 193(9): 2252-60. 
Cogan, T. A., F. Jorgensen, H. M. Lappin-Scott, C. E. Benson, M. J. Woodward and 
T. J. Humphrey (2004). "Flagella and curli fimbriae are important for the 
growth of Salmonella enterica serovars in hen eggs." Microbiology 150(Pt 4): 
1063-71. 
204 
 
Collinson, S. K., J. M. Parker, R. S. Hodges and W. W. Kay (1999). "Structural 
predictions of AgfA, the insoluble fimbrial subunit of Salmonella thin 
aggregative fimbriae." J Mol Biol 290(3): 741-56. 
Costerton, J. W. (2001). "Cystic fibrosis pathogenesis and the role of biofilms in 
persistent infection." Trends Microbiol 9(2): 50-2. 
Costerton, J. W., K. J. Cheng, G. G. Geesey, T. I. Ladd, J. C. Nickel, M. Dasgupta 
and T. J. Marrie (1987). "Bacterial Biofilms in Nature and Disease." Ann Rev 
Microbiol 41(1): 435-464. 
Crosa, J. H., D. J. Brenner, W. H. Ewing and S. Falkow (1973). "Molecular 
relationships among the Salmonelleae." J Bacteriol 115(1): 307-15. 
Crump, J. and E. Mintz (2010). "Emerging Infections: Global Trends in Typhoid and 
Paratyphoid Fever." Clin Infect Dis 50(2): 241-246. 
Da Re, S. and J. M. Ghigo (2006). "A CsgD-independent pathway for cellulose 
production and biofilm formation in Escherichia coli." J Bacteriol 188(8): 3073-
87. 
Darby, J. and H. Sheorey (2008). "Searching for Salmonella." Aust Fam Physician 
10(37): 806-810. 
Datsenko, K. A. and B. L. Wanner (2000). "One-step inactivation of chromosomal 
genes in Escherichia coli K-12 using PCR products." Proc Natl Acad Sci U S A 
97(12): 6640-5. 
Dibb-Fuller, M. P., E. Allen-Vercoe, C. J. Thorns and M. J. Woodward (1999). 
"Fimbriae- and flagella-mediated association with and invasion of cultured 
epithelial cells by Salmonella Enteritidis." Microbiology 145 ( Pt 5): 1023-31. 
Diederen, B. M. (2008). "Legionella spp. and Legionnaires' disease." J Infect 56(1): 
1-12. 
Dismukes, W. E., A. W. Karchmer, M. J. Buckley, W. G. Austen and M. N. Swartz 
(1973). "Prosthetic valve endocarditis. Analysis of 38 cases." Circulation 48(2): 
365-77. 
Doller, P. C., K. Dietrich, N. Filipp, S. Brockmann, C. Dreweck, R. Vonthein, C. 
Wagner-Wiening and A. Wiedenmann (2002). "Cyclosporiasis outbreak in 
Germany associated with the consumption of salad." Emerg Infect Dis 8(9): 
992-4. 
Dorel, C., O. Vidal, C. Prigent-Combaret, I. Vallet and P. Lejeune (1999). 
"Involvement of the Cpx signal transduction pathway of E. coli in biofilm 
formation." FEMS Microbiol Lett 178(1): 169-75. 
Dueholm, M. S., M. Albertsen, D. Otzen and P. H. Nielsen (2013). "Curli functional 
amyloid systems are phylogenetically widespread and display large diversity in 
operon and protein structure." PLoS One 7(12): e51274. 
Dutta, P., M. R. Saha, U. Mitra, R. Rasaily, S. K. Bhattacharya, M. K. Bhattacharya, 
B. Kundu and A. Gupta (1995). "Treatment of severe Salmonella Typhimurium 
infection with ciprofloxacin." Indian Pediatr 32(7): 804-7. 
Dutta, U., P. K. Garg, R. Kumar and R. K. Tandon (2000). "Typhoid carriers among 
patients with gallstones are at increased risk for carcinoma of the gallbladder." 
Am J Gastroenterol 95(3): 784-7. 
Eaves, D. J., V. Ricci and L. J. Piddock (2004). "Expression of acrB, acrF, acrD, 
marA, and soxS in Salmonella enterica serovar Typhimurium: role in multiple 
antibiotic resistance." Antimicrob Agents Chemother 48(4): 1145-50. 
205 
 
Effa, E. E., Z. S. Lassi, J. A. Critchley, P. Garner, D. Sinclair, P. L. Olliaro and Z. A. 
Bhutta (2011). "Fluoroquinolones for treating typhoid and paratyphoid fever 
(enteric fever)." Cochrane Database Syst Rev(10): CD004530. 
Elkins, C. A. and H. Nikaido (2002). "Substrate specificity of the RND-type multidrug 
efflux pumps AcrB and AcrD of Escherichia coli is determined predominantly 
by two large periplasmic loops." J Bacteriol 184(23): 6490-8. 
Fatica, M. K. and K. R. Schneider (2011). "Salmonella and produce: survival in the 
plant environment and implications in food safety." Virulence 2(6): 573-9. 
Fookes, M., G. N. Schroeder, G. C. Langridge, C. J. Blondel, C. Mammina, T. R. 
Connor, H. Seth-Smith, G. S. Vernikos, K. S. Robinson, M. Sanders, N. K. 
Petty, R. A. Kingsley, A. J. Baumler, S. P. Nuccio, I. Contreras, C. A. 
Santiviago, D. Maskell, P. Barrow, T. Humphrey, A. Nastasi, M. Roberts, G. 
Frankel, J. Parkhill, G. Dougan and N. R. Thomson (2011). "Salmonella 
bongori provides insights into the evolution of the Salmonellae." PLoS Pathog 
7(8): e1002191. 
Garcia-Contreras, R., X. S. Zhang, Y. Kim and T. K. Wood (2008). "Protein 
translation and cell death: the role of rare tRNAs in biofilm formation and in 
activating dormant phage killer genes." PLoS One 3(6): e2394. 
Garcia, B., C. Latasa, C. Solano, F. Garcia-del Portillo, C. Gamazo and I. Lasa 
(2004). "Role of the GGDEF protein family in Salmonella cellulose 
biosynthesis and biofilm formation." Mol Microbiol 54(1): 264-77. 
Gast, R. K., J. Guard-Bouldin and P. S. Holt (2005). "The relationship between the 
duration of fecal shedding and the production of contaminated eggs by laying 
hens infected with strains of Salmonella Enteritidis and Salmonella 
Heidelberg." Avian Dis 49(3): 382-6. 
Geipel, U. (2009). "Pathogenic organisms in hip joint infections." Int J Med Sci 6(5): 
234-40. 
George, J. R., L. Pine, M. W. Reeves and W. K. Harrell (1980). "Amino acid 
requirements of Legionella pneumophila." J Clin Microbiol 11(3): 286-91. 
Gerstel, U. and U. Romling (2003). "The csgD promoter, a control unit for biofilm 
formation in Salmonella Typhimurium." Res Microbiol 154(10): 659-67. 
Gomez, M. I. and A. Prince (2007). "Opportunistic infections in lung disease: 
Pseudomonas infections in cystic fibrosis." Curr Opin Pharmacol 7(3): 244-51. 
Gophna, U., M. Barlev, R. Seijffers, T. A. Oelschlager, J. Hacker and E. Z. Ron 
(2001). Curli fibers mediate internalization of Escherichia coli by eukaryotic 
cells. 69: 2659 - 2665. 
Govan, J. R. and V. Deretic (1996). "Microbial pathogenesis in cystic fibrosis: mucoid 
Pseudomonas aeruginosa and Burkholderia cepacia." Microbiol Rev 60(3): 
539-74. 
Grantcharova, N., V. Peters, C. Monteiro, K. Zakikhany and U. Romling (2009). 
"Bistable expression of CsgD in biofilm development of Salmonella enterica 
serovar typhimurium." J Bacteriol 192(2): 456-66. 
Greub, G. and D. Raoult (2004). "Microorganisms resistant to free-living amoebae." 
Clin Microbiol Rev 17(2): 413-33. 
Grund, S. and A. Weber (1988). "A new type of fimbriae on Salmonella typhimurium." 
Zentralbl Veterinarmed B 35(10): 779-82. 
206 
 
Grundmann, H., M. Aires-de-Sousa, J. Boyce and E. Tiemersma (2006). "Emergence 
and resurgence of methicillin-resistant Staphylococcus aureus as a public-
health threat." Lancet 368(9538): 874-85. 
Guinta, A. R. (2010). New Approaches for Controlling Biofilm Formation. Graduate 
School of Biomedical Sciences. New Brunswick, The State University of New 
Jersey. Master of Science: 44. 
Hall-Stoodley, L., J. W. Costerton and P. Stoodley (2004). "Bacterial biofilms: from 
the Natural environment to infectious diseases." Nat Rev Micro 2(2): 95-108. 
Hamilton, S., R. J. Bongaerts, F. Mulholland, B. Cochrane, J. Porter, S. Lucchini, H. 
M. Lappin-Scott and J. C. Hinton (2009). "The transcriptional programme of 
Salmonella enterica serovar Typhimurium reveals a key role for tryptophan 
metabolism in biofilms." BMC Genomics 10: 599. 
Hammar, M., A. Arnqvist, Z. Bian, A. Olsen and S. Normark (1995). "Expression of 
two csg operons is required for production of fibronectin- and Congo red-
binding curli polymers in Escherichia coli K-12." Mol Microbiol 18(4): 661-70. 
Hardy, A. (2004). "Salmonella: a continuing problem." Clin Infect Dis 80(947): 541-
545. 
Harish, B. N. and G. A. Menezes (2011). "Antimicrobial resistance in typhoidal 
salmonellae." Indian J Med Microbiol 29(3): 223-9. 
Helms, M., J. Simonsen and K. r. MÃ¸lbak (2004). "Quinolone Resistance Is 
Associated with Increased Risk of Invasive Illness or Death during Infection 
with Salmonella serotype Typhimurium." J Infect Dis 190(9): 1652-1654. 
Herwaldt, B. L. (2000). "Cyclospora cayetanensis: a review, focusing on the 
outbreaks of cyclosporiasis in the 1990s." Clin Infect Dis 31(4): 1040-57. 
Herwaldt, B. L. and M. L. Ackers (1997). "An outbreak in 1996 of cyclosporiasis 
associated with imported raspberries. The Cyclospora Working Group." N Engl 
J Med 336(22): 1548-56. 
Hirakata, Y., A. Kondo, K. Hoshino, H. Yano, K. Arai, A. Hirotani, H. Kunishima, N. 
Yamamoto, M. Hatta, M. Kitagawa, S. Kohno and M. Kaku (2009). "Efflux 
pump inhibitors reduce the invasiveness of Pseudomonas aeruginosa." Int J 
Antimicrob Agents 34(4): 343-6. 
Hirakata, Y., R. Srikumar, K. Poole, N. Gotoh, T. Suematsu, S. Kohno, S. Kamihira, 
R. E. Hancock and D. P. Speert (2002). "Multidrug efflux systems play an 
important role in the invasiveness of Pseudomonas aeruginosa." J Exp Med 
196(1): 109-18. 
Hirakawa, H., K. Nishino, T. Hirata and A. Yamaguchi (2003). "Comprehensive 
studies of drug resistance mediated by overexpression of response regulators 
of two-component signal transduction systems in Escherichia coli." J Bacteriol 
185(6): 1851-6. 
Hirakawa, H., A. Takumi-Kobayashi, U. Theisen, T. Hirata, K. Nishino and A. 
Yamaguchi (2008). "AcrS/EnvR represses expression of the acrAB multidrug 
efflux genes in Escherichia coli." J Bacteriol 190(18): 6276-9. 
Høiby, N., B. Frederiksen and T. Pressler (2005). "Eradication of early Pseudomonas 
aeruginosa infection." Journal of Cystic Fibrosis 4(2): 49-54. 
Holmqvist, E., J. Reimegard, M. Sterk, N. Grantcharova, U. Romling and E. G. 
Wagner (2010). "Two antisense RNAs target the transcriptional regulator 
CsgD to inhibit curli synthesis." Embo J 29(11): 1840-50. 
207 
 
Horiyama, T., A. Yamaguchi and K. Nishino (2010). "TolC dependency of multidrug 
efflux systems in Salmonella enterica serovar Typhimurium." J Antimicrob 
Chemother 65(7): 1372-6. 
http://woundsinternational.wordpress.com/ "Wounds International Website." 
http://www.emedicine.com "E medicine website." 
http://www.emedicine.com (2010). "E medicine website." 
http://www.enter.net (2008). "Enter-Net website." 
http://www.food.gov.uk. "Food standards agency website." 
http://www.hpa.org.uk. "Health Protection Agency Website." 
http://www.hpa.org.uk. (2010). "Health Protection Agency Website." 
http://www.who.int (2010). "World Health Organisation Website." 
Huang, C. J., Z. C. Wang, H. Y. Huang, H. D. Huang and H. L. Peng (2013). "YjcC, a 
c-di-GMP Phosphodiesterase Protein, Regulates the Oxidative Stress 
Response and Virulence of Klebsiella pneumoniae CG43." PLoS One 8(7): 
e66740. 
Huang, Y. H., L. Ferrieres and D. J. Clarke (2006). "The role of the Rcs phosphorelay 
in Enterobacteriaceae." Res Microbiol 157(3): 206-12. 
Itoh, Y., Y. Sugita-Konishi, F. Kasuga, M. Iwaki, Y. Hara-Kudo, N. Saito, Y. Noguchi, 
H. Konuma and S. Kumagai (1998). "Enterohemorrhagic Escherichia coli 
O157:H7 present in radish sprouts." Appl Environ Microbiol 64(4): 1532-5. 
Jackson, D. W., K. Suzuki, L. Oakford, J. W. Simecka, M. E. Hart and T. Romeo 
(2002). "Biofilm formation and dispersal under the influence of the global 
regulator CsrA of Escherichia coli." J Bacteriol 184(1): 290-301. 
Jacques, I., J. Derelle, M. Weber and M. Vidailhet (1998). "Pulmonary evolution of 
cystic fibrosis patients colonized by Pseudomonas aeruginosa and/or 
Burkholderia cepacia." Eur J Pediatr 157(5): 427-31. 
Janssens, J. C., H. Steenackers, S. Robijns, E. Gellens, J. Levin, H. Zhao, K. 
Hermans, D. De Coster, T. L. Verhoeven, K. Marchal, J. Vanderleyden, D. E. 
De Vos and S. C. De Keersmaecker (2008). "Brominated furanones inhibit 
biofilm formation by Salmonella enterica serovar Typhimurium." Appl Environ 
Microbiol 74(21): 6639-48. 
Jarvik, T., C. Smillie, E. A. Groisman and H. Ochman (2010). "Short-term signatures 
of evolutionary change in the Salmonella enterica serovar typhimurium 14028 
genome." J Bacteriol 192(2): 560-7. 
Jerse, A. E., N. D. Sharma, A. N. Simms, E. T. Crow, L. A. Snyder and W. M. Shafer 
(2003). "A gonococcal efflux pump system enhances bacterial survival in a 
female mouse model of genital tract infection." Infect Immun 71(10): 5576-82. 
Jonas, K., H. Tomenius, A. Kader, S. Normark, U. Romling, L. M. Belova and O. 
Melefors (2007). "Roles of curli, cellulose and BapA in Salmonella biofilm 
morphology studied by atomic force microscopy." BMC Microbiol 7: 70. 
Joo, H. S. and M. Otto (2012). "Molecular basis of in vivo biofilm formation by 
bacterial pathogens." Chem Biol 19(12): 1503-13. 
Jubelin, G., A. Vianney, C. Beloin, J. M. Ghigo, J. C. Lazzaroni, P. Lejeune and C. 
Dorel (2005). "CpxR/OmpR interplay regulates curli gene expression in 
response to osmolarity in Escherichia coli." J Bacteriol 187(6): 2038-49. 
Kader, A., R. Simm, U. Gerstel, M. Morr and U. Romling (2006). "Hierarchical 
involvement of various GGDEF domain proteins in rdar morphotype 
208 
 
development of Salmonella enterica serovar Typhimurium." Mol Microbiol 
60(3): 602-16. 
Kalia, N. P., P. Mahajan, R. Mehra, A. Nargotra, J. P. Sharma, S. Koul and I. A. Khan 
(2012). "Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the 
intracellular invasion of Staphylococcus aureus." J Antimicrob Chemother. 
Kamer, A. R., R. G. Craig, A. P. Dasanayake, M. Brys, L. Glodzik-Sobanska and M. 
J. de Leon (2008). "Inflammation and Alzheimer's disease: possible role of 
periodontal diseases." Alzheimers Dement 4(4): 242-50. 
Kamer, A. R., A. P. Dasanayake, R. G. Craig, L. Glodzik-Sobanska, M. Bry and M. J. 
de Leon (2008). "Alzheimer's disease and peripheral infections: the possible 
contribution from periodontal infections, model and hypothesis." J Alzheimers 
Dis 13(4): 437-49. 
Karatan, E., T. R. Duncan and P. I. Watnick (2005). "NspS, a predicted polyamine 
sensor, mediates activation of Vibrio cholerae biofilm formation by 
norspermidine." J Bacteriol 187(21): 7434-43. 
Karlyshev, A. V., M. J. Pallen and B. W. Wren (2000). "Single-primer PCR procedure 
for rapid identification of transposon insertion sites." Biotechniques 28(6): 
1078, 1080, 1082. 
Kauffmann, F. (1966). "[On the history of Salmonella research]." Zentralbl Bakteriol 
Orig 201(1): 44-8. 
Kim, J. J., H. N. Kim, R. Masui, S. Kuramitsu, J. H. Seo, K. Kim and M. H. Sung 
(2008). "Isolation of uncultivable anaerobic thermophiles of the family 
Clostridiaceae requiring growth-supporting factors." J Microbiol Biotechnol 
18(4): 611-5. 
Kim, S. H. and C. I. Wei (2009). "Molecular characterization of biofilm formation and 
attachment of Salmonella enterica serovar Typhimurium DT104 on food 
contact surfaces." J Food Prot 72(9): 1841-7. 
Kobayashi, K., N. Tsukagoshi and R. Aono (2001). "Suppression of hypersensitivity 
of Escherichia coli acrB mutant to organic solvents by integrational activation 
of the acrEF operon with the IS1 or IS2 element." J Bacteriol 183(8): 2646-53. 
Kobayashi, N., K. Nishino and A. Yamaguchi (2001). "Novel macrolide-specific ABC-
type efflux transporter in Escherichia coli." J Bacteriol 183(19): 5639-44. 
Korber, D. R., A. Choi, G. M. Wolfaardt, S. C. Ingham and D. E. Caldwell (1997). 
"Substratum topography influences susceptibility of Salmonella Enteritidis 
biofilms to trisodium phosphate." Appl Environ Microbiol 63(9): 3352-8. 
Koronakis, V., J. Eswaran and C. Hughes (2004). "Structure and function of TolC: the 
bacterial exit duct for proteins and drugs." Annu Rev Biochem 73: 467-89. 
Kumar, S., S. Kumar and S. Kumar (2006). "Infection as a risk factor for gallbladder 
cancer." J Surg Oncol 93(8): 633-9. 
Kuo, L. C., A. M. Polson and T. Kang (2008). "Associations between periodontal 
diseases and systemic diseases: a review of the inter-relationships and 
interactions with diabetes, respiratory diseases, cardiovascular diseases and 
osteoporosis." Public Health 122(4): 417-33. 
Kvist, M., V. Hancock and P. Klemm (2008). "Inactivation of efflux pumps abolishes 
bacterial biofilm formation." Appl Environ Microbiol 74(23): 7376-82. 
Lai, C. W., R. C. Chan, A. F. Cheng, J. Y. Sung and J. W. Leung (1992). "Common 
bile duct stones: a cause of chronic salmonellosis." Am J Gastroenterol 87(9): 
1198-9. 
209 
 
Lamm, S. H., A. Taylor, Jr., E. J. Gangarosa, H. W. Anderson, W. Young, M. H. Clark 
and A. R. Bruce (1972). "Turtle-associated salmonellosis. An estimation of the 
magnitude of the problem in the United States, 1970-1971." Am J Epidemiol 
95(6): 511-7. 
Latasa, C., B. Garcia, M. Echeverz, A. Toledo-Arana, J. Valle, S. Campoy, F. Garcia-
del Portillo, C. Solano and I. Lasa (2012). "Salmonella biofilm development 
depends on the phosphorylation status of RcsB." J Bacteriol 194(14): 3708-22. 
Latasa, C., A. Roux, A. Toledo-Arana, J. M. Ghigo, C. Gamazo, J. R. Penades and I. 
Lasa (2005). "BapA, a large secreted protein required for biofilm formation and 
host colonization of Salmonella enterica serovar Enteritidis." Mol Microbiol 
58(5): 1322-39. 
Lawler, A. J., V. Ricci, S. J. Busby and L. J. Piddock (2013). "Genetic inactivation of 
acrAB or inhibition of efflux induces expression of ramA." J Antimicrob 
Chemother 68(7): 1551-7. 
Lazazzera, B. A. (2005). "Lessons from DNA microarray analysis: the gene 
expression profile of biofilms." Curr Opin Microbiol 8(2): 222-7. 
Le Minor, L., M. Veron and M. Popoff (1982). "[A proposal for Salmonella 
nomenclature]." Ann Microbiol (Paris) 133(2): 245-54. 
Le Minor, L., M. Veron and M. Popoff (1982). "[The taxonomy of Salmonella]." Ann 
Microbiol (Paris) 133(2): 223-43. 
Lebeaux, D. and J. M. Ghigo (2013). "[Management of biofilm-associated infections: 
what can we expect from recent research on biofilm lifestyles?]." Med Sci 
(Paris) 28(8-9): 727-39. 
Ledeboer, N. A. and B. D. Jones (2005). "Exopolysaccharide sugars contribute to 
biofilm formation by Salmonella enterica serovar typhimurium on HEp-2 cells 
and chicken intestinal epithelium." J Bacteriol 187(9): 3214-26. 
Lee, J., T. Maeda, S. H. Hong and T. K. Wood (2009). "Reconfiguring the quorum-
sensing regulator SdiA of Escherichia coli to control biofilm formation via 
indole and N-acylhomoserine lactones." Appl Environ Microbiol 75(6): 1703-
16. 
Lee, J., V. Sperandio, D. E. Frantz, J. Longgood, A. Camilli, M. A. Phillips and A. J. 
Michael (2009). "An alternative polyamine biosynthetic pathway is widespread 
in bacteria and essential for biofilm formation in Vibrio cholerae." J Biol Chem 
284(15): 9899-907. 
Lee, S. C. and P. Liu (2009). "Construction of gene-targeting vectors by 
recombineering." Cold Spring Harb Protoc 2009(9): pdb prot5291. 
Lewis, K. (2007). "Persister cells, dormancy and infectious disease." Nat. Rev. 
Microbiol. 5(1): 48-56. 
Lin, J. and A. Martinez (2006). "Effect of efflux pump inhibitors on bile resistance and 
in vivo colonization of Campylobacter jejuni." J Antimicrob Chemother 58(5): 
966-72. 
Lin, T. Y., C. H. Chiu, P. Y. Lin, M. H. Wang, L. H. Su and T. Y. Lin (2003). "Short-
term ceftriaxone therapy for treatment of severe non-typhoidal Salmonella 
enterocolitis." Acta Paediatr 92(5): 537-40. 
Ljungh, A. and T. Wadstrom (1982). "Salt aggregation test for measuring cell surface 
hydrophobicity of urinary Escherichia coli." Eur J Clin Microbiol 1(6): 388-93. 
Lomovskaya, O., M. S. Warren, A. Lee, J. Galazzo, R. Fronko, M. Lee, J. Blais, D. 
Cho, S. Chamberland, T. Renau, R. Leger, S. Hecker, W. Watkins, K. 
210 
 
Hoshino, H. Ishida and V. J. Lee (2001). "Identification and characterization of 
inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: 
novel agents for combination therapy." Antimicrob Agents Chemother 45(1): 
105-16. 
Lopez, A. S., D. R. Dodson, M. J. Arrowood, P. A. Orlandi Jr, A. J. da Silva, J. W. 
Bier, S. D. Hanauer, R. L. Kuster, S. Oltman, M. S. Baldwin, K. Y. Won, E. M. 
Nace, M. L. Eberhard and B. L. Herwaldt (2001). "Outbreak of cyclosporiasis 
associated with basil in Missouri in 1999." Clin Infect Dis 32(7): 1010-7. 
Lovegrove, J. M. (2004). "Dental plaque revisited: bacteria associated with 
periodontal disease." J N Z Soc Periodontol(87): 7-21. 
Lucey, B., C. Feurer, P. Greer, P. Moloney, B. Cryan and S. Fanning (2000). 
"Antimicrobial resistance profiling and DNA Amplification Fingerprinting (DAF) 
of thermophilic Campylobacter spp. in human, poultry and porcine samples 
from the Cork region of Ireland." J Appl Microbiol 89(5): 727-34. 
Lyczak, J. B., C. L. Cannon and G. B. Pier (2002). "Lung infections associated with 
cystic fibrosis." Clin Microbiol Rev 15(2): 194-222. 
Ma, D., M. Alberti, C. Lynch, H. Nikaido and J. E. Hearst (1996). "The local repressor 
AcrR plays a modulating role in the regulation of acrAB genes of Escherichia 
coli by global stress signals." Mol Microbiol 19(1): 101-12. 
Ma, D., D. N. Cook, M. Alberti, N. G. Pon, H. Nikaido and J. E. Hearst (1995). "Genes 
acrA and acrB encode a stress-induced efflux system of Escherichia coli." Mol 
Microbiol 16(1): 45-55. 
Mandell GL, Bennett JE and D. R. (2005). Douglas and Bennett’s principles and 
practice of infectious diseases. Pennsylvania, Elsevier, Churchill Livingstone. 
Marsh, P. D. (2003). "Plaque as a biofilm: pharmacological principles of drug delivery 
and action in the sub- and supragingival environment." Oral Dis 9 Suppl 1: 16-
22. 
Martin, R. G. and J. L. Rosner (2002). "Genomics of the marA/soxS/rob regulon of 
Escherichia coli: identification of directly activated promoters by application of 
molecular genetics and informatics to microarray data." Mol Microbiol 44(6): 
1611-24. 
Mathura, K., D. Gurubacharya, A. Shrestha, S. Pant, P. Basnet and D. Karki (2003). 
"Clinical profile of typhoid patients." Kathmandu Univ Med J 2(1): 135-137. 
Matsui, H., V. E. Wagner, D. B. Hill, U. E. Schwab, T. D. Rogers, B. Button, R. M. 
Taylor, 2nd, R. Superfine, M. Rubinstein, B. H. Iglewski and R. C. Boucher 
(2006). "A physical linkage between cystic fibrosis airway surface dehydration 
and Pseudomonas aeruginosa biofilms." Proc Natl Acad Sci U S A 103(48): 
18131-6. 
Mattila, K. J., P. J. Pussinen and S. Paju (2005). "Dental Infections and 
Cardiovascular Diseases: A Review." J Periodontol 76(11-s): 2085-2088. 
McKenney, D., K. E. Brown and D. G. Allison (1995). "Influence of Pseudomonas 
aeruginosa exoproducts on virulence factor production in Burkholderia 
cepacia: evidence of interspecies communication." J Bacteriol 177(23): 6989-
92. 
Meakins, S., I. S. Fisher, C. Berghold, P. Gerner-Smidt, H. Tschape, M. Cormican, I. 
Luzzi, F. Schneider, W. Wannett, J. Coia, A. Echeita and E. J. Threlfall (2008). 
"Antimicrobial drug resistance in human nontyphoidal Salmonella isolates in 
211 
 
Europe 2000-2004: a report from the Enter-net International Surveillance 
Network." Microb Drug Resist 14(1): 31-5. 
Mika, F. and R. Hengge (2013). "Small Regulatory RNAs in the Control of Motility 
and Biofilm Formation in E. coli and Salmonella." Int J Mol Sci 14(3): 4560-79. 
Mochmann, H. and W. Kohler (1989). "[The discovery of bacterial agglutinins and 
origin of serodiagnosis--a priority battle from the history of medical 
microbiology. 2: Biographical sketches of the contenders Max v. Gruber (1853-
1927), Richard Pfeiffer (1858-1945), Herbert Edward Durham (1869-1921) 
and Fernand Widal (1862-1929)]." Z Arztl Fortbild (Jena) 83(21): 1085-90. 
Moller, S., C. Sternberg, J. B. Andersen, B. B. Christensen, J. L. Ramos, M. Givskov 
and S. Molin (1998). "In situ gene expression in mixed-culture biofilms: 
evidence of metabolic interactions between community members." Appl 
Environ Microbiol 64(2): 721-32. 
Monteiro, C., X. Fang, I. Ahmad, M. Gomelsky and U. Romling (2011). "Regulation of 
biofilm components in Salmonella enterica serovar Typhimurium by lytic 
transglycosylases involved in cell wall turnover." J Bacteriol 193(23): 6443-51. 
Mourino, M., C. Madrid, C. Balsalobre, A. Prenafeta, F. Munoa, J. Blanco, M. Blanco, 
J. E. Blanco and A. Juarez (1996). "The Hha protein as a modulator of 
expression of virulence factors in Escherichia coli." Infect Immun 64(7): 2881-
4. 
Murakami, S., R. Nakashima, E. Yamashita, T. Matsumoto and A. Yamaguchi (2006). 
"Crystal structures of a multidrug transporter reveal a functionally rotating 
mechanism." Nature 443(7108): 173-9. 
Murakami, S., R. Nakashima, E. Yamashita and A. Yamaguchi (2002). "Crystal 
structure of bacterial multidrug efflux transporter AcrB." Nature 419(6907): 
587-93. 
Nagakubo, S., K. Nishino, T. Hirata and A. Yamaguchi (2002). "The putative 
response regulator BaeR stimulates multidrug resistance of Escherichia coli 
via a novel multidrug exporter system, MdtABC." J Bacteriol 184(15): 4161-7. 
Natrajan, N. and B. W. Sheldon (2000). "Inhibition of Salmonella on poultry skin using 
protein- and polysaccharide-based films containing a nisin formulation." J 
Food Prot 63(9): 1268-72. 
Nichols, D., K. Lewis, J. Orjala, S. Mo, R. Ortenberg, P. O'Connor, C. Zhao, P. 
Vouros, T. Kaeberlein and S. S. Epstein (2008). "Short peptide induces an 
"uncultivable" microorganism to grow in vitro." Appl Environ Microbiol 74(15): 
4889-97. 
Nieto, J. M., C. Madrid, E. Miquelay, J. L. Parra, S. Rodriguez and A. Juarez (2002). 
"Evidence for direct protein-protein interaction between members of the 
enterobacterial Hha/YmoA and H-NS families of proteins." J Bacteriol 184(3): 
629-35. 
Nikaido, E., I. Shirosaka, A. Yamaguchi and K. Nishino (2011). "Regulation of the 
AcrAB multidrug efflux pump in Salmonella enterica serovar Typhimurium in 
response to indole and paraquat." Microbiology 157(Pt 3): 648-55. 
Nikaido, E., A. Yamaguchi and K. Nishino (2008). "AcrAB multidrug efflux pump 
regulation in Salmonella enterica serovar Typhimurium by RamA in response 
to environmental signals." J Biol Chem 283(35): 24245-53. 
Nikaido, H. (1996). "Multidrug efflux pumps of gram-negative bacteria." J Bacteriol 
178(20): 5853-9. 
212 
 
Nikaido, H. and Y. Takatsuka (2009). "Mechanisms of RND multidrug efflux pumps." 
Biochim Biophys Acta 1794(5): 769-81. 
Nishino, K., T. Latifi and E. A. Groisman (2006). "Virulence and drug resistance roles 
of multidrug efflux systems of Salmonella enterica serovar Typhimurium." Mol 
Microbiol 59(1): 126-41. 
Nishino, K., E. Nikaido and A. Yamaguchi (2007). "Regulation of multidrug efflux 
systems involved in multidrug and metal resistance of Salmonella enterica 
serovar Typhimurium." J Bacteriol 189(24): 9066-75. 
Nishino, K., E. Nikaido and A. Yamaguchi (2009). "Regulation and physiological 
function of multidrug efflux pumps in Escherichia coli and Salmonella." 
Biochim Biophys Acta 1794(5): 834-43. 
Nishino, K., J. Yamada, H. Hirakawa, T. Hirata and A. Yamaguchi (2003). "Roles of 
TolC-dependent multidrug transporters of Escherichia coli in resistance to 
beta-lactams." Antimicrob Agents Chemother 47(9): 3030-3. 
Nishino, K. and A. Yamaguchi (2002). "EvgA of the two-component signal 
transduction system modulates production of the yhiUV multidrug transporter 
in Escherichia coli." J Bacteriol 184(8): 2319-23. 
Offenbacher, S., V. Katz, G. Fertik, J. Collins, D. Boyd, G. Maynor, R. McKaig and J. 
Beck (1996). "Periodontal infection as a possible risk factor for preterm low 
birth weight." J Periodontol 67(10 Suppl): 1103-13. 
Ogasawara, H., K. Yamada, A. Kori, K. Yamamoto and A. Ishihama (2010). 
"Regulation of the Escherichia coli csgD promoter: interplay between five 
transcription factors." Microbiology 156(Pt 8): 2470-83. 
Padmanabhan, R. A. and T. G. Fraser (2005). "The emergence of methicillin-
resistant Staphylococcus aureus in the community." Cleve Clin J Med 72(3): 
235-41. 
Pages, J. M., M. Masi and J. Barbe (2005). "Inhibitors of efflux pumps in Gram-
negative bacteria." Trends Mol Med 11(8): 382-9. 
Parkinson, J. S. (2003). "Bacterial chemotaxis: a new player in response regulator 
dephosphorylation." J Bacteriol 185(5): 1492-4. 
Patel, C. N., B. W. Wortham, J. L. Lines, J. D. Fetherston, R. D. Perry and M. A. 
Oliveira (2006). "Polyamines are essential for the formation of plague biofilm." 
J Bacteriol 188(7): 2355-63. 
Patterson, F. P. and C. S. Brown (1972). "The McKee-Farrar total hip replacement. 
Preliminary results and complications of 368 operations performed in five 
general hospitals." J Bone Joint Surg Am 54(2): 257-75. 
Paulsen, I. T., M. H. Brown and R. A. Skurray (1996). "Proton-dependent multidrug 
efflux systems." Microbiol Rev 60(4): 575-608. 
Pedersen, K., A. M. Lassen-Nielsen, S. Nordentoft and A. S. Hammer (2009). 
"Serovars of Salmonella from captive reptiles." Zoonoses Public Health 56(5): 
238-242. 
Peel, T. N., K. L. Buising and P. F. Choong (2012). "Diagnosis and management of 
prosthetic joint infection." Curr Opin Infect Dis 25(6): 670-6. 
Pesci, E. C., J. B. Milbank, J. P. Pearson, S. McKnight, A. S. Kende, E. P. Greenberg 
and B. H. Iglewski (1999). "Quinolone signaling in the cell-to-cell 
communication system of Pseudomonas aeruginosa." Proc Natl Acad Sci U S 
A 96(20): 11229-34. 
213 
 
Petrova, O. E. and K. Sauer (2012). "Sticky situations: key components that control 
bacterial surface attachment." J Bacteriol 194(10): 2413-25. 
Piddock, L. J. (2006). "Clinically relevant chromosomally encoded multidrug 
resistance efflux pumps in bacteria." Clin Microbiol Rev 19(2): 382-402. 
Piddock, L. J. (2006). "Multidrug-resistance efflux pumps - not just for resistance." 
Nat Rev Microbiol 4(8): 629-36. 
Prigent-Combaret, C., O. Vidal, C. Dorel and P. Lejeune (1999). "Abiotic surface 
sensing and biofilm-dependent regulation of gene expression in Escherichia 
coli." J Bacteriol 181(19): 5993-6002. 
Reacher, M. H., A. Shah, D. M. Livermore, M. C. Wale, C. Graham, A. P. Johnson, H. 
Heine, M. A. Monnickendam, K. F. Barker, D. James and R. C. George (2000). 
"Bacteraemia and antibiotic resistance of its pathogens reported in England 
and Wales between 1990 and 1998: trend analysis." Bmj 320(7229): 213-6. 
Rello, J., A. Ochagavia, E. Sabanes, M. Roque, D. Mariscal, E. Reynaga and J. 
Valles (2000). "Evaluation of outcome of intravenous catheter-related 
infections in critically ill patients." Am J Respir Crit Care Med 162(3 Pt 1): 
1027-30. 
Ren, Q. and I. T. Paulsen (2007). "Large-scale comparative genomic analyses of 
cytoplasmic membrane transport systems in prokaryotes." J Mol Microbiol 
Biotechnol 12(3-4): 165-79. 
Robbe-Saule, V., V. Jaumouille, M. C. Prevost, S. Guadagnini, C. Talhouarne, H. 
Mathout, A. Kolb and F. Norel (2006). "Crl activates transcription initiation of 
RpoS-regulated genes involved in the multicellular behavior of Salmonella 
enterica serovar Typhimurium." J Bacteriol 188(11): 3983-94. 
Robinson, L. S., E. M. Ashman, S. J. Hultgren and M. R. Chapman (2006). 
"Secretion of curli fibre subunits is mediated by the outer membrane-localized 
CsgG protein." Mol Microbiol 59(3): 870-81. 
Rogers, J., A. B. Dowsett, P. J. Dennis, J. V. Lee and C. W. Keevil (1994). "Influence 
of temperature and plumbing material selection on biofilm formation and 
growth of Legionella pneumophila in a model potable water system containing 
complex microbial flora." Appl Environ Microbiol 60(5): 1585-92. 
Romling, U. (2005). "Characterization of the rdar morphotype, a multicellular 
behaviour in Enterobacteriaceae." Cell Mol Life Sci 62(11): 1234-46. 
Romling, U. and C. Balsalobre (2012). "Biofilm infections, their resilience to therapy 
and innovative treatment strategies." J Intern Med 272(6): 541-61. 
Romling, U. and M. Rohde (1999). "Flagella modulate the multicellular behavior of 
Salmonella Typhimurium on the community level." FEMS Microbiol Lett 
180(1): 91-102. 
Romling, U., M. Rohde, A. Olsen, S. Normark and J. Reinkoster (2000). "AgfD, the 
checkpoint of multicellular and aggregative behaviour in Salmonella 
Typhimurium regulates at least two independent pathways." Mol Microbiol 
36(1): 10-23. 
Rosner, J. L. and R. G. Martin (2013). "Reduction of cellular stress by TolC-
dependent efflux pumps in Escherichia coli indicated by BaeSR and CpxARP 
activation of spy in efflux mutants." J Bacteriol 195(5): 1042-50. 
Rouf, S. F., I. Ahmad, N. Anwar, S. K. Vodnala, A. Kader, U. Romling and M. Rhen 
(2011). "Opposing contributions of polynucleotide phosphorylase and the 
214 
 
membrane protein NlpI to biofilm formation by Salmonella enterica serovar 
Typhimurium." J Bacteriol 193(2): 580-2. 
Saier, M. H., Jr., J. T. Beatty, A. Goffeau, K. T. Harley, W. H. Heijne, S. C. Huang, D. 
L. Jack, P. S. Jahn, K. Lew, J. Liu, S. S. Pao, I. T. Paulsen, T. T. Tseng and P. 
S. Virk (1999). "The major facilitator superfamily." J Mol Microbiol Biotechnol 
1(2): 257-79. 
Saiman, L., G. Cacalano and A. Prince (1990). "Pseudomonas cepacia adherence to 
respiratory epithelial cells is enhanced by Pseudomonas aeruginosa." Infect 
Immun 58(8): 2578-84. 
Salmon, D. E. (1885). "The Virus of Hog Cholera." Public Health Pap Rep 11: 73-7. 
Salmon, D. E. (1886). "Recent Progress in Investigation of Hog Cholera." Public 
Health Pap Rep 12: 38-40. 
Santos, A. C., J. A. Roberts, A. J. Cook, R. Simons, R. Sheehan, C. Lane, G. K. 
Adak, F. A. Clifton-Hadley and L. C. Rodrigues (2010). "Salmonella 
Typhimurium and Salmonella Enteritidis in England: costs to patients, their 
families, and primary and community health services of the NHS." Epidemiol 
Infect 139(5): 742-53. 
Savage, A., K. A. Eaton, D. R. Moles and I. Needleman (2009). "A systematic review 
of definitions of periodontitis and methods that have been used to identify this 
disease." J Clin Periodontol 36(6): 458-467. 
Schembri, M. A., K. Kjaergaard and P. Klemm (2003). "Global gene expression in 
Escherichia coli biofilms." Mol Microbiol 48(1): 253-67. 
Schoenbaum, S. C., P. Gardner and J. Shillito (1975). "Infections of cerebrospinal 
fluid shunts: epidemiology, clinical manifestations, and therapy." J Infect Dis 
131(5): 543-52. 
Schoolnik, G. K., M. I. Voskuil, D. Schnappinger, F. H. Yildiz, K. Meibom, N. A. 
Dolganov, M. A. Wilson and K. H. Chong (2001). "Whole genome DNA 
microarray expression analysis of biofilm development by Vibrio cholerae O1 
E1 Tor." Methods Enzymol 336: 3-18. 
Simm, R., A. Lusch, A. Kader, M. Andersson and U. Romling (2007). "Role of EAL-
containing proteins in multicellular behavior of Salmonella enterica serovar 
Typhimurium." J Bacteriol 189(9): 3613-23. 
Sinnott, C. R. and A. J. Teall (1987). "Persistent gallbladder carriage of Salmonella 
Typhi." Lancet 1(8539): 976. 
Siryaporn, A. and M. Goulian (2008). "Cross-talk suppression between the CpxA-
CpxR and EnvZ-OmpR two-component systems in E. coli." Mol Microbiol 
70(2): 494-506. 
Solano, C., B. Garcia, J. Valle, C. Berasain, J. M. Ghigo, C. Gamazo and I. Lasa 
(2002). "Genetic analysis of Salmonella Enteritidis biofilm formation: critical 
role of cellulose." Mol Microbiol 43(3): 793-808. 
Sommerfeldt, N., A. Possling, G. Becker, C. Pesavento, N. Tschowri and R. Hengge 
(2009). "Gene expression patterns and differential input into curli fimbriae 
regulation of all GGDEF/EAL domain proteins in Escherichia coli." 
Microbiology 155(Pt 4): 1318-31. 
Stevens, M. P., T. J. Humphrey and D. J. Maskell (2009). "Molecular insights into 
farm animal and zoonotic Salmonella infections." Philos Trans R Soc Lond B 
Biol Sci 364(1530): 2709-23. 
215 
 
Stoodley, P., K. Sauer, D. Davies and J. Costerton (2002). "Biofilms as complex 
differentiated communities." Annu. Rev. Microbiol. 56: 187-209. 
Sukupolvi, S., R. G. Lorenz, J. I. Gordon, Z. Bian, J. D. Pfeifer, S. J. Normark and M. 
Rhen (1997). "Expression of thin aggregative fimbriae promotes interaction of 
Salmonella Typhimurium SR-11 with mouse small intestinal epithelial cells." 
Infect Immun 65(12): 5320-5. 
Tagliabue, L., A. Maciag, D. Antoniani and P. Landini (2010). "The yddV-dos operon 
controls biofilm formation through the regulation of genes encoding curli fibers' 
subunits in aerobically growing Escherichia coli." FEMS Immunol Med 
Microbiol 59(3): 477-84. 
Tanaka, Y., S. Hanada, A. Manome, T. Tsuchida, R. Kurane, K. Nakamura and Y. 
Kamagata (2004). "Catellibacterium nectariphilum gen. nov., sp. nov., which 
requires a diffusible compound from a strain related to the genus 
Sphingomonas for vigorous growth." Int J Syst Evol Microbiol 54(Pt 3): 955-9. 
Tauxe, R. V. (1997). "Emerging foodborne diseases: an evolving public health 
challenge." Emerg Infect Dis 3(4): 425-34. 
Thomas, M. G. and A. J. Morris (2005). "Cannula-associated Staphylococcus aureus 
bacteraemia: outcome in relation to treatment." Intern Med J 35(6): 319-30. 
Tikhonova, E. B., V. K. Devroy, S. Y. Lau and H. I. Zgurskaya (2007). "Reconstitution 
of the Escherichia coli macrolide transporter: the periplasmic membrane fusion 
protein MacA stimulates the ATPase activity of MacB." Mol Microbiol 63(3): 
895-910. 
Tindall, B. J., P. A. Grimont, G. M. Garrity and J. P. Euzeby (2005). "Nomenclature 
and taxonomy of the genus Salmonella." Int J Syst Evol Microbiol 55(Pt 1): 
521-4. 
Tomlin, K. L., O. P. Coll and H. Ceri (2001). "Interspecies biofilms of Pseudomonas 
aeruginosa and Burkholderia cepacia." Can J Microbiol 47(10): 949-54. 
Troxell, B., M. L. Sikes, R. C. Fink, A. Vazquez-Torres, J. Jones-Carson and H. M. 
Hassan (2007). "Fur negatively regulates hns and is required for the 
expression of HilA and virulence in Salmonella enterica serovar Typhimurium." 
J Bacteriol 193(2): 497-505. 
Vaishnavi, C., S. Singh, R. Kochhar, D. Bhasin, G. Singh and K. Singh (2005). 
"Prevalence of Salmonella enterica serovar Typhi in bile and stool of patients 
with biliary diseases and those requiring biliary drainage for other purposes." 
Jpn J Infect Dis 58(6): 363-5. 
Valdezate, S., M. Arroyo, R. Gonzalez-Sanz, R. Ramiro, S. Herrera-Leon, M. Usera, 
D. l. Fuente and A. Echeita (2007). "Antimicrobial Resistance and Phage and 
Molecular Typing of Salmonella strains isolated from food for human 
consumption in Spain." J. Food Prot. 70(12): 2741-8. 
van der Straaten, T., L. Zulianello, A. van Diepen, D. L. Granger, R. Janssen and J. 
T. van Dissel (2004). "Salmonella enterica serovar Typhimurium RamA, 
intracellular oxidative stress response, and bacterial virulence." Infect Immun 
72(2): 996-1003. 
van Velkinburgh, J. C. and J. S. Gunn (1999). "PhoP-PhoQ-regulated loci are 
required for enhanced bile resistance in Salmonella spp." Infect Immun 67(4): 
1614-22. 
Vartoukian, S. R., R. M. Palmer and W. G. Wade (2010). "Strategies for culture of 
'unculturable' bacteria." FEMS Microbiol Lett. 
216 
 
Veldman, A., H. A. Vahl, G. J. Borggreve and D. C. Fuller (1995). "A survey of the 
incidence of Salmonella species and Enterobacteriaceae in poultry feeds and 
feed components." Vet Rec 136(7): 169-72. 
Vestby, L. K., T. Moretro, S. Langsrud, E. Heir and L. L. Nesse (2009). "Biofilm 
forming abilities of Salmonella are correlated with persistence in fish meal- and 
feed factories." BMC Vet Res 5: 20. 
Vidal, O., R. Longin, C. Prigent-Combaret, C. Dorel, M. Hooreman and P. Lejeune 
(1998). "Isolation of an Escherichia coli K-12 mutant strain able to form 
biofilms on inert surfaces: involvement of a new ompR allele that increases 
curli expression." J Bacteriol 180(9): 2442-9. 
von Eiff, C., B. Jansen, W. Kohnen and K. Becker (2005). "Infections associated with 
medical devices: pathogenesis, management and prophylaxis." Drugs 65(2): 
179-214. 
Wang, R. F. and S. R. Kushner (1991). "Construction of versatile low-copy-number 
vectors for cloning, sequencing and gene expression in Escherichia coli." 
Gene 100: 195-9. 
Watnick, P. and R. Kolter (2000). Biofilm, City of Microbes. 182: 2675-2679. 
Watts, A., E. M. Crimmins and M. Gatz (2008). "Inflammation as a potential mediator 
for the association between periodontal disease and Alzheimer's disease." 
Neuropsychiatr Dis Treat 4(5): 865-76. 
Webber, M. A., A. M. Bailey, J. M. Blair, E. Morgan, M. P. Stevens, J. C. Hinton, A. 
Ivens, J. Wain and L. J. Piddock (2009). "The global consequence of 
disruption of the AcrAB-TolC efflux pump in Salmonella enterica includes 
reduced expression of SPI-1 and other attributes required to infect the host." J 
Bacteriol 191(13): 4276-85. 
White, A. P., S. K. Collinson, P. A. Banser, D. L. Gibson, M. Paetzel, N. C. Strynadka 
and W. W. Kay (2001). "Structure and characterization of AgfB from 
Salmonella Enteritidis thin aggregative fimbriae." J Mol Biol 311(4): 735-49. 
White, A. P., D. L. Gibson, S. K. Collinson, P. A. Banser and W. W. Kay (2003). 
"Extracellular polysaccharides associated with thin aggregative fimbriae of 
Salmonella enterica serovar Enteritidis." J Bacteriol 185(18): 5398-407. 
Whiteley, M., M. G. Bangera, R. E. Bumgarner, M. R. Parsek, G. M. Teitzel, S. Lory 
and E. P. Greenberg (2001). "Gene expression in Pseudomonas aeruginosa 
biofilms." Nature 413(6858): 860-4. 
Wilson, P. D., Jr. (1977). "What's new in surgery: orthopaedic surgery." Bull Am Coll 
Surg 62(1): 28-32. 
Wood, J. M. (1999). "Osmosensing by bacteria: signals and membrane-based 
sensors." Microbiol Mol Biol Rev 63(1): 230-62. 
Yu, V. L. (2002). "Legionella surveillance: political and social implications--a little 
knowledge is a dangerous thing." J Infect Dis 185(2): 259-61. 
Zimmerman, S. W., M. O'Brien, F. A. Wiedenhoeft and C. A. Johnson (1988). 
Staphylococcus aureus Peritoneal Catheter-Related Infections: A Cause of 
Catheter Loss and Peritonitis. 8: 191-194. 
Zobell, C. E. (1943). "The Effect of Solid Surfaces upon Bacterial Activity." J Bacteriol 
46(1): 39-56. 
Zogaj, X., W. Bokranz, M. Nimtz and U. Romling (2003). Production of cellulose and 
curli fimbriae by members of the family Enterobacteriaceae isolated from the 
human gastrointestinal tract. 71: 4151 - 4158. 
217 
 
Zogaj, X., M. Nimtz, M. Rohde, W. Bokranz and U. Romling (2001). "The multicellular 
morphotypes of Salmonella Typhimurium and Escherichia coli produce 
cellulose as the second component of the extracellular matrix." Mol Microbiol 
39(6): 1452-63. 
 
 
